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Abstract 
Implanted titanium (Ti) devices such as dental implants have been shown to produce 
metallic species within adjacent tissues. The effect of the presence of these species 
within oral epithelial tissues is currently not well characterised or known. This thesis 
investigates the effects of TiO2 nanoparticles (TiO2 NPs) at a range of concentrations on 
oral epithelial cells in the context of cell viability, cellular functions and interactions via 
a variety of methods. A co-culture model was established, and the difficulties of using 
a nano-scale insoluble stimulus were explored, and high content screening techniques 
were shown to be potentially more appropriate methods than conventional assays in 
this context. Interactions between TiO2 NPs and oral epithelial cells were imaged and 
investigated using a variety of imaging techniques. Oral epithelial cells were shown to 
take up TiO2 NPs within vacuole type structures. Cell viability appeared to not be 
affected at lower concentrations. Gene expression changes of oral epithelial cells in 
response to TiO2 NPs in the presence and absence of pathogenic bacteria were 
investigated. Cytokines important in cell-cell signalling were shown to bind TiO2 NPs, 
therefore creating potential for TiO2 NPs within tissues to modify immune responses 
within tissues adjacent to implanted Ti devices. 
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1.1         The use of Titanium as a biomaterial 
1.1.1              Physical properties and presentation 
Titanium (Ti) is a silver coloured transition metal, with notable characteristics of having 
both a relatively low density (4.507 g/cm3) (Boyer et al., 2004) and a high strength. Its 
atomic number is 22 and its atomic weight is 47.88 (Boyer et al., 2004). Ti exists in an 
elemental (unalloyed) form, structured as hexagonal close packed crystals, known as 
its α phase. This phase is stable up to 882.5°C whereupon it transforms into a body 
centred cubic structure, known as the β phase, up to its melting point at 1668 °C 
(Ratner, 2013).  
Ti and alloys of Ti are popular as biomedical materials due to their favourable physical 
properties, corrosion resistance, and most importantly their perceived 
biocompatibility. Ti in its unalloyed form is described as Commercially Pure (CP), which 
is presented in various “Grades” for biomedical applications, which are discriminated 
by their purity. For many biomedical applications improved mechanical properties than 
those conferred by CPTi are required. To achieve this Ti is alloyed and common alloying 
elements include Aluminium (Al), Vanadium (V), Niobium (Nb), Tantalum (Ta) and 
Zirconium (Zr). CPTi is most commonly used to manufacture dental implants, whilst Ti 
alloys are widely used in dental applications and for the fabrication of orthopaedic 
prostheses. 
1.1.2   Suitability as a biomedical alloy 
Among metals, Ti is often favoured as a biomedical material as it has both a high yield 
strength and possesses an elastic modulus that is closer to that of bone than 
alternatives (Ratner, 2013) (Table 1). Under standard testing conditions Ti exhibits high 
corrosion resistance and possesses suitable strength for it to be used in load bearing 
applications (Bertrand et al., 2010).  
Material CPTi Ti-6Al-4V Ti-35Nb-
5Ta-7Zr 
Stainless 
steel 
Bone 
Elastic Modulus (GPa) 105 110 55 205-210 10-40 
Table 1.1 - Elastic moduli of selected materials (Ratner, 2013) 
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In the orthopaedic context, there is a long and successful history of the use of Ti (Cook 
et al., 1988), mainly in the form of an alloy with Al and V (Ti-6%Al-4%V, wt%) which is 
used in fixation screws, plates, and components of Total Joint Arthroplasties (TJA). 
Other Ti based materials commonly used in orthopaedic surgery include the alloy with 
Al and Nb, Ti6Al7Nb which is incorporated in hip replacement units. (Cadosch et al., 
2009a). One of the desirable features of Ti and its alloys, is the ability to manufacture 
components in a variety of different ways, including casting, drawing, pressing, 
subtractive machining and laser sintering. This flexibility in manufacturing route is 
particular useful to achieve the complex shapes and surface finishes demanded by 
orthopaedic and dental implantable devices (Liu et al., 2004). 
Ti has been described as the most well tolerated metal by the human body (Ratner, 
2013). It is widely accepted that Ti and its alloys are “relatively ‘bioinert’” (Li et al., 
2010, Tschernitschek et al., 2006) and hence Ti is commonly reported as being a 
“biocompatible material”. The term “biocompatibility” is frequently used by both 
medical professionals and laypeople. It has been defined as:  
“the ability of a material to perform with an appropriate host response in a specific 
application” (Donaruma, 1988). 
Importantly this definition can be interpreted according to both the material and the 
context in which it is being used. Therefore, to broadly classify any material as 
biocompatible or not is unwise. However, in many applications, Ti has indeed been 
shown to induce minimal responses from the body in vivo.  
1.1.3   Ti surface stability conferred by a Titanium Oxide surface layer (TiO2) 
Ti itself is a highly reactive metal, and Ti surfaces in physiological environments are 
covered by a thin but resilient oxide layer (TiO2) (Kasemo, 1983). This layer forms 
spontaneously under atmospheric conditions (Branemark et al., 2001) and so any 
interactions described in a biomedical setting between Ti and tissues are actually 
referring to the interaction between the surface oxide layer and the tissue contents. 
The naturally formed surface oxide layer is typically 3-7 nm thick (Wang et al., 2016) 
and has been characterised as consisting mainly of rutile and anatase crystalline forms 
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of TiO2 (Effah et al., 1995) (Figure 1.1). The structure of these two forms is described as 
Ti atoms surrounded octahedrally by six oxygen atoms (Jolivet et al., 2010). 
 
Figure 1.1 - Crystalline structures of Anatase, Brookite and Rutile (Jolivet et al., 2010). 
The physio-chemical behaviour of the TiO2 oxide layer depends on its chemical 
composition and thickness, which are sensitive to the manufacturing conditions and 
post-processing surface treatments (Li et al., 2004). Considerable research into the 
surface treatment of Ti materials has been undertaken, with the aim of optimising 
interactions between biological tissues and the material (Sul et al., 2002, Klokkevold et 
al., 1997, Germanier et al., 2006). It is therefore important to note that this wide range 
of different surface treatments for Ti based biomedical devices will inevitably result in 
differences in surface oxide layer formation and structure. 
1.1.4   Classification of Ti 
Ti can be classified according to different systems. The American Society for Testing 
and Materials (ASTM) has classified 23 Ti ‘Grades’ as biomedical materials (Elias, 2008). 
Of these, CPTi is preferred for the manufacture of dental implants, and is graded 1-4 by 
the ASTM. Grade 1 Ti is the purest and also has the most ductility (ability to deform 
under tensile stress) but has the lowest yield strength (Elias, 2008). However, this is 
typically of less importance in a dental rather than an orthopaedic setting. 
Contrastingly, Grade 4 is the least pure (containing ~1 wt% Fe), has the least ductility 
and highest yield strength (Table 1.2). Grades 2 and 4 are the most common grades of 
CPTi for dental implant manufacture. A summary of the properties of the CPTi grades 
and of the alloy Ti-6Al-4V (also known as ASTM grade 5) is shown in Table 1.2. 
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                                                                  ASTM Grade                                                              Ti6AlV 
Property 1 2 3 4 5 
Yield Strength (MPa) 170 275 380 483 795 
Ultimate Tensile Strength (MPa) 240 345 450 550 860 
Elongation (%) 24 20 18 15 10 
Elastic Modulus (GPa) 103-107 103-107 103-107 103-107 114-120 
Table 1.2 - Physical properties of Ti grades. Reproduced from Elias et al., 2008 
1.2    The use of Ti in dental implants 
1.2.1    History of dental implants 
Early attempts to produce a replacement for missing teeth have been identified as 
long ago as the end of the first or beginning of the second century AD, as reported in a 
Gallo-Roman necropolis in France (Crubzy et al., 1998). Cruzby reported the discovery 
of a wrought iron dental implant in the upper right second premolar of a male, over 
the age of 30. Modern implantology has been developed hugely since its infancy in the 
1940s and 1950s, when a variety of implants were being placed, both to replace whole 
arches as well as individual teeth (Misch, 1999). Implants were being placed 
transosteally (through the bone) and also on top of the bone, beneath the periosteum 
(subperiosteally) as well as the approach which has continued to be developed into 
contemporary implant dentistry,  within the bone (endosteally) (Caswell, 1991). At this 
stage of implant development, a variety of materials were being used which included 
cobalt-chromium-molybdenum (Goldberg and Gershkoff, 1949). Throughout the 1960s 
and 1970s, different designs and materials were placed, including endo-osseous 
“blade” designs made of surgical stainless steel (Linkow and Dorfman, 1991), and 
intramucosal implanted devices to aid the stability of maxillary removable dentures 
(Weiss and Judy, 1974). Problems with these early implant designs were 
unpredictability of soft tissue outcomes, leading to loss or instability of the implanted 
device, as well as infection (Caswell, 1991). 
1.2.2    Osseointegration 
Osseointegration is defined as  
“a direct structural and functional connection between ordered, living bone and the 
surface of a load carrying implant” (Branemark, 1983). 
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Osseointegration was discovered serendipitously by Brånemark, a Swedish 
orthopaedic surgeon in 1952, in a study which was investigating imaging of blood flow 
in the tibias of rabbits. Brånemark observed that Ti chambers which had been placed 
within the bones of rabbits could not be removed at the end of the experiment, 
therefore were assumed to be integrated within the bone itself (Branemark, 1959). 
The applications for orthopaedic and indeed dental implant surgery of this finding 
were noted by a number of groups, and research then focussed on the use of Ti as a 
material to produce dental implants. 
Osseointegration continues to be the subject of a large amount of scientific research, 
and the evidence suggests that Ti has  an excellent capacity to become 
osseointegrated (Brånemark et al., 2001, Albrektsson et al., 1994). The absence of soft 
tissue between an implant surface and living bone has also been used to define 
osseointegration (Carlsson et al., 1986); however the ability to determine the presence 
of soft tissue between the implant and bone is limited in a clinical setting, so the 
definition provided here is likely to be more clinically useful. Histological examination 
of implanted devices is not possible without removing the device, so determination of 
osseointegration in vivo is performed by clinical and radiographic examinations alone. 
Osseointegration occurs via a series of complex events following implant insertion into 
a prepared bone site: 
 Proteins and biomolecules will adsorb to the implant surface from the blood 
(Junker et al., 2009); 
 An inflammatory process occurs, after which the peri-implant blood clot begins 
to be replaced by fibrin, which allows anchorage of bone forming cells to the 
implant surface (Junker et al., 2009); 
 This weak initial bony attachment is strengthened and remodelled over time by 
osteogenic cells, to form an organised bone structure (Junker et al., 2009). 
Early animal studies demonstrated the potential of Ti as a material with the ability to 
osseointegrate (Carlsson et al., 1986), a process shown to rely on a number of factors 
such as stability, sterility and surface finish of Ti implanted devices (Albrektsson et al., 
1994). Implants which failed to osseointegrate have been shown to lack a consistent 
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surface, including variability in the surface oxide layer (Arys et al., 1998). A drive to 
enhance and speed up osseointegration has contributed to the development of 
modern implant systems. 
 
1.2.3    The development of modern “root form” Ti implants 
A series of in vivo studies following Brånemark’s initial discovery of the 
osseointegration potential of Ti (Weiss and Rostoker, 1981), led to the development of 
root form Ti implant geometries. Adell et al., trialled Ti implants in humans over 15 
years  (Adell et al., 1981), with over 2700 fixtures being placed in 410 jaws of 310 
edentulous patients. Within this study, 81 % of maxillary fixtures and 91 % of 
mandibular fixtures were described as being stable during the follow-up period (Adell 
et al., 1981), therefore osseointegrated Ti root form dental implants were established 
as a viable treatment option for restoration of edentulous areas.  
In contemporary dentistry, CPTi is most often used for the manufacture of dental 
implants which are osseointegrated (Albrektsson et al., 1994) and support 
supragingival restorations. Implant retained restorations can be in the form of 
removable or fixed prostheses. Figure 1.2 shows a diagrammatic representation of a 
modern root form dental implant retained single unit restoration.  
  
Figure 1.2 – Illustration highlighting the anatomical differences between a natural tooth and a 
single unit root form implant supported restoration. Diagram from abostonsmile.com (2012). 
The move towards the root form design shown in Figure 1.2 was driven by the need to: 
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 Shorten the osseointegration time (Esposito et al., 2013); 
 Optimise the bone and soft tissue contour surrounding an implant to enhance 
function and aesthetics;  
 Aid oral hygiene maintenance and therefore soft tissue health; 
 Optimise the long term retention of implants.  
Ti root form implants were established as a robust treatment option in the 1980s. 
However, many more variables exist with regard to the design, placement and 
restoration of these implants, so a large body of research has taken place in order to 
continually optimise various aspects of the implant restoration processes. 
Size and number of implants 
The size and number of implants required to adequately restore an edentulous area is 
still unclear, and clinicians tend to select configurations, sizes and locations based on 
traditional prosthodontic practice and their own clinical experience and judgement 
(Lindhe et al., 2008). The size of a “standard” implant is approximately 4-5 mm in 
diameter, and is used for anterior or premolar tooth replacement, while a wider >5 
mm diameter implant may be used for molar tooth replacement. The size of the 
implant is often key to the aesthetic success, as a wide crown narrowing down to a 
small diameter implant may appear aesthetically unacceptable (Lazzara, 1993) and 
impede adequate plaque removal. However, the available bone in both quantity and 
quality in all dimensions may limit implant diameter selection. The amount of bone 
present can be examined radiographically using plain film radiography, through Cone 
Beam Computerised Tomography (CBCT) scans, and clinically using palpation and bone 
mapping. The length of an implant is also a feature that must be determined by the 
clinician, as bone should cover the entire threaded section of the implant, and a longer 
implant will have a higher surface area available for osseointegration (Olate et al., 
2010). Implants should be placed so the transition from the intraoral restoration to the 
implant itself is at a biologically and aesthetically acceptable level when compared 
with any surrounding natural teeth, to avoid an artificial aesthetic result. If insufficient 
bone is present in either a horizontal (buccal-palatal) or vertical dimension, there are a 
number of surgical options to increase the potential implant bearing bone volume: 
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 Bone augmentation using either autogenous bone in either a block or chips 
harvested from a distant site, or the use of bone substitutes (such as BioOss®, a 
granular bovine origin bone substitute). These techniques can be used 
alongside surgery such as sinus lift procedures to further enhance the available 
space for implant placement (Balaji, 2013). 
  Procedures such as distraction osteogenesis, where force is applied across an 
ossifying interface to accelerate the formation of new bone in the site to be 
restored (Vega and Bilbao, 2010).  
Soft tissue quantity and quality 
Treatment planning when restoring a patient’s dentition using dental implants can be 
complex, as many factors need to be taken into account other than the quantity and 
quality of bone available for implant placement. Soft tissue profiles surrounding 
implants will affect not only the aesthetics of a restored dental implant, but also the 
ease of oral hygiene maintenance, as interference from overhanging restoration 
margins will impede patient plaque control. Poor oral hygiene surrounding a dental 
implant is a key risk factor in reducing the long term prognosis of the implant and is 
discussed in Section 1.3.3 (Jepsen et al., 2015, Renvert et al., 2014). The quantity and 
quality of both keratinised and non-keratinised soft tissues in an edentulous area 
should be clinically examined and taken into account during the treatment planning 
process in order to maximise aesthetic and functional outcomes. 
Surface finish of implants 
Over 1300 different implant systems exist with a variety of shapes, dimensions, surface 
materials, thread design, surface topography and surface modification (Junker et al., 
2009). The surface finish, coating and topography of dental implants has been shown 
to affect osseointegration and the eventual “success” of the restoration (Dohan 
Ehrenfest et al., 2010). A positive correlation exists between surface roughness and 
osseointegration (Shalabi et al., 2006) when comparing etched surfaces to polished Ti 
implants. Furthermore, surface wettability and hydrophilicity has been shown to 
promote osseointegration (An et al., 2012). Many contemporary implant 
manufacturers treat the surfaces of implants with different bioactive molecules or 
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bone morphogenetic proteins (Avila et al., 2009) with the aim of increasing the 
likelihood and speed of osseointegration.  
1.2.4   “Success, survival and failure” criteria for dental implants 
Dental implants are a popular, successful and largely predictable way of restoring 
spaces (Klokkevold and Newman, 2000) where teeth have been lost or are congenitally 
absent. According to the American Academy of Implant Dentistry, three million 
Americans have dental implants and that number is increasing every year. “Success” 
rates are difficult to ascertain, as statistics can be used to “prove” a number of 
frequently opposing views. Moreover, much of the published literature focuses on 
small cohorts or describes systems and approaches that may be outdated.  
Implant “success” and “survival” are now more frequently used terms to describe 
implant outcomes (Misch et al., 2008), and were outlined in 2008 at the Pisa 
Consensus Conference of the International Congress of Oral Implantologists: 
Implant quality scale group Clinical conditions 
Success (optimum health): No pain or tenderness upon function, no mobility, <2 mm 
radiographic bone loss from initial surgery, no exudate 
history. 
Satisfactory survival: No pain on function, no mobility, 2-4 mm radiographgic 
bone loss, no exudates history. 
Compromised survival: May have pain on function, no mobility, radiographic bone 
loss >4 mm (less than half the length of implant body), 
probing depth >7 mm, may have exudates history 
Failure (clinical or absolute): Any of the following: pain on function, mobility, radiographic 
bone loss > half length of the implant body, uncontrolled 
exudate, loss of implant. 
Table 1.3 – Implant success scale recreated from Misch et al., 2008. 
Therefore, to define “failure” as simply the loss of an implant is no longer acceptable, 
as a successful implant by this measure could have a variety of problems which 
indicate it is failing, such as bone loss, suppuration and mobility, but if it has not been 
lost completely then it would have been classed as “survival”. For example Roos-
Jansaker et al., demonstrated in a longitudinal observational study of 218 patients (999 
implants) over 9-14 years that implant based survival (defined as implant retention 
only) rates were 95.6 %, however analysis of the same data demonstrated a success 
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rate of 88.5 % (Roos-Jansaker et al., 2006). It is also important to recognise that many 
implants are not examined radiographically on a regular basis with X-rays frequently 
taken only if there is a suspicion of a clinical problem. Therefore, many implants which 
are still symptom free may exhibit bone loss which is otherwise undetected. Another 
important factor when interpreting implant success rates is that many practitioners 
would classify an implant as being “successful” after initial osseointegration has taken 
place, and will not consider problems occurring later in the life of the restoration as a 
“failure”. There is an important biological distinction to be made between immediate 
failure (within 6 months) and failure after osseointegration has occurred. The former 
reflects failed osseointegration and the latter has a distinctly altered pathogenic 
process, referred to as “peri-implantitis”.  
  
1.3   Peri-implant disease 
1.3.1   Definitions of peri-implant diseases 
The presence of peri-implant inflammation potentially causing bone loss is a known 
complication of dental implant rehabilitation (Lindhe and Meyle, 2008). Inflammatory 
conditions involving the peri-implant tissues (referred to collectively as peri-implant 
diseases) can be categorised as: 
 Peri-implant mucositis (reversible inflammation localised to the soft tissues) 
 Peri-implantitis (a more advanced lesion where supporting bone is lost), 
defined as > 1mm bone loss after the first year of installation together with 
bleeding and/or suppuration (Sanz et al., 2012). 
1.3.2   Prevalence of peri-implant diseases 
A recent systematic review and meta-analysis of 9 studies (from 504 screened studies), 
based upon 6283 implants in 1497 patients, with a mean follow up of 5-13 years 
demonstrated a prevalence of peri-implant mucositis of 64% and peri-implantitis of 
almost 20% (Atieh et al., 2013). In this study, the patient was used as the basis of the 
analysis, i.e. how many patients with implants had peri-implantitis present in their 
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mouths, where peri-implantitis was defined as a Probing Depth (PD) > 5 mm and bone 
loss of > 2 mm. 
Mucositis is characterised by bleeding on probing and a clinical appearance of 
reddened, inflamed gingivae adjacent to an implant supported prosthesis in the 
absence of suppuration. Radiographic examination reveals no associated bone loss. 
Peri-implant mucositis is reversible, and can be treated successfully with non-surgical 
debridement and oral hygiene improvement (Renvert et al., 2008). Bone loss 
associated with peri-implantitis usually presents in a circumferential pattern and is 
diagnosed by radiographic or surgical examination, and cannot be reversed by simple 
mechanical debridement (Renvert et al., 2008). 
Many similarities have been drawn between peri-implantitis and periodontitis (defined 
as a chronic inflammatory disease that affects the supporting tissues of the dentition 
(Aisenberg, 1952)). Both are chronic inflammatory diseases caused by an aberrant host 
response to a bacterial challenge. Soft tissue explants from sites exhibiting peri-
implantitis show an inflammatory infiltrate rich in innate immune cells and B cells and 
plasma cells (Berglundh et al., 2004), and are very similar to lesions found in 
periodontal disease (Esposito et al., 1997). However, peri-implant lesions do not 
respond predictably to non-surgical or surgical therapies, and it is claimed that the 
progression of peri-implantitis is similar to the progression of bone loss seen in 
furcation lesions with limited access to maintain oral hygiene (Renvert et al., 2014).  
As both periodontal disease and peri-implantitis appear to have similar aetiologies and 
clinical presentation, it is often assumed that patients who are more at risk from 
periodontal disease will be more at risk from peri-implantitis (Heitz-Mayfield and Lang, 
2010). Genetic factors, tobacco use, poor oral hygiene, poorly controlled glycaemia 
and various other co-morbidities have been shown to be significant risk factors for 
periodontal disease (Heitz-Mayfield, 2005), and are therefore thought to also pose 
similar risks for development of peri-implantitis.  
1.3.3    The pathogenesis of peri-implant disease 
Peri-implant diseases are inflammatory diseases which involve a number of complex 
interactions. The current understanding is that there is not one discrete causative 
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agent, but a pathogenic challenge from polymicrobial agents coupled with an 
abnormal host response produces the inflammation and tissue destruction seen in 
peri-implantitis (Renvert et al., 2014). The key risk factors for peri-implant disease are 
common with those for periodontitis: 
 Poor oral hygiene, leading to an increased bacterial load adhered to the 
implant surface; 
 A history of periodontal disease; 
 Poorly controlled diabetes mellitus; 
 Smoking or other tobacco use (Heitz-Mayfield and Lang, 2010).  
Whenever a new surface is introduced to the oral environment, an opportunity for 
colonisation with a microbial biofilm is presented (Nociti et al., 2001). An implant 
surface is no exception, and these surfaces will become rapidly colonised by bacteria 
(Lindhe et al., 2008). The composition of this biofilm and the host response are 
considered to determine the probability of a peri-implant lesion developing, although 
current understanding is that further modifying factors may play a role in disease 
progression (Levin, 2013).  
1.3.4   The role of, and composition of microflora in the peri-implant milieu 
To date, the majority of research in the field of peri-implantitis has focused on the 
bacterial challenge and the host’s response to the biofilm, as the likely causative 
agents of peri-implant disease. Implant surfaces are colonised by bacteria and at 28 
days post-placement, a complex biofilm has been shown to form on Ti implants in the 
oral environment (Lindhe et al., 2008). Peri-implant soft tissues take several weeks to 
fully mature, and so the early biofilm will be initially in contact with immature 
epithelial tissue. Biofilms are complex ecosystems containing bacteria in an 
extracellular matrix, which can be highly resistant to antimicrobial agents (Donlan, 
2002). The bacterial biofilm is in direct contact with the host tissues, and will illicit an 
immune response. The likely microbial succession on the surface of a dental implant 
(Lindhe et al., 2008) is illustrated in Table 1.4 and is organised into coloured complexes 
according to Socransky’s classification (Socransky et al., 1998). 
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Early colonisers Late colonisers 
Actinomyces: Green complex Yellow / Purple 
complex 
Orange complex Red complex 
A. 
genernscerae 
A. israelii 
A. naeslundii 
 
A. actinomycete-
mcomitans 
C. gingivalis 
C. ochracea 
C. sputigena 
E. corrodens 
 
S. gordonii 
S. intermedius 
S. mitis 
S. oralis 
S. sanguinis 
A. 
odontolyticus 
V. parvula 
C. gracillis 
C. rectus 
C. showae 
E. nodatum 
F. nucleatum ** 
F. periodonticum 
P. micros 
P. intermedia 
T. forsythia 
P. gingivalis ** 
T. denticola 
Table 1.4 – Bacterial colonisation of implant surfaces separated into Socransky’s groupings. 
Starred bacterial species were selected as stimuli for oral epithelial cell responses in this thesis 
(Socransky et al., 1998).  
Where disease is present and implants are failing, the composition of the microflora 
within the implant surface biofilm changes from that in health (Mombelli and Décaillet, 
2011). In (clinically) healthy implants, the biofilm consists of almost exclusively aerobic 
cocci and non-motile rods. In failing implants, a much larger proportion of motile rods, 
spirochaetes and fusiform bacteria are present (Lindhe et al., 2008), indicating that 
these types of anaerobic bacteria are potentially associated with peri-implant disease. 
However, it is also possible that these bacteria are simply more able to colonise an 
area that is chronically inflamed which will have an altered pH, available nutrient 
profile (including iron from haemoglobin) and altered biofilm composition to a healthy 
site. 
A recent study demonstrated that periodontally significant bacteria such as 
Treponema, Prevotella, Campylobacter and Eubacteria are the dominant species in the 
peri-implantitis biofilm. In addition the levels of Treponema, Campylobacter and 
Eubacterium were significantly higher in both peri-implant health and disease than in 
periodontitis (Kumar et al., 2012). Generally, peri-implant samples were also found to 
contain a higher proportion of Gram-negative bacteria than sub-gingival samples in 
periodontitis patients (Kumar et al., 2012). These findings suggest that Gram-negative 
bacteria probably play an important role in peri-implant disease pathogenesis, but 
whether they colonise following the development of inflammation, or drive the initial 
inflammatory response remains to be determined. 
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Peri-implant biofilms have been and continue to be the subject of extensive research. 
While it is highly probable that there is no clear causative organism for peri-implantitis, 
it is likely that: 
 Implant surfaces are covered in an acquired pellicle of proteins, peptides and 
other proteins very similar to those found on natural teeth in the oral cavity; 
 This creates an environment suited to colonisation by various bacterial species, 
and biofilm formation; 
 As a biofilm matures it becomes more complex with a predominance of Gram-
negative anaerobic motile bacteria; 
 The peri-implant milieu surrounding implants in partially dentate patients with 
periodontitis contains more periodontal pathogens than those in patients who 
are either edentulous or do not have periodontitis (Lindhe et al., 2008). This 
appears to increase the long term risk of peri-implantitis, therefore indicating 
that known periodontal pathogens may also play a role in peri-implantitis; 
 The introduction of species such as P. gingivalis in animal models (such as dogs) 
has been shown to initiate and progress ligature associated lesions (Nociti et 
al., 2001), implying certain periodontal pathogens may be of particular 
importance in the initiation of or progression of peri-implant disease.  
1.3.5   The role of host responses in the progression of peri-implant disease 
It is interesting to note that in large studies of implant failure, peri-implantitis appears 
to cluster in certain patients. The aforementioned study by Roos-Jansaker et al., (Roos-
Jansaker et al., 2006) found that implant loss appeared to cluster in a few patients (a 
group of 22 out of a total of 218 patients lost 46 implants; of these, 8 patients lost 
more than one fixture), indicating a strong association between implant complications 
and patient phenotype. Current thoughts on the progression of peri-implant mucositis 
to peri-implant disease is that the process is similar to the progression of gingivitis to 
periodontitis in susceptible patients (Heitz-Mayfield and Lang, 2010). The disease 
process is initiated by key bacteria present within the biofilm which cause a complex 
host immune inflammatory response. A key cell is the neutrophil which has been 
shown to be hyperactive and hyper-reactive in periodontally susceptible patients, and 
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as a result neutrophils are implicated in the tissue damage characteristic of the disease 
process (Ling et al., 2015, Matthews et al., 2007). 
Polymorphonuclear leukocytes (PMNLs)  
The host response to a bacterial challenge in the context of periodontal disease has 
been the subject of a large body of research (Chapple, 2006, Wright et al., 2008, 
Matthews et al., 2007). PMNLs are known to form a key role in the host response to 
bacterial pathogens. The crevicular epithelium is intimately related to the plaque 
biofilm and key periodontal pathogens have been shown to elicit a pro-inflammatory 
response via activation of NFκB (Milward et al., 2007). This inflammatory response 
induces a wide range of pro-inflammatory sequelae including (PMNL) neutrophil 
recruitment. 
Neutrophils are the first line of defence in immune cell recruitment. They are 
numerous in the circulating blood, and are produced in the bone marrow of a healthy 
adult at the rate of approximately 1011 cells per day (Mollinedo et al., 1999). 
Neutrophils are recruited to the site of bacterial challenge in response to the release of 
cytokines from the host tissues (Baggiolini et al., 1989, Mollinedo et al., 1999), where 
their function is to phagocytose and kill invading organisms. During maturation, 
neutrophils develop granules that enable microbial killing by the cell to take place by 
one or more of three killing mechanisms: phagocytosis, degranulation and NETosis 
(cellular killing via release of decondensed chromatin and granular contents (Remijsen 
et al., 2011).  
One of the mechanisms by which neutrophils can kill bacteria is by releasing Reactive 
Oxygen Species (ROS). However, these species not only kill bacteria, but if released in 
excess are also capable of causing host tissue damage. Patients with periodontal 
disease have been shown to exhibit a hyperactive and hyper-reactive phenotype 
(Matthews et al., 2007). In such situations the susceptible patient shows a 
disproportionate response to bacterial challenge which contributes to the tissue 
damage observed in periodontal lesions (Matthews et al., 2007). In health, a fine 
balance exists between ROS production from neutrophils and local levels of 
antioxidants which are able to modulate ROS activity. However, if excess ROS are 
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produced and /or local antioxidant defences are compromised this can result in local 
tissue damage characteristic of the periodontal lesion (Chapple, 2006, Dias et al., 
2013). The mechanisms by which ROS can cause tissue damage are: 
 Oxidation of low molecular weight molecules, proteins and lipids 
 DNA strand breaks and base hydroxylation (Matthews et al., 2007). 
It is highly likely therefore that the nature of the host responses taking place within the 
tissues in response to a pathogenic challenge will impact upon the amount and type of 
tissue damage which occurs during any inflammatory disease process, including peri-
implant diseases.  
 
1.3.6   Treatment of peri-implant diseases 
Peri-implantitis can lead to pain, loss of function, infection and implant loss. These 
have a negative impact on the patient in both physical and psychological terms, and 
also financial implications for both the patient and the health service provider. Due to 
the increased life expectancy of the population and the increasing number of implants 
being placed it is reasonable to assume that the incidence of this condition will 
increase further over time (Levin, 2013). 
A wide range of treatment modalities have been proposed to manage peri-implantitis 
(Lindhe and Meyle, 2008) including debridement, the use of local or systemic 
antimicrobials, photodynamic therapy, and surgical interventions including surgical 
debridement, implantoplasty, regenerative material placement or implant removal. 
However, there is a lack of consensus on a “gold standard treatment” (Levin, 2013). 
This was confirmed by a recent review which concluded there is no reliable evidence 
supporting a single effective intervention in the treatment of peri-implantitis (Bidra, 
2012). However, it is agreed that the prevention of peri-implantitis by maintaining 
optimal oral hygiene is an essential aspect of good patient care (Jepsen et al., 2015). 
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1.4        Stability of Ti surfaces in vivo 
1.4.1   Corrosion of Ti  
Ti is frequently described as an “inert” biomaterial that is resistant to corrosion in a 
physiological setting. As previously discussed, all favourable biological interactions 
with Ti implant surfaces are mediated by a surface oxide layer of a few nanometres 
thickness. Any disruption of the TiO2 surface leads to rapid re-passivation due to an 
immediate reaction between the exposed ‘bare’ metal and oxygen in the environment. 
However a number of scenarios where sustained disruption of the surface oxide layer 
can occur in vivo are now recognised, and consequently the extent to which metals 
really are inert in a biomedical setting is now being more carefully considered (Cadosch 
et al., 2009a). 
Theories of Ti release into tissues  
Clinical evidence demonstrating the deterioration of metal implant surfaces in vivo has 
been widely reported and it is accepted that released metal ions, wear and/or 
corrosion products may have biological consequences (Addison et al., 2012, Cadosch et 
al., 2009a, Olmedo et al., 2008, Olmedo et al., 2012, Thomas et al., 2004). Metal 
release from bearing surfaces of articulating orthopaedic devices is ubiquitous with 
their design and is principally due to tribological and tribocorrosion mechanisms 
(Cadosch et al., 2009a). In contrast, metal release from ‘passive surfaces’ that are not 
subjected to obvious wear has been more difficult to explain, but key mechanisms that 
may be operative include: 
 Mechanically assisted crevice corrosion;  
 Physiochemical corrosion; 
 Cellular-gated corrosion (biocorrosion) mechanisms (Cadosch et al., 2009a).  
Although Ti has superior corrosion resistance when compared with other metals 
(Ratner, 2013), it has been shown that Ti will corrode in certain physiological 
environments, and is capable of producing a variety of potentially bioactive corrosion 
products (Cadosch et al., 2009a, Addison et al., 2012, Olmedo et al., 2008, Jonas et al., 
2001, Torgersen et al., 1995). In vitro experiments have shown that although in many 
simulated physiological conditions Ti has high corrosion resistance (Kedici et al., 1998), 
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factors such as pH, inorganic ions such as Fluoride (F-) (Stajer et al., 2008, Schiff et al., 
2002, Nakagawa et al., 1999) and relevant biomolecules such as lipopolysaccharide (Yu 
et al., 2015a) may reduce this resistance leading to significantly enhanced metal 
release. These modifying factors are of particular interest in the field of dental 
implants, as the oral environment into which abutments or threaded sections of Ti 
implants are exposed varies widely in pH, and for example, F- is a ubiquitous additive in 
oral hygiene products. The oral pH varies as a result  of dietary intake, saliva buffering 
capacity, oral hygiene practices and is also strongly influenced by certain medical 
conditions, for example gastric oesophageal reflux disorder (Filipi et al., 2011, 
Piangprach et al., 2009) . Many oral pathogens are also known to be acidogenic and 
are found in dental implant biofilms.  
Recently it has been shown that the inflammatory biomolecule H2O2, and albumin, the 
most common protein in tissue fluid, act synergistically to significantly increase metal 
ion release from Ti6Al4V alloys when tested in physiological saline (Yu et al., 2015b). 
These findings would not have been predicted by standard in vitro tests performed 
with either species as a stimulus alone. The findings highlight our lack of understanding 
of how the contents of biological environments can influence the stability of metal 
surface oxide layers in vivo. Such findings may help explain why Ti levels detected in 
peri-implant tissues and fluids associated with inflammation are elevated (Olmedo et 
al., 2012).    
Biocorrosion 
Biocorrosion is corrosion which occurs as a consequence of, or is enhanced by, the 
presence of prokaryotic or eukaryotic cells. From a structural perspective, the loss of 
material is minimal, and therefore is unlikely to produce any functional change in the 
implanted device. However, generation of potentially bioactive particles and their 
subsequent release into tissues surrounding an implanted device may stimulate 
biological responses which may influence peri-implant tissue outcomes. It is now 
accepted that corrosion of metallic materials implanted in vivo is inevitable and leads 
to the production of insoluble and soluble corrosion products which have been 
associated with inflammation, and in the case of certain orthopaedic implants, device 
failure (Cadosch et al., 2009a). It has also been suggested that certain cell types such as 
 20 
 
osteoclasts and innate immune cells are able to corrode metal surfaces such as 
stainless steel (Cadosch et al., 2009b, Cadosch et al., 2009a). Whilst the exact 
mechanisms involved in such corrosive processes have not yet been characterised, it is 
highly likely from the current body of evidence that there is an interaction between 
bacterial or host cells and the implanted metal surfaces.  
1.4.2   Evidence of metal release in the absence of wear 
Whilst physical wear processes such as those observed between two bearing surfaces 
of artificial joints can potentially generate large amounts of wear debris, there is a 
growing body of evidence to support the hypothesis that potentially bioactive debris is 
generated even in the absence of obvious tribology (Sections 1.4.1 and 1.4.2).  
Evidence of corrosion in vivo of cemented Ti femoral stems has been established, 
showing clear corrosion visible on non-articulated areas following implant retrieval. 
The corrosion has been attributed to mechanically assisted crevice corrosion (MACC) 
processes that lead to sustained disruption of passive oxide surfaces (Thomas et al., 
2004). Ti species have been identified in tissue samples adjacent to failing Bone 
Anchored Hearing aids (BAHs), which, like dental implants, are transmucosal CPTi 
implanted devices which have no articulating parts. Corrosion products have been 
identified at up to 800 µm from the implant site, and include both metallic and oxide 
based species, including both rutile and anatase (Addison et al., 2012). It was 
hypothesised that these Ti species within the tissues had formed from MACC (between 
the abutment and osseointegrated fixture) and through cellular gated corrosion 
mechanisms. Figures 1.3-1.5 show unpublished images generated using synchrotron X-
ray Fluorescence mapping (method detailed in Section 4.6.1) of peri-implant 
epithelium, showing the presence of Ti in surrounding tissues. These images were 
taken of tissue adjacent to failing BAHs which are percutaneous, non-articulated 
devices, fabricated from Grade 4 CPTi.   
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Figure 1.3 - X-ray fluorescence map of peri-implant epithelium showing significant 
accumulation of Ti (red) in the peri-implant soft tissues. Measurements taken of a 5 μm 
thickness tissue section, using a 5 μm focussed X-ray beam footprint at 5.7 KeV at I-18 
beamline, Diamond Light Source, UK. Three colour elemental image – (Green = Phosphorous, 
Blue = Potassium, Red = Titanium). 
 
Figure 1.4 - High resolution, X-ray fluorescence map of peri-implant epithelium showing 
significant accumulation of Ti in the both epithelial and connective tissue layers. 
Measurements taken on a 5 μm thickness tissue Section mounted on Si3N4, using a 600 nm 
focussed X-ray beam footprint at 5.7 KeV at beamline, ID-21, ESRF, Grenoble, France. Three 
colour elemental image – (Green = Phosphorous, Blue = Potassium, Red = Titanium). 
 
 
250 μm 
100 μm 
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Figure 1.5 - Nano-focussed Ti (red) X-ray fluorescence map of peri-implant epithelium –focused 
region taken from Figure 1.4. Measurements taken on a 5 μm thickness tissue Section 
mounted on Si3N4, using a 50 nm focussed X-ray beam with a 17.5 KeV pink beam, using 
beamline ID-16-B, ESRF, Grenoble, France. Demonstrates a disperse distribution of Ti particles 
(red) ranging in size from 1-2 µm down to single pixel (50 nm) scale.  
 
Figures 1.3-1.5 show the presence of a variety of sizes of Ti particles within epithelium, 
or in sub-epithelial tissues adjacent to an implanted device. The presence of Ti distant 
to the surface and speciation (not metallic) suggests that these species are generated 
by means other than mechanical wear.  
1.4.3    The potential biological consequences of free Ti in tissues  
Ti ions and particles have been reported to be pro-inflammatory, increasing the 
production of cytokines such as IL8, (Haleem-Smith et al., 2012, Wilson et al., 2000) 
from mesenchymal and epithelial cells, and Tumour Necrosis Factor alpha (TNFα) and 
Receptor Activator of Nuclear Factor Kappa-B ligand (RANKL) in fibroblasts (Irshad et 
al., 2013, Qian et al., 2013). Particles in the ultrafine size bracket (<100 nm in 
diameter) have shown stronger pro-inflammatory effects at an equal mass dose to fine 
TiO2 particle sizes (Singh et al., 2007). TiO2 has also been shown to induce apoptosis in 
bronchial epithelial cells (Park et al., 2008). Therefore, it is widely reported in the 
literature that while Ti in bulk has many favourable properties with regard to 
biocompatibility, Ti species when in contact with the tissues in an ionic or particulate 
form can be highly bioactive. 
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Ti Species Cell type Author, year 
Anatase, rutile HaCaT (human immortalised 
keratinocyte) 
Jin et al., 2011 
Mixture of anatase and rutile H1299 (Human non-small lung cancer 
cells) 
Lee et al., 2009 
Anatase/rutile  Rat lung tissue Silva et al., 2013 
Ultrafine anatase/rutile and 
fine anatase 
A549 (human lung epithelial cells) Singh et al., 2007 
Anatase and rutile Human monoblastoid cell line Vamanu et al., 
2008 
Anatase and rutile  Human lymphocytes Tavares et al., 2014 
Pure Ti Human osteoblasts Choi et al., 2005 
Anatase BEAS-2B (human bronchial epithelial 
cell line) 
Gurr et al., 2005 
Rutile Human fibroblasts Irshad et al., 2013 
TiO2 (unspecified)  BEAS-2B  Park et al., 2008 
Ti Human fibroblasts Qian et al., 2013 
Anatase  HaCaT cells Tucci et al., 2013 
Anatase A549 Srivastava et al., 
2013 
Anatase Human dermal fibroblasts Prasad et al., 2013 
Anatase HEK-293 (human embryonic kidney 
cell line) 
Meena et al., 2012 
Anatase HeLa (human cervical 
adenocarcinoma cells) 
Ramkumar et al., 
2012 
Anatase/rutile Human foetal lung fibroblasts Zhang et al., 2011 
TiO2 (unspecified) HUVEC (human umbilical vein 
endothelial cells) 
Montiel-Dávalos et 
al. 
Rutile/anatase CaCo-2 (human epithelial colorectal 
adenocarcinoma cells) 
Gerloff et al., 2012 
Anatase HepG2 (human hepatocellular liver 
carcinoma cell line) 
Shukla et al., 2013 
Anatase/rutile Primary human foreskin 
keratinocytes 
Simon et al., 2011 
Anatase A431 (human epidermal cell line) Shukla et al., 2011 
Anatase NCTC2544 (human keratinocyte cell 
line) 
Kocbeck et al., 
2010 
Rutile In vivo rat pulmonary tissues Warheit et al., 
1997 
Table 1.5 - Documented reported toxicological effects of Ti particles on different cell types, 
including the Ti species identified, the cell type and the author / date. 
 
To date, very little research has been carried out into the effects of Ti species on oral 
epithelium. Due to the reported bioactive potential of Ti species over a range of cell 
types it is proposed that Ti released by dental implants may have deleterious effects 
on cells, which are in intimate contact or are adjacent to the device. Any interactions 
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between Ti species and host epithelial cells may be a potential modifying factor in a 
soft tissue reaction to a prosthesis. 
1.5    The role of epithelium in implant soft tissue outcomes 
The function of oral epithelial cells and tissue has long been established as a protective 
one, whereby surface cells are shed, eliminating adherent bacteria, and form a 
constantly renewed tissue of cells adhered tightly together (Squier and Kremer, 
2001a). However, far from being a simple physical barrier tissue, the oral epithelium 
has a more complex role in protecting the body from invasion by pathogens than was 
originally described. It is now established that stimulation of the oral epithelium by 
(periodontal) pathogens leads to specific transcriptional events aimed at mounting a 
pro-inflammatory protective response (Milward et al., 2007).  
1.5.1   The structure of the peri-implant tissues 
While the clinical and histopathological features of periodontitis and peri-implantitis 
have many similarities, there are also important structural differences between the 
periodontal and peri-implant tissues (Figure 1.6). 
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Figure 1.6 – Comparison of peri-implant tissues (A) with periodontal tissues (B). (A) adapted 
from Lindhe et al., 2008 and (B) courtesy of Professor ILC Chapple. 
As shown in Figure 1.6, important differences between the periodontal and peri-
implant tissues exist. Peri-implant tissues (compared with periodontal tissues) are: 
 Less keratinised 
 Have attachment fibres which run parallel to the implant surface as opposed 
to investing into the cementum of a tooth (dentogingival fibres) 
 Less vascularised 
 Apically to have connective tissue cells in contact with an implant – in the 
periodontal situation the tissue in contact with a tooth is epithelial (Lindhe et 
al., 2008) 
 No periodontal ligament containing undifferentiated mesenchymal stem cells. 
Despite these differences, the overwhelming similarity of peri-implant and periodontal 
tissues means the disease process within these structures are often expected to be 
similar. Therefore, the role of epithelial cells in periodontitis has potentially important 
ramifications for their role in peri-implant disease initiation and progression.  
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1.5.2   The structure and function of the oral epithelial tissues 
Oral epithelial cells are defined as those cells found in oral tissues, which cover 
surfaces and form linings. Epithelium can be stratified or non-stratified, keratinised or 
non-keratinised. Epithelial cells join tightly together to form epithelia through a variety 
of mechanisms, including tight junctions, desmosomes, adherens and gap junctions. 
The oral epithelium is a stratified squamous epithelium which maintains its integrity by 
a continuous renewal process, where cells are produced in the deepest layer by 
mitosis, and undergo differentiation as they migrate passively towards the epithelial 
surface (Nanci and Ten Cate, 2008). The specific structure and function of the mucosa 
varies in accordance to its location within the oral cavity.   
The gingival epithelium can be divided into the oral epithelium, the sulcular 
epithelium, and the junctional epithelium (Figure 1.7). 
  
                                       
Figure 1.7 - Diagram (bucco-lingual Section) through the periodontal tissues. 
These epithelia together form the dentogingival junction. In the absence of 
inflammation (via periodontal disease or trauma) the junctional epithelium forms a 
tight junction with fibres of the periodontal ligament that insert into the cementum of 
the tooth (Nanci and Ten Cate, 2008). It is important to appreciate the wide variety of 
Junctional epithelium  
Sulcular epithelium  
Enamel 
space 
Alveolar bone 
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bacteria and bacterial products that will colonise the tooth surface, meaning the 
protective role of the junctional epithelium is essential in maintaining periodontal 
health. In the presence of inflammation however, the junctional epithelium migrates 
apically (Bosshardt and Lang, 2005).  During this process, a periodontal pocket is 
formed, and the resulting pocket lining epithelium differs in structure and function to 
the junctional epithelium. Pocket lining epithelium is a barrier epithelium  with Rete 
ridges as opposed to a semi-permeable membrane. A summary of the different 
features of the cell layers of non-keratinised epithelium is shown in Table 1.6. In 
humans, the outer surface of the gingival epithelium is usually para-keratinised, while 
the inner (crevicular) surface is non-keratinised. 
Cell layer Features 
Basal Cuboidal or columnar cells; site of most cell divisions 
Prickle / spinosum Larger ovoid cells; filaments become more numerous 
Intermediate Slightly flattened cells containing many filaments 
Superficial Slightly flattened cells; fewer organelles present but nuclei persist 
Table 1.6  – Maturation features in non-keratinised epithelium (Nanci and Ten Cate, 2008) 
Although there is some distinction between the epithelial cell layers in non-keratinised 
epithelium, this is far less pronounced than in keratinised epithelium. All epithelium is 
separated from the underlying connective tissue by a structure known as the basal 
lamina, which acts as a filter and barrier, as well as having important cell signalling 
properties (Nanci and Ten Cate, 2008).  
Figure 1.8 shows an electron micrograph of a gingival epithelial cell biopsy. Clearly 
visible are the cell-cell junctions, and gross structure of the epithelial cells. 
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Figure 1.8 – Gingival epithelial tissue viewed under Transmission Electron Microscopy (TEM) 
(see Section 2.8.1 for sample preparation technique).  
The functions of the oral epithelial tissues 
Far from being a simple physical barrier, the oral epithelium has a number of other 
functions which differ according to the region of the mouth in which the mucosa is 
located. Areas such as the palate and gingivae are keratinised, and although 
significantly less permeable than other non-keratinised areas such as the buccal 
mucosa, still have some permeability (Wertz and Squier, 1991). Aside from this 
protective function as a semi-permeable barrier, the oral mucosa has been shown to 
have an important role in responding to pathogens and is discussed in Section 1.5.4.  
1.5.3   The link between soft tissues and long term implant health 
It has long been established that healthy soft tissues surrounding teeth or implants will 
act as a barrier to subgingival plaque formation. The peri-implant soft tissues can 
establish a cuff-like barrier tightly adherent to the Ti implant abutment (Berglundh et 
al., 1991). The width of keratinised mucosa surrounding an implant has also been 
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shown to be important in influencing soft tissue outcomes, and a smaller band of 
keratinised mucosa adjacent to an implant may create an increased risk of soft tissue 
mucositis at that site (Schrott et al., 2009). It is logical to presume that the more 
cleansable an implant is the more effective oral hygiene measures will be. Given that 
oral hygiene maintenance and regular disruption of the peri-implant biofilm will 
decrease the bacterial challenge, it follows that those implants where oral hygiene 
maintenance is possible will be more likely to have favourable long term soft tissue 
outcomes than those where oral hygiene measures are compromised. Maintenance of 
oral hygiene measures, and therefore long term implant health, are potentially 
compromised in the following situations: 
 The patient is not compliant with oral hygiene regime (either not willing or 
unable to comply) 
 Soft tissues surrounding the implant are hypertrophic, causing plaque 
accumulation 
 Soft tissues have receded surrounding an implant, exposing the complex 
anatomy of the threaded part of the implant and allowing plaque 
accumulation 
 Poorly designed implant based restoration which will compromise oral 
hygiene maintenance 
 Implant has been placed inappropriately, leading to a lack of adequate soft 
tissue coverage on one or more aspects of the implant surface 
 Presence of subgingival cement from implant superstructure which retains 
plaque. 
It has also been established that a “thinner” mucosal biotype (meaning a pocket 
measuring probe inserted to the gingival crevice can be seen through the tissues) as 
opposed to a “thick” biotype (where the probe cannot be seen) predisposes to 
recession of peri-implant soft tissues (Nisapakultorn et al., 2010), therefore potentially 
adversely affecting long term soft tissue health.  
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1.5.4   Epithelium, the bacterial challenge and inflammation 
Epithelial cells are the first cells (apart from crevicular neutrophils) that pathogens will 
encounter. Contact between epithelial cells and pathogenic bacteria plays an 
important role in forming a localised immune response in the periodontal and peri-
implant setting. Epithelium can be penetrated by bacterial, viral and fungal pathogens, 
which may either directly invade the epithelial cells or may travel between epithelial 
cell junctions (Eick et al., 2006). The ability of pathogens to adhere to epithelial cells or 
invade epithelial cells stimulates an inflammatory response. Various pathogens that 
were identified in Section 1.3.4, such as P. gingivalis, have been shown to adhere to 
epithelial cells in large numbers (Yilmaz et al., 2002). This adhesion is aided by a variety 
of virulence factors including bacterial lipopolysaccharide (LPS) (Lamont and Jenkinson, 
1998). Therefore, it is important to appreciate that an immune response can be 
initiated by contact with, passage between, or invasion of epithelial cells by pathogens. 
It is likely that in the periodontal or peri-implant context, all three processes will arise 
due to the structure of the epithelium surrounding an implant, and the biofilm 
covering the implant surface. 
Epithelial cells are now known to be far more than simply a structural barrier, and their 
role in immune responses in periodontitis is well documented (Milward et al., 2007, 
Milward et al., 2013). Receptors called Toll-like Receptors (TLRs) are central to this 
immune response (Philpott et al., 2001), and have the ability to recognise key bacterial 
components such as lipopolysaccharides (LPS) of Gram-negative bacteria. Activation of 
TLRs initiates a number of molecular signalling pathways which culminate in the 
activation of Nuclear Factor Kappa B (NFκB). NFκB is the key pro-inflammatory gene 
transcription factor, which upon activation splits from its inhibitor (I-κB) and 
translocates from the cytoplasm of epithelial cells to the nucleus. Here it binds to DNA 
resulting in gene transcription changes and downstream protein production (e.g. IL8), 
(Milward et al., 2007). Activation of the pathway will lead to the recruitment of 
immune cells from the underlying connective tissues, such as neutrophils and 
macrophages, leading to inflammation, and potentially apoptosis of infected cells.  
Although NFκB represents an important pro-inflammatory pathway, it is not the only 
mechanism by which transcription of inflammatory genes can be upregulated. Other 
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molecules such as activation protein 1 (AP-1) can also create an immune response  
(Philpott et al., 2001). There are a variety of complex pathways by which different 
bacteria may stimulate an immune response from contact with epithelial cells, many of 
which are as yet uncharacterised. AP-1 and NFκB are examples of REDOX sensitive 
transcription factors, meaning that changes in cellular oxidative stress can lead to their 
activation (Chapple and Matthews, 2007).  
1.5.5   Cell-cell signalling and immune cell recruitment 
Epithelial cells play an important role in cell-to-cell signalling pathways including in the 
presence of a pathogenic challenge. Signalling molecules are produced to recruit other 
cell types and initiate an immune response (Yilmaz et al., 2003, Krisanaprakornkit et 
al., 2000, Milward et al., 2007). Therefore, if this signalling process is in some way 
compromised (for example by the presence of Ti species) and results in perturbation of 
the production or function of these cell signalling molecules, immune responses such 
as neutrophil function or chemotaxis, could be compromised. Neutrophils are the 
predominant acute inflammatory cells in peri-implant sites, therefore cell signalling 
between epithelial cells and neutrophils is a potentially important regulator of peri-
implant inflammatory outcomes. 
 
1.6   Aims and objectives 
The introduction and literature review has demonstrated that there is a need to 
elucidate the effects that implant derived Ti products may have on epithelial cells in 
the context of peri-implant disease. Currently, little is known about the potential 
interactions between Ti products and epithelial cells, and how any interactions which 
may arise could affect cell signalling, immune responses and potentially peri-implant 
inflammation. These questions will be investigated using a number of techniques with 
the aim of determining the impact of insoluble Ti products on the epithelium and once 
elucidated, may offer potential therapeutic targets for treating peri-implant diseases.   
1.6.1  Justification for the research enquiry 
The fact that peri-implant tissues from failed implanted Ti devices have been shown to 
contain Ti particles that suggests that Ti does not, as initially thought, remain passive 
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and stable in vivo. Insoluble Ti products in the form of TiO2 NPs have been 
demonstrated to be co-located with epithelium and with innate immune cell infiltrates 
in the adjacent tissues.  The established evidence from the orthopaedic literature and 
extensive in vitro modelling has shown that Ti in these forms has clear biological 
reactivity and hence it is possible that when Ti accumulates in peri-implant tissues it 
will generate epithelial cell responses.  
1.6.2   Aims of the project 
The aims of this project are: 
1. To develop a clinically relevant in vitro model system to investigate the effects 
of relevant Ti products on epithelial cell viability. 
2. To determine any interactions that may occur between clinically relevant Ti 
species and epithelial cells and characterise these. 
3. To investigate the direct cellular effects of any interactions on epithelial cells. 
4. To investigate the molecular effects of any interactions using microarray 
screening and confirmatory Polymerase Chain Reactions (PCR). 
5. To determine any effects these interactions may have on known epithelial cell 
responses and their role in the inflammatory immune response to known 
pathogens. 
Based on the lack of reported evidence in this area the work reported in this thesis will 
test the null hypothesis (H0) that: 
“Ti species similar to those released from implanted Ti devices do not elicit 
significant biological responses from oral epithelial cells”. 
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Chapter 2 
Materials and methods 
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Synopsis 
The aim of this chapter is to provide a general overview of the main cell culture and 
assay techniques used in this body of work. Cell culture technique, stimulus 
preparation and overarching experimental methods are described. Due to the breadth 
of methods used, the specific details of experimental protocols are included within the 
individual experimental chapters. 
2. 1   Titanium stimuli 
2.1.1   Titanium oxide stimulus preparation 
To limit the number of experimental variables this study focused predominantly on the 
use of one Ti stimulus. Many different Ti species could potentially come into contact 
with oral epithelial cells, however deposits of TiO2 in anatase form in both nanoscale 
and larger particle sizes have been detected within the epithelial tissues surrounding 
transmucosal CPTi implanted devices (Addison et al., 2012, Haleem-Smith et al., 2012, 
Olmedo et al., 2012). For all work unless otherwise specified, TiO2 suspensions were 
prepared using TiO2 (powder, anatase form, purity 99.7 %, catalogue number 637254, 
Sigma-Aldrich, UK) in the form of nanoparticles with a particle size of <25 nm.  
TiO2 was weighed using a balance (Ohaus Precision Standard, Ohaus UK) accurate to 3 
decimal places in plastic weigh boats. The TiO2 powder was added to a quantity of 
reverse osmosis (RO) water (see below) that had been sterilised in an autoclave (Little 
Sister 2, Eschmann UK) at 134°C for 3 min. The suspension was made up in a sterile 
100 mL glass beaker using the following masses of TiO2: 
Ti mass Amount RO water Stock concentration Final working concentration 
0.05 g 50 mL 100 µg/mL 10 µg/mL (10 ppm) 
0.50 g 50 mL 1000 µg/mL 100 µg/mL (100 ppm) 
5.00 g 50 mL 10 000 µg/mL 1000 µg/mL (1000 ppm) 
25.00g 50 mL 50 000 µg/mL 5000 µg/mL (5000ppm) 
Table 2.1 – Ti stimulus preparation 
The beaker containing the TiO2 / water suspension was then placed within a plastic 
container with ice and sonified using a Branson Sonifier 250 (Branson Ultrasonics, 
Danbury, Connecticut USA), according to a published protocol (Taurozzi et al., 2013). A 
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standard ½” clean titanium horn was inserted centrally within the 100 mL beaker to a 
depth 1 cm from the base of the vessel. Sonification was performed using a 50 W 
power output and 80 % duty cycle for 15 min. Sonifcation was conducted in a positive 
flow biological hood (MSC12, ThermoScientific, USA) to help maintain sterility. The 
resultant sonified suspension was stored in sterile conditions within a sterile plastic 
tube prior to use and re-sonified prior to use if stored for longer than 48 h in order to 
minimise the chances of settling of the TiO2 NPs, which would result in a reduction in 
accuracy of the suspension concentration.  
2.1.2    Addition to cell culture medium 
150 µL of the TiO2 NP suspension was transferred to a sterile 25 mL universal container 
which contained 18.75 µL of 80 mg/mL sterile Bovine Serum Albumin (BSA) solution 
(Sigma-Aldrich, UK) made by adding 0.80 g of BSA granules to 10 mL of sterile RO 
water. BSA was added to the TiO2 NPs in order to minimise agglomeration  (Taurozzi et 
al., 2013). The TiO2 / BSA mixture was then augmented with 14.83 mL of cell culture 
medium as appropriate to the experiment (see Section 2.1.1) to make 15 mL medium 
with a known concentration of TiO2 nanoparticles (NPs) in suspension.  
2.2    H400 (oral epithelial cell line) cell culture 
2.2.1    Cell culture media and reagents 
Dulbecco’s modified Eagle’s medium (DMEM)  
DMEM was supplemented to form the growth culture media for H400 cells. Ham’s F12 
DMEM (Life Technologies, UK) was supplemented with L-Glutamine (Sigma-Aldrich, 
UK), foetal calf serum (FCS) (Labtech, UK) and hydrocortisone (Sigma-Aldrich, UK) to 
the following concentrations (see below) under aseptic conditions in a biological 
positive flow hood. For experiments using dynasore hydrate, the FCS was omitted for 
the final medium replenishment as described in more detail within Section 4.2.2. 
L-Glutamine  2 mM final concentration 
FCS   10 % v/v final concentration 
Hydrocortisone 0.5 ng/mL final concentration 
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Trypsin ethylenediaminetetraacetic acid (Trypsin-EDTA) 
Trypsin-EDTA (Gibco, UK) was used to detach the adherent H400 cell monolayer from 
the cell culture flask. This allows a single cell suspension to be created to facilitate re-
seeding of cells into other flasks or growth receptacles. Trypsin-EDTA used in this work 
contained 0.5 g/L trypsin and 0.2 g/L EDTA in Hank’s balanced salt solution and was 
purchased ready for use (Sigma-Aldrich, UK). Once received the solution was 
aseptically split into 5 mL aliquots and stored at -20°C prior to use in order to prevent 
repeated freeze-thaw cycles and any potential loss of activity. Before use, aliquots 
were defrosted and warmed to 37 ± 1°C in a water bath. 
Phosphate buffered saline (PBS) 
Commercially available Dulbecco’s phosphate buffered saline without Ca2+ or Mg2+ (D-
PBS) (Gibco, UK) was used to wash cells prior to detachment from the cell culture 
plasticware. D-PBS was stored aseptically at 4 ± 1°C prior to use, then warmed to 37 ± 
1°C before washing cells. 
2.2.2    H400 cell culture and passage 
The H400 cell line is an immortal cell line derived from an oral squamous cell 
carcinoma (SCC). It is used as a robust model for oral epithelial cells (OECs) (Prime et 
al., 1990) and is a cell line kept at the University of Birmingham following donation 
from Professor S Prime. This cell line was derived from a Stage 2 moderately 
differentiated SCC in the alveolar process of a 55-year-old female, and has been shown 
to exhibit qualities strongly representative of OECs (Prime et al., 1990). This cell line 
has been extensively used in studies relating to periodontal disease and inflammatory 
responses (Milward et al., 2007, Milward et al., 2013, Grant et al., 2010a, Wylie et al., 
2010). All experiments were performed between passages 4-30. Cells were archived by 
freezing in supplemented cell culture medium containing 20 % FCS and 10 % Dimethyl 
sulphoxide (DMSO), which was added to prevent cell membrane rupture during the 
freezing process. Once frozen, cells were stored at -80°C.  
General cell culture methods 
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H400 cells were cultured in an incubator (Galaxy S, SLS, UK) at 37 ± 1°C in a humidified 
atmosphere and 20 % CO2. H400 cells will form a confluent, adherent monolayer when 
cultured on many different surfaces. Tissue culture treated plasticware was used for 
the majority of work in this thesis, but H400 cells will also successfully adhere to and 
divide on untreated (sterilised) glass cover-slips and microscope slides. The majority of 
H400 cell culture was performed using 75 cm2 or 25 cm2 sterile cell culture treated 
flasks (TC coated plasticware, Corning, New York, U.S.). 
All work with H400 cells was performed without the addition of antibiotics or 
antifungal agents to the cell culture media so as to negate additional confounding 
factors. As antimicrobials were not included, all experiments were reliant on careful 
and thorough aseptic technique. All aliquots of reagents were split using sterile single 
use pipettes in a biological positive flow hood in sterile receptacles, with all cell culture 
techniques utilising careful aseptic technique. If any flasks became turbid or light 
yellow in colour, these were presumed infected and disposed of immediately. 
Antimicrobial-free culture was not possible when initially culturing primary cells due to 
the non-sterile nature of the tissues from which the cells were cultured when 
compared to cell lines. 
Supplemented DMEM contains phenol red (a pH indicator) which will indicate an acidic 
pH when the medium is becoming exhausted and requires refreshing, becoming 
orange, then yellow in colour. H400 cells were cultured to approximately 80 % 
confluency before use as determined by light microscopy, to allow representative cell 
responses whilst not risking total confluence which can induce contact inhibition and 
media exhaustion and result in cell death. The degree of monolayer confluence was 
assessed using light microscopy at 10x and 20x magnification.  
Cell passage / splitting 
H400s were split and reseeded (passaged) when an 80% confluent monolayer had 
been reached, to allow further growth and division of cells following re-seeding into 
different plasticware or glassware. The process for a 75 cm2 flask is outlined below. 
1. Cells were examined visually using a 10x objective on an inverted light 
microscope (Primo Vert, Zeiss, Germany) to establish level of confluence. 
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2. Cell culture medium was removed from the flask using a sterile Pasteur 
pipette. 
3. Cells were washed gently with 5 mL warmed D-PBS (37 ± 2°C) to remove 
remaining cell culture medium, as the FCS contained in the media will inhibit 
the action of trypsin-EDTA. 
4. 5 mL of warmed (37 ± 2°C) trypsin-EDTA was added to the flask and gently 
agitated, re-sealed, and incubated at 37°C in a 20 % CO2  atmosphere for 10 
min. 
5. After 10 min the level of dissociation was examined using light microscopy as 
before. If cells were still attached, the flask was incubated for a further 3-4 
min and re-examined until full dissociation was achieved. 
6. The resulting cell suspension was aseptically removed from the flask and 
added to an equal volume of pre-warmed H400 culture medium in a sterile 25 
mL universal tube. As the medium contains FCS it will stop the action of 
trypsin thereby preventing undue cellular damage.  
7. The suspension was then centrifuged at 1000 rpm for 10 min (IEC Centra CL2, 
Thermo Scientific, UK) following which the supernatant was removed and 
discarded with a sterile Pasteur pipette taking care not to disturb the cell 
pellet. 
8. The cell pellet was gently re-suspended in approximately 1 mL cell culture 
medium (37 ± 2°C), and the cell concentration quantified by counting using a 
haemocytometer before re-seeding the correct number of cells into fresh 
medium in an appropriate cell culture vessel. 
9. H400s were visually inspected at 24 and 48 h to assess cellular adherence, 
growth and morphology. When H400s were seeded at an appropriate density, 
the medium was changed after approximately 4 days and confluency was 
reached in approximately 5-7 days post passage. 
Cell freezing / recovery from storage 
To retrieve archived frozen cells, a vial containing cells was warmed quickly to 37°C in a 
water bath and added to 9 mL of pre-warmed cell culture medium. The suspension 
was spun at 800 rpm for 10 min, then the supernatant discarded and the pellet re-
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suspended in 1 mL warmed cell culture medium. The suspension was then added to a 
flask to containing a total of 10 mL of warm supplemented DMEM, and incubated and 
monitored as previously indicated above.  
To freeze aliquots of H400s, 1x106 cells in 1 mL supplemented DMEM containing 20 % 
FCS and 10 % dimethyl sulphoxide (DMSO, Sigma-Aldrich, UK) were placed into 2 mL 
sterile cryo-vials (Corning, USA). The vials were wrapped in cotton wool to ensure slow 
freezing and stored at -80°C until needed, upon which they were defrosted and seeded 
as previously described. Long term storage of H400s has traditionally been undertaken 
in liquid nitrogen, however all H400s used in this work were successfully stored at -
80°C for a number of months with no loss of viability on retrieval from storage (data 
not shown).  
Cell growth in well plates 
Experiments were undertaken to establish the ideal seeding densities when using 
different cell culture plasticware. Table 2.2 shows a list of seeding densities in number 
of cells and expected time to confluency: 
Vessel Cell count Volume of  
medium 
Time to 
“just” 
confluence 
96-well plate 8 x 103 cells per well 100 µL or 200 µL  48-72 h 
6 well plate 1 x 105 cells per well 2 mL  48-72 h 
25 cm2 flask 2 x 105 cells per flask 5 mL  5-7 days 
75 cm2 flask 5 x 105 cells per flask 10 mL  5-7 days 
Transwells in 24 
well plate 
3 x 104 cells per top chamber 300 µL  3-5 days 
Table 2.2 – Seeding densities of epithelial cells 
The seeding densities in Table 2.2 were used for the majority of experiments however 
these were adapted if the time to confluence needed to be reduced or extended. The 
stage in the cell cycle and potential cell behaviour may be altered if a significantly 
different length of time between seeding and confluency occurs. Therefore, if cells had 
not achieved the appropriate degree of growth expected, they were discarded and 
new cultures set up in order to maximise experimental consistency. 
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Cell growth on coverslips and glass slides 
For certain staining and histological techniques, H400s were grown on sterile 
microscope slides (Hendley-Essex, UK) and coverslips (Scientific Laboratory Supplies, 
UK). The H400 cell line did not require collagen coating of microscope slides or other 
glassware in order to adhere sufficiently. All glassware was sterilised by immersion in 
70 % alcohol for 30 s then rinsed in sterile D-PBS before use. Cells were cultured on 
coverslips (1.5 mm thickness, 13 mm diameter, Scientific Laboratory Supplies, 
Nottingham, UK) in standard 24, 12 or 6 well sterile tissue culture plates (Corning, New 
York, U.S.) containing 1, 1.5 or 2 mL cell culture medium respectively. 
Trypan blue staining 
Cell viability was determined using a trypan blue exclusion staining protocol. Trypan 
blue 0.4 % (Gibco, UK) was added to the cell suspension at a ratio of 1:1, mixed gently 
by hand for 60 s at room temperature and a cell count then performed using a 
haemocytometer (Figure 2.1). Positively stained cells appear blue and are assigned as 
non-viable as trypan blue cannot pass the cell membrane of viable cells. Viability is 
expressed as a percentage of total cell number and is expected to be in excess of 90%.  
 
Figure 2.1 – Diagram representing a cell count of cells stained with trypan blue exclusion (5/80 
cells = 94 % viability). Blue cells would be counted as non-viable. 
2.3    Use of cell viability assays 
There are many different methods of assessing cell viability within a population. As will 
be discussed further in Chapter 3, there are potential interactions between the 
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insoluble nanoparticles (NPs) and assays, therefore it is imperative that all assays used 
were validated for use in the presence of TiO2 NPs. This body of work employed a 
number of assays to determine cell “viability”, and utilized indirect pathways in 
conjunction with direct pathways to build a clear picture of the likely status of cells in 
response to NP exposure. 
2.3.1   CellTiter-Glo®assay 
CellTiter-Glo® (Promega, UK) is a commercially available luminescence-based assay. 
The assay provides a substrate (luciferin) which is converted to oxyluciferin, through a 
reaction that releases light. This reaction is dependent upon the presence of ATP and 
oxygen present in viable cells.  
 
Figure 2.2 – The luciferase reaction which takes place using the CellTiter-Glo® assay. Mono-
oxygenation of luciferin occurs and is catalysed by luciferase in the presence of oxygen, Mg2+ 
and ATP. The output measured is light produced during this process in arbitrary units. 
Non-viable cells produce no ATP, therefore will not catalyse the reaction contained in 
the assay resulting in no light output (Riss and Moravec, 2004). Light output is 
measured after a short incubation period using a luminometer (Berthold, Bad Wildbad, 
Germany). The assay lyses the cells, so can only be carried out once per sample. 
Beetle Luciferin 
Recombinant 
Luciferase Mg
2+
 
+ Oxyluciferin Light 
+ ATP + O
2
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For all the work in this thesis using CellTiter-Glo®, the following protocol was adopted 
with the light output measured in Relative Light Units (RLU) per well. 
1. H400 cells were seeded into a cell culture treated 96-well white walled plate 
(Appleton Woods, Birmingham, UK) and exposed to a relevant stimulus 
according to the specific experimental design, along with the relevant controls 
(both cell free and stimulus free). Whenever possible the outer wells of the 
plate were not used to avoid excess evaporation of medium during 
incubation. The total medium volume in each well was either 100 or 200 µL 
depending upon whether 100 µL of supernatant was needed for another 
assay (for example an LDH assay, see Section 2.3.2).  
2. Following incubation with stimuli determined by the specific experimental 
design, the 96-well plate was removed from the incubator.  
3. The supernatant was removed from the cell monolayer. Wells were then 
washed 3 times with 100 µL warmed D-PBS to remove any remaining stimulus 
as far as possible. 100 µL of fresh warmed cell culture medium was then 
pipetted into the well. 
4. CellTiter-Glo® reagent (at room temperature, 23 ± 2°C, made up as per 
manufacturer’s protocol) was added in an equal volume to the cell culture 
medium in each well. 
5. The plate was covered with the lid, and incubated for a minimum of 10 min at 
room temperature. The manufacturer reports this signal to be stable for up to 
60 min, but all plates in this thesis were read within 30 min to ensure accuracy 
and consistency between experimental repeats. 
6. Plates were read using a TriStar2 942 multifunction plate reader (Berthold, 
Bad Wildbad, Germany) at a temperature of 37 ± 1°C and a counting time of 
0.10 s, as per a protocol on ICE Software (Version 1.0.6.0) or a LB96V 
luminometer (Berthold, Germany) if the TriStar2 was unavailable. Data were 
captured using WinGlow software (Berthold, Germany). 
7. Data were exported to a Microsoft Excel file and analysed according to the 
objectives of the specific experiment. The data captured was the mean of the 
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two RLU readings closest to 30 min after the assay reagent was added to the 
plate. 
8. Control wells were run for every experiment consisting of cell free wells 
containing each stimulus used, and wells containing cells but no stimuli. 
2.3.2    CytoTox-ONETM  
CytoTox-ONE™ (Promega, UK) is a commercially available fluorometric assay kit used 
to determine the concentration of the enzyme lactate dehydrogenase (LDH) in a 
sample. LDH is an intracellular enzyme, released extracellularly into the cell culture 
medium if a cell membrane becomes damaged (e.g. during necrosis). Therefore, the 
concentration of LDH in the supernatant of a cell population will increase as the 
numbers of necrosing or necrotic cells increases. The cell culture medium will contain 
some LDH due to the inclusion of FCS. Positive samples will fluoresce at an excitation 
wavelength of 560 nm 590 nm, and appropriate filters were used.  
 
 
Figure 2.3 - Standard curve for LDH content in wells using CytoTox-ONE™ assay demonstrating 
a linear relationship between the LDH concentration in cell culture medium and the relative 
fluorescence (in RFU) of the well containing the cell culture medium. 
For all the work in this thesis detecting LDH concentrations, the following protocol was 
used. Data were recorded as Relative Fluorescence Units (RFU) per well. 
1. Cells were cultured in a tissue culture treated, white walled, clear bottomed 
96-well plate (Appleton Woods, Birmingham, UK) with a total volume of 200 
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µL medium (including any stimulus) for a pre-determined length of time 
according to the specific objectives of the experiment. 
2. At the time of performing the LDH assay, 100 µL of supernatant was removed 
from the white walled clear bottomed plate the cells were incubated in, and 
transferred to a plate with black wells in order to read the fluorescence of the 
sample. White or clear bottomed plates are not compatible with reading 
fluorescence. 
3. An equal volume of CytoTox-ONE™ assay reagent (prepared as per 
manufacturer’s protocol) was added at room temperature to each well. 
4. The plate was incubated at room temperature for 10 min. Fluorescence was 
read using a multimode plate reader (TriStar2, Berthold, Bad Wildbad, 
Germany) with excitation and emission filters of 560 nm and 590 nm 
respectively at 37 ±1°C, with a count time of 0.1s and lamp energy of 70 %. 
Data were exported as described in Section 2.3.1. Cell free wells were run as 
controls in each experiment to ensure no interference from cell culture 
medium or stimuli. A standard curve was also performed to ensure the assay’s 
accuracy (Figure 2.3). 
2.3.3    Caspase-Glo® 3/7 assay 
Caspase-Glo® 3/7 is a commercially available luminescence assay used to determine 
the quantity of caspase 3/7 activity in a population of cells. Caspases are enzymes 
which are activated during apoptosis. Caspases 3 and 7 are detected via:  
 cell lysis, which will liberate any caspase present within the cell  
 the assay substrate (containing the tetrapeptide sequence DEVD) is in turn 
cleaved by caspase 3/7 to produce a luminous product (Riss and Moravec, 
2004) 
 luminescence will be proportional to the amount of luminous product, 
therefore representative of the amount of caspase 3 and 7 present. 
For all the work in this thesis using Caspase-Glo® 3/7, the following protocol was used 
and data were expressed as Relative Light Units (RLU) per well. 
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1. Cells were cultured according to Section 2.3.1 in white-walled clear bottomed 
96-well plates and stimulated as the specific objectives of the experiment 
demanded. The total well volume was consistent between wells. 
2. After the incubation time necessary for each specific experiment the 96-well 
plate was removed from the incubator. 
3. The supernatant was removed and the cell monolayer was washed 3 times 
with warmed D-PBS to remove any remaining stimulus as far as possible. 
Fresh warmed cell culture medium was pipetted into each well.  
4. Caspase-Glo® 3/7 reagent (at room temperature, made up as per 
manufacturer’s protocol) was added in an equal volume to the cell culture 
medium in each well. This was either 50 or 100 µL depending on the specific 
protocol of the experiment. 
5. The plate was covered with the lid and incubated in the dark for a minimum of 
30 min at room temperature (23 ± 2°C) as per the manufacturer’s protocol.  
All plates in this thesis were read within 40 min from the addition of the 
reagent to minimise any change in light output over time. 
6. The plate was read and data were collected as for the CellTiter-Glo® assay 
(see 2.3.1). 
2.3.4   Sytox® Green Nucleic Acid Stain 
Sytox® green is a high affinity nucleic acid stain, which will rapidly stain the nuclei of 
cells with a non-intact cell membrane. Stained nuclei will fluoresce bright green when 
excited with a 450 – 490 nm light source. This light output can be measured either with 
a fluorescence plate reader or visualised using a microscope.  
1. H400 cells were cultured in tissue culture compatible, white walled, clear 
bottomed 96-well plates (Appleton Woods, Birmingham, UK) containing 100 
µL cell culture media. The media was changed once approximately 80 % 
confluence was reached, and new media was added containing TiO2 NPs in 
concentrations of 0, 1, 10, 100 and 1000 ppm and incubated for 24 h. 
2. The media was aspirated and the cell monolayer washed 3 times with warmed 
PBS, then 40 µL of warmed PBS was added to each well to avoid the 
monolayer dessication. 
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3. 10 µL of Sytox® Green stock solution (S7020, Life Technologies, UK) was added 
to each well to give a final concentration of 0.2 µM. The plate was incubated 
at room temperature for 5 min, then images were captured using an epi-
fluorescent microscope (Nikon Eclipse TE300) with a fluorescence filter 
(excitation 472 nm and emission 520 nm, BrightLine® GFP-3035B, Semrock) at 
x40 magnification. 3 randomly positioned images were taken from each well 
using a digital camera (Nikon Coolpix 990) using standard settings. This 
process was completed quickly to avoid the cells becoming non-viable due to 
lack of cell culture medium and/or being out of the incubator. 
4. Images were captured at exposure times of 1500 ms for the laser excitation 
and 50 ms brightfield, and adjusted using FIJI (ImageJ) software 1.49k 
(National Institutes of Health, USA) to enhance clarity. The total number of 
stained cells was counted manually by viewing the captured images and 
expressed as a percentage of the total cell number.  
2.3.5    MTT assay 
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay 
functions via the actions of NAD(P)H dependent enzymes in viable cells, which will 
reduce the assay substrate tetrazolium dye MTT to its insoluble form which is purple in 
colour. If more viable cells are present in a sample, the solution will become 
increasingly purple during the controlled conditions of the assay. 
The following protocol was used: 
1. H400 cells were cultured in a tissue culture, white walled, clear bottomed 96-
well plate (Appleton Woods, Birmingham, UK) with 100 µL cell culture media. 
Cells were treated with stimuli as demanded by the specific experimental 
protocol.  
2. MTT substrate (Sigma-Aldrich, UK) was diluted in PBS to form a stock at a 
concentration of 5 mg/mL. The stock was filtered through a 0.2 µL syringe 
filter (Sterilitech, UK) and stored at 4 ± 1 °C in the dark until use. 
 47 
 
3. When the assay was due to be performed, 10 µL of MTT stock solution was 
added to each well and the plate was incubated for 4h at 37 ±1°C with 5 % 
CO2. 
4. 100 µL of dimethyl sulfoxide (DMSO, Sigma-Aldrich, UK) was added to each 
well and thoroughly pipetted to mix and dissolve any crystals of insoluble dye 
which had formed. 
5. The absorbance of each well was measured immediately at 570 nM (ELx800 
Universal Microplate Reader, Biotek UK).  Data were exported to Microsoft 
Excel for analysis in the form of a single absorbance value generated for each 
well. 
2.4   Primary oral epithelial cell culture 
2.4.1  Primary epithelial cell culture using a 3T3 feeder layer 
3T3 cells are a murine cell line now accepted as a well characterised fibroblastic cell 
line. Cells used were a gift from Dr RM Shelton at the University of Birmingham. The 
following previously described protocol was used in to establish a ‘feeder layer’ for 
primary epithelial cells (Gray et al., 1983, Taylor-Papadimitriou et al., 1977). This 
feeder layer is then treated to prevent cell division within the feeder layer but to 
maintain cell viability in order to continue to produce the growth factors necessary for 
primary epithelial cell survival. 
3T3 Cell culture media and reagents   
Supplemented DMEM 
DMEM supplemented with FCS and penicillin-streptomycin (Sigma-Aldrich, UK) was 
used as the standard cell culture medium for 3T3 cells in accordance with existing in-
house protocols. All cell culture reagents and passage were performed in a positive 
flow biological hood to ensure an aseptic technique. DMEM with high glucose and with 
L-Glutamine and HEPES buffer (Gibco, UK) was used and supplemented as below: 
FCS  Final concentration 10 % v/v 
Penicillin/streptomycin  Final concentration 100 U/mL penicillin, 0.1 mg/mL streptomycin 
Table 2.3 – DMEM supplementation  
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Additional cell culture reagents 
Additional cell culture reagents were as for H400 cell culture. Trypsin-EDTA and D-PBS 
reagents used were as previously described for H400 passage. Primary cells were 
seeded at the same density as H400 cells. All cells were incubated at 37°C in 20 % CO2.  
3T3 feeder layer culture 
1. 3T3 cells were cultured in a 75 cm2 tissue culture medium treated sterile flask 
(as for H400 cells, see Section 2.2) until 30 – 40 % confluent (approximately 24 
hours post seeding). 
2. 3T3 cells were then treated with mitomycin C (4 µg/mL) (Sigma-Aldrich, UK) 
for 2 h at 37°C in 5 % CO2 to arrest cell division. Following incubation for 2 h 
the medium was changed for fresh growth media (without mitomycin C). 
Following treatment with mitocycin C, the feeder layer was kept in the incubator until 
the primary epithelial tissue had been prepared (maximum 2 h). 
Culture media for primary epithelial cells – feeder layer method 
Primary epithelial cells were cultured in the same media as H400 cells (see 2.2.1) but 
with additions outlined in Table 2.4.  
Penicillin – streptomycin (Sigma-Aldrich, UK) 100 U/mL penicillin, 0.1 mg/mL streptomycin 
Amphotericin-B (Sigma-Aldrich, UK) 2.5 µg/mL 
Cholera toxin (Sigma-Aldrich, UK) 10-10 M  
Epithelial Growth Factor (Sigma-Aldrich, UK) 10 ng/mL 
Insulin (Sigma-Aldrich, UK) 0.01 mg/mL 
Table 2.4 – Primary cell culture medium 
Primary tissue treatment 
2 mm diameter gingival punch biopsies were collected from healthy volunteers as part 
of an ongoing clinical trial (NHS R&D Reference: R&D1398, REC Reference Number: 
10/H1208/48). Waste tissue was also collected with consent from patients undergoing 
routine surgery including gingivectomy or third molar extraction. The tissue was stored 
in transport medium (Ham’s F12 DMEM supplemented with 10 % Fetal Calf Serum and 
100 U/mL penicillin, 0.1 mg/mL streptomycin [Sigma-Aldrich, UK]) immediately 
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following collection. As soon as possible (and always within 24 h) the tissue was 
trypsinised with trypsin-EDTA (see Section 2.2.1) at 4 ± 1°C overnight to separate the 
epithelial cell layer from the underlying connective tissue. This was conducted at low 
temperatures to minimise the uptake of the trypsin-EDTA by the epithelial cells. 
Separation of the epithelial layer from connective tissue was carried out aseptically 
under magnification using a sterile scalpel. The epithelial layer was then placed into 
the flask with the mitomycin C treated 3T3 cells immediately following removal of the 
3T3 culture medium.  
10 mL pre-warmed epithelial cell culture media (as described in Section 2.4.1) was 
added and the flask was incubated at 37 ± 2°C, in 5 % CO2 and monitored using light 
microscopy for signs of growth. 
2.4.2  Primary epithelial cell culture using the explant method  
An alternative method for culturing primary epithelial cells was explored following 
problems experienced when using the method described in Section 2.4.1. These issues 
are described in detail in Section 3.2.3. 
Primary epithelial cell culture media and reagents – explant method 
The explant method uses different growth media in which to culture cells than 
previously described. Wash-PBS and cell culture media were made up as indicated in 
Tables 2.5 and 2.6, and stored aseptically at 4°C until use.  
Wash-PBS: 
PBS without Mg2+or Ca2+ (Gibco, UK) with the addition of the following antimicrobials: 
Penicillin /Streptomycin (Sigma-Aldrich, UK)  100U, 0.1mg/mL 
Amphotericin B (Sigma-Aldrich, UK) 0.25 µg/mL 
Table 2.5 – Wash-PBS 
Serum free culture media (SFM): 
DMEM with or without Ca2+ (Gibco, UK) 75% plus DMEM F-12 (Gibco, UK) 25% with the 
following supplements: 
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L-Glutamine (Sigma-Aldrich, UK) 2 mM 
Hydrocortisone 0.4 ng/mL 
Penicillin / streptomycin (Sigma-Aldrich, UK) 100U, 0.1 mg/mL 
Gentamycin (Sigma-Aldrich, UK) 0.1 mg/mL 
HEPES buffer (Gibco, UK) 1 in 100 (1M) 
ITS-X (Insulin-Transferrin-Selenium-Ethanolamine, Gibco, UK) 1 in 100 (100x) 
HEGF (Human Epidermal Growth Factor, Gibco, UK) 10 ng/mL 
Choleratoxin (Sigma-Aldrich, UK) 1 µg/mL 
Table 2.6 – Serum free culture medium 
DMEM without Ca2+ was used when cells were growing and multiplying as anticipated. 
Initially, DMEM with Ca2+ was used to aid cellular attachment and proliferation.  
Explant method protocol  
Biopsy samples or waste tissue were stored in transport medium as previously 
described (Section 2.4.1). Samples were washed repeatedly in warmed wash-PBS to 
remove any blood contamination or bacterial contaminants on the tissue surface. A 
sterile disposable scalpel (Schwann-Morton, UK) was then used to dissect the epithelial 
layer from any attached connective tissue under 3x magnification. The epithelium was 
subsequently divided into small pieces of approximately 1-2 mm in diameter. These 
were then re-washed in wash-PBS and placed onto tissue culture treated polystyrene 
as required (flasks or well plates were employed, Corning, UK). The tissue was left for 
15-20 min to dry slightly and to adhere. Subsequently an appropriate volume 
(depending on flask or well size) of warmed SFM was gently dropped onto the 
explanted tissue. The explants were then incubated at 37 ± 1°C in 5% CO2 and 
examined using light microscopy daily. Medium was changed every 4 days. 
 
2.5   RNA isolation and Polymerase Chain Reaction (PCR) 
2.5.1   RNA isolation from cultured cells 
Cells were cultured in 25 cm2 flasks and treated with trypsin-EDTA, washed and re-
suspended (see Section 2.2.2). The resulting single cell suspension was centrifuged at 
1000 rpm for 10 min and the resulting cell pellet was treated with 1 mL TRIreagent® 
(Sigma-Aldrich, UK) and pipetted thoroughly to mix. The resulting emulsification was 
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then either frozen and stored at -80°C until RNA isolation or used immediately 
according to the following protocol. Due to the presence of TiO2 NPs within the 
experimental system it was decided to use an alternative method of RNA extraction to 
the standard filter columns as a precaution, as it was possible that the TiO2 NPs may 
interfere with the filtration process. 
1. 200 µL of chloroform (Sigma-Aldrich, UK) was added to the homogenised TRI 
reagent containing the cell lysate in an autoclaved 1.5 mL centrifuge tube 
(Eppendorf, Germany). 
2. The tube was vortexed for 30 s and checked visually to ensure a homogenous 
colour. 
3. The tube was left at room temperature for 5 min. 
4. The tube was then centrifuged at 12,000 g for 15 min. 
5. The top clear aqueous layer from the tube was carefully removed using a 
pipette and placed into a clean centrifuge tube. Any remaining TiO2 NP 
stimulus was observed at the bottom of the centrifuge tube. 
6. 500 µL of isopropanol alcohol (Sigma-Aldrich, UK) was added to the tube and 
pipetted thoroughly to mix. 
7. The tube was left at room temperature (23 ± 2 °C) for 10 min. 
8. The tube was centrifuged at 12,000 g for 10 min, and the tube was oriented so 
the resulting pellet could be located after centrifugation. 
9. The supernatant was carefully removed, leaving the white pellet containing 
the RNA in the tube. 
10. The RNA pellet was washed with 1 mL of 70 % ethanol made up by adding 
pure ethanol (Sigma-Aldrich, UK) to RNase free water (Qiagen, UK) in a ratio 
of 7 parts in 10. 
11. The tube was centrifuged at 7,500 g for 10 min. 
12. The supernatant was removed and the resulting pellet was left to air dry until 
clear (after approximately 5-10 min) then dissolved in 50 µL of RNase free 
water. The resulting sample was then either purified as below or frozen at -
80°C until purification. 
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2.5.2   RNA purification and DNase digestion 
Before gene expression analysis, the resulting RNA was purified to ensure the quality 
of the samples was as high as possible. A commercial kit was used (RNeasy® mini kit, 
Qiagen, UK) with the following protocol. 
1. 600 µL of 70 % ethanol was added to the 50 µL RNA in water as prepared 
above. 
2. 650 µL of the resulting mixture was then transferred to the RNeasy spin 
column in a 2 mL collection tube and centrifuged at 10,000 rpm for 30 s. 
3. The flow through was discarded and 350 µL of buffer RW1 was added, then 
the column was centrifuged at 10,000 rpm for 30 s. 
4. The flow through was discarded. 70 µL of DNase I (Qiagen UK, made up 
according to the manufacturer’s instructions) was added directly to the 
column membrane, taking care not to touch the edge of the column. This was 
left for 10-15 min at room temperature (23 ± 2°C). 
5. 350 µL of RW1 buffer was added and then the column was centrifuged at 
10,000 rpm for 30 s. 
6. The flow through was discarded. 500 µL of RPE buffer was added and the 
column was centrifuged at 10,000 rpm for 30 s. 
7. The flow through was discarded. 500 µL of RPE buffer was added and the 
column was centrifuged at 10,000 rpm for 2 min. The flow through was 
discarded. 
8. The column was placed in a new 1.5 mL collection tube and centrifuged at 
15,000 rpm for 1 min. 
9. The column was placed into a new 1.5 mL collection tube and 30 µL of RNase 
free water was added. The column was centrifuged at 10,000 rpm for 1 min to 
elute the purified RNA. 
Care was taken to avoid samples becoming degraded so samples were stored on ice 
whenever possible. Following purification, quantified samples were stored at -80°C 
until use.  
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2.5.3   RNA quantification 
RNA was quantified spectrophotometrically using a Biophotometer (Eppendorf, UK) to 
establish the concentration of RNA in the samples. A dilution of each RNA sample (2 µL 
of sample with 68 µL of RNase free water) was produced and placed into a cuvette 
(Eppendorf, UK). The absorbance at 260 nm was read, with a value of 1 unit at 260 nm 
at the dilution of 2 µL in 70µL indicating a concentration of 40 µg/mL of RNA or single 
stranded DNA. Sample purity was also determined by assessing the ratio between 
absorbances at 260 and 280 nm (A260/A280), with a higher ratio indicating a higher 
purity (ideal range 1.7+). 
2.5.4   Reverse transcription (RT) 
RT is the process by which cDNA (a DNA strand complementary to the mRNA) is 
synthesised. RT was performed on samples using the Tetro cDNA Synthesis Kit (Bioline, 
US) according to the following protocol. Oligo (dT) primer was used to incorporate a 
sequence of 15-20 thymine bases complementary to the sequence of Adenine bases 
located at the 3‟ end of eukaryotic mRNA molecules. Therefore, only mRNA species 
within the total RNA sample were reverse transcribed due to the fact that other RNA 
species will not possess poly-A tails. 
1. A mastermix was made per sample of the below constituents for each RNA 
sample processed: 
 1 µL oligo (dT)18  
 1 µL 10 nM dNTP 
 4 µL 5x RT buffer 
 1 µL reverse transcriptase (200 U/µL)  
2. 2 µg of RNA were made up (depending on the quantification result, see 
Section 2.5.3) per sample to give a final volume of 12 µL in RNAse free water 
in a 0.5 mL Eppendorf plastic tube. 
3. 8 µL of mastermix was added per tube. 
4. A thermal cycling block (Eppendorf Mastercycler gradient, Eppendorf, UK) was 
used to incubate samples at 45°C for 30 min followed by 85°C for 5 min. 
Samples were then held at 4°C. 
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2.5.5  Purification and concentration of cDNA 
The resulting cDNA was concentrated and purified to remove unincorporated RT 
components. RNAse free water was added to each sample up to a volume of 500 µL. 
This mix was then added to a microcon filter (Amicon 0.5 mL centrifugal filter unit, 
Millipore, UK) and centrifuged according to the protocol below: 
1. Centrifuged at 10,000 rpm for 2 min 
2. The level was checked to ensure there was still sample within the filter 
3. Centrifuged at 8,000 rpm for 1 min 
4. The level was checked again to ensure there was still adequate sample in the 
filter 
5. Centrifuged at 8,000 rpm for 1 min 
6. There now should remain approximately 50-60 µL sample within the filter. 
The column was then inverted into a new collection tube and centrifuged at 
8,000 rpm for 1 min to remove the sample from the filter. 
This sequence of filtering ensures cDNA is collected while contaminants are removed 
in the water which is spun through the filter. The samples were then stored at -20°C 
until use.  
2.5.6  Semi-quantitative PCR 
Semi-quantitative PCR was performed on agarose gels for all experiments in this work. 
All samples were prepared using the RedTaq system (Sigma-Aldrich, UK) in 25 µL 
reaction volumes in PCR tubes (Eppendorf, UK) as per the following protocol: 
 12.5 µL RedTaq 
 2 µL forward and reverse primer mix (primers were purchased from Life 
Technologies, UK. The primer mix was made by adding 60 µL RNAse free 
water to 10 µL of the forward and reverse primer once reconstituted 
according to the manufacturer’s protocol). 
 9.5 µL RNAse free water 
 1 µL cDNA 
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The resulting mix was then cycled using the thermal cycling block as before according 
to the Table 2.8 (altered according to primers used as per information from 
manufacturer and also according to the amount of target sequence present in the 
sample): 
Reaction stage Temperature Time  
 
Repeated cycles dependent 
upon amount of target 
sequence 
Denaturation 94°C 5 min 
Denaturation 94°C 30 s 
Annealing Individual to primer 20 s 
Polymerisation 68°C 20 s 
Hold 4°C indefinite  
Table 2.8 – PCR cycling 
Agarose gel preparation and electrophoresis 
A 1.5 % agarose gel was prepared in 1 x TAE buffer (40 mM Tris base, 20 mM acetic 
acid and 1 mM EDTA in distilled water) by adding 0.9 g agarose powder (Bioline, UK) 
with 60 mL of 1 x TAE buffer. The mixture was heated to boiling point to dissolve the 
agarose, then cooled slightly before adding 5 µL Web Green Advance DNA Stain (Web 
Scientific, UK) and mixing. The gel was then poured into a gel tray and sample wells 
were created using a plastic comb before being left to set at room temperature for 
approximately 30 min to 1 h.  
To run the electrophoresis, the gel was placed in an electrophoresis tank (Fisher 
Scientific, UK) and immersed in TAE buffer. The sample combs were removed and any 
resultant air bubbles in the sample wells were gently dislodged. 5 µL of each PCR 
sample was loaded into each experimental well alongside a DNA ladder (PCRRanger 
100bp DNA Ladder, Geneflow, UK) to enable size determination of the DNA products. 
Electrophoresis was then performed for approximately 20 min at 120 V, or long 
enough to show adequate band separation before the red tracking dye ran off the gel. 
After electrophoresis, gel images were captured using the Electrophoresis 
Documentation and Analysis System (Kodak, UK) under exposure to UV light and 
analysed using AIDA image analysis software (Fuji, UK). 
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Sample normalisation 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an enzyme involved in 
glucose breakdown, and the genetic expression of GADPH is used as a ‘housekeeping’ 
marker to normalise samples of cDNA. This protein should be evenly expressed 
between samples, therefore if the expression of GAPDH is normalised between 
samples then any up or down-regulation of other proteins can be attributed to 
changes within the cells being studied as opposed to the quality or abundance of cDNA 
within individual samples. An example of normalisation of samples is shown below: 
 
Figure 2.4 – Bands of GAPDH expression selected and the intensity of each ‘blot’ is generated 
by AIDA image analysis software. This is then calculated as per the equation below to give the 
volume of cDNA required from each sample. The brightest blot was used as the band to 
normalise to. This process is repeated until values within 10-15 % are obtained.  
𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑡𝑒𝑠𝑡 𝑏𝑎𝑛𝑑
𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑡ℎ𝑒 𝑏𝑟𝑖𝑔ℎ𝑡𝑒𝑠𝑡 𝑏𝑎𝑛𝑑
× 𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑠𝑎𝑚𝑝𝑙𝑒 = 𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑐𝐷𝑁𝐴 𝑟𝑒𝑞𝑢𝑖𝑟𝑒𝑑 
 
Cycle number was also optimised for each different primer and an example is shown in 
Figure 2.5. 
Sample           1                   2                    3                   4    
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Figure 2.5 – PCR gel image at 30, 35 and 40 cycles for 4 samples and 3 primers tested, showing 
more definite bars at 35 and 40 cycles compared with 30 cycles for all 3 primers. 
Following normalisation of samples according to intensity of initial results and 
optimisation of cycles for each primer, gels were run accordingly and the intensity of 
the bands generated gives an approximate quantity of gene product expression, hence 
“semi-quantitative” PCR. 
2.5.7  Quantitative Real Time Polymerase Chain Reaction (qPCR) 
The PCR method detailed in Section 2.5.6 has limitations due to the fact that it is only 
semi-quantitative. The alternative method, qPCR, detects changes in protein 
expression during cycling, instead of identifying an amplification or reduction in gene 
expression after a set time of cycling. qPCR is carried out in a thermal cycler which can 
detect the fluorescence emitted by a fluorophore specific to the target protein.  
qPCR method and housekeeping gene selection 
Reference genes were selected from a panel of targets suggested by the literature. 
Target genes were chosen to firstly confirm the microarray data findings (see Chapter 
6) and secondly to further investigate cytokine expression (see Chapter 7). Specific 
cDNA primers were purchased (Sigma-Aldrich, UK) as per Table 2.9. 
 
Primer 1              Primer 2             Primer 3    
                      30 cycles 
                       35 cycles 
                       40 cycles 
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Housekeeping genes Targets selected 
GAPDH  ID1, ID2, ID3 for microarray confirmation
  
YWHAZ (tyrosine 3/tryptophan, 5-
monooxygenase activation protein, zeta 
polypeptide) 
IL8 
 
 
 
                            For ELISA comparison 
TNFα           
 
IL-1β 
 
IFN-ɣ 
B2M (beta-2-microglobulin) 
ACTB (Beta Actin) 
 
Table 2.8 – qPCR primers 
The thermal cycler used was a Roche LightCycler 480 system. A 96-well microtiter plate 
(LightCycler® 480) containing a total of 20 µL per well: 
Constituent Volume in well 
cDNA  1 µL 
LightCycler® SYBR green PCR mix (Sigma-Aldrich, 
UK) 
10 µL 
Primers at 0.5 µM concentration variable 
RNase and DNase free water variable 
Table 2.9 – qPCR reagent mix 
The plate was covered, centrifuged for 3 min at 1500 rcf and then placed into the 
thermal cycler. Samples were amplified in duplicate and two controls for each primer 
containing no template were included for every run. The cycling protocol is described 
in Table 2.10, and an example of the output of amplification data in graphical format is 
in Figure 2.4. 
 Temperature (°C) Time  Cycles 
Pre-incubation 98 5 min 1 
Denaturation 98 20 s 60 
Annealing 60 20 s 60 
Extension 72 30 s 60 
Melting 98 - 1 
Cooling 4 Hold 1 
Table 2.10 – The qPCR cycling protocol used. 
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Figure 2.6 - Amplification of YWHAZ gene according to the protocol previously described. 
Features are: Denaturation (    ), Quantification during each denaturing/annealing/extending 
cycle shown by the green dots, and the melting of the product (     ). 
Following cycling, data were gathered and analysed following the manufacturer’s 
instructions from crossing point (Cp) values by methods within the thermal cycler’s 
software (Roche diagnostics version 1.5). The housekeeper gene data were inputted 
into the BestKeeper algorithm (Pfaffl et al., 2004), and using information on the 
expression of each housekeeper gene, a panel of results for each is analysed (Cp 
values, standard deviation and coefficient of variance), and the most appropriate 
housekeeper for the target cells is recommended. The data generated by BestKeeper 
are shown in Figure 2.7. The lowest standard deviation implies the most consistent 
gene, therefore YWHAZ was chosen as an appropriate housekeeper gene from this 
panel, and used as a reference gene for quantification of the target genes. 
  GapdH YWHAZ B2M ACTB 
n 9 9 9 9 
geo Mean [Cp] 17.31 17.65 19.36 19.50 
ar Mean [Cp] 17.32 17.65 19.37 19.50 
min [Cp] 16.79 16.73 18.88 19.03 
max [Cp] 18.75 18.47 20.70 20.90 
std dev [± Cp] 0.40 0.33 0.43 0.39 
CV [% Cp] 2.34 1.89 2.20 1.99 
min [x-fold] -1.39 -1.80 -1.38 -1.40 
max [x-fold] 2.50 1.69 2.44 2.72 
std dev [± x-fold] 1.29 1.24 1.31 1.28 
Table 2.11 - Cp data of housekeeping genes 
qPCR results and analysis 
A set of curves is generated for each gene. Figure 2.7 shows the amplification curve, 
standard curve and melt curves for the YWHAZ housekeeping gene. 
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Figure 2.7 – Amplification curve, efficiency standard curve and melt curve for YWHAZ 
housekeeper gene. The amplification curve is of a series of dilutions of YWHAZ and two no-
template controls (flat lines), and this information was used to generate the standard curve by 
the LightCycler® 480 software. An efficiency of 2.0 is considered to be 100% efficient in this 
context, and the efficiency of the above curve is 1.93. The melt curve shows a single peak, 
ensuring that only the target is being amplified by the primers. These curves are produced for 
each reference gene and target gene.  
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2.6   Immunocytochemistry 
Immunocytochemistry (ICC) is a method where antibodies to specific cellular antigens 
are counterstained with a label to permit visualisation of either the presence or 
absence of the target antigen, or localisation of the antigen within a cell. Different 
labels can be used, for instance fluorescent conjugates or stains visible under light 
microscopy. These labels can be directly conjugated to the antibody in the case of 
direct ICC or immunofluoresence (IF), or indirectly linked via a third molecule in the 
case of indirect ICC or IF.  
The method used in this thesis was based on indirect staining of the target antigen 
with a brown stain visible under light microscopy called the biotin-streptavidin 
amplified technique (SuperSensitive® Link-Detection Kit, BioGenex). The staining 
mechanism has been previously used to investigate NFκB activation (Milward et al., 
2007, Milward et al., 2013) as the translocation of NFκB from the cytoplasm to the 
nucleus of activated cells can be visualised using this method. The effects of TiO2 NPs 
both alone and alongside known NFκB activating factors was investigated by the 
following method. 
2.6.1 Staining for NFκB activation using the SuperSensitive® Link-Detection Kit 
overview 
The protocol for staining described below has four main stages to allow visualisation of 
the location of NFκB within cells.  
 The first stage requires a primary antibody to link to the target antigen (NFκB 
in this case).  
 The second stage involves a link immunoglobulin which specifically binds to 
the primary antibody.  
 The third stage is where a streptavidin label binds to the link molecule and 
expresses horseradish peroxidase (HRP). 
 The final stage is the addition of diaminobenzidine (DAB), a clear stain which 
oxidises on exposure to peroxide in the label molecule to produce a brown 
precipitate visible by light microscopy.  
 62 
 
Figure 2.8 is a diagrammatic representation of the indirect ICC staining method. After 
staining with DAB, the nuclei of the cells were counterstained using Mayer’s 
haematoxylin to allow better visualisation of any translocation of NFκB into the nuclei 
of the cells during activation. The reagents for this staining system are supplied in kit 
form from BioGenex. A test was carried out to optimise the use of this system and 
ascertain the optimum incubation times for the DAB and haematoxylin.  
 
Figure 2.8 – Diagrammatic representation of an indirect ICC system. 
Each slide contained a positive and negative control well to ensure that the staining 
protocol had worked successfully and that any staining seen is likely to be a true result. 
Figure 2.9 illustrates the layout of each slide. 
  
             
 
+ve control -ve control Experimental 
wells 
 + - 
1 2 
Visible stain 
diaminobenzidene (DAB) 
oxidises to brown on contact 
with HRP 
Label (links streptavidin to 
horseradish peroxidase 
(HRP)) 
Link molecule (Links primary 
antibody to streptavidin) 
Primary monoclonal antibody  
 
Cell substrate 
Figure 2.9 – layout of multiwell slides for ICC. Positive control incubated with Ki-67 antibody, 
negative control incubated with PBS/BSA only.  
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Positive control: The left well was treated with a monoclonal antibody to the Ki-67 
nuclear protein. The expected result would be brown staining confined to only the 
nucleus of the cells in this well, as Ki-67 is not expressed in the cytoplasm of human 
cells. Any brown staining in the cytoplasm would therefore imply cross contamination 
between wells of primary antibodies or a lack of specificity in the staining system. 
Negative control: The right well was treated with PBS BSA (1 %) in the place of a 
primary antibody, therefore the expected result would be no brown staining in the 
cells. Any brown staining in this well would imply cross contamination of antibody or a 
lack of specificity in the staining system. Both positive and negative control wells were 
counterstained with Meyer’s haematoxylin so should have blue staining visible in the 
nuclei.  
ICC NFκB staining protocol using the SuperSensitive® Link-Detection Kit (SS L-D) 
1. H400 cells were grown on 4 well slides (Hedley-Essex, UK) until approximately 
70 – 80 % confluent. Cells were seeded directly into the wells on cleaned 4 
well slides at a concentration of 4 x 105 cells in 15 mL supplemented DMEM. 
The slide was placed into an autoclaved glass petri dish and incubated as 
described in Section 2.2.2. The glass petri dish and slides were autoclaved 
prior to use to prevent contamination. The DMEM was changed at day 4 
under aseptic conditions as previously described. Cells were cultured for 5 
days prior to use to minimise the potential stimulatory effects of passage and 
re-seeding cells on any inflammatory pathways.  
2. Cells were stimulated as described in Section 2.6.2, then removed from the 
dish and washed quickly in chilled PBS (4 ± 1°C). 
3. Slides were fixed in dry acetone (Sigma-Aldrich, UK) at room temperature for 
15 min and then allowed to air dry for 10 min at room temperature.  
4. Following fixation, the wells in each slide were circled with a water repellent 
pen (Sigma-Aldrich, UK) to decrease the likelihood of cross contamination 
between wells. Primary antibodies were then added to each well as follows: 
a. Positive control: 100 µL Clone MM1 antibody to Ki-67 (NovacastraTM, UK) at 
a dilution of 1:100 in PBS BSA 1 %. 
b. Negative control: 100 µL dilutent only. 
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c. Experimental wells: 100 µL monoclonal antibody to NFκB p65 subunit 
(Clone F-6, Santa Cruz Biotechnology, US) at a dilution of 1:100 in PBS BSA 
1 %.  
5. Slides were placed in a humidity box at room temperature for 1 h. After this 
stage, the slides were not allowed at any point to dry. 
6. After 1 h, the antibody was tipped quickly away to prevent cross 
contamination, and the slides were washed in fresh PBS 3 times for 2 min and 
gently agitated on an orbital mixing platform. 
7. Every well was then treated with 2-3 drops of ‘Link’ reagent from the SS L-D. 
Care was taken to ensure the whole of the well was covered. The slides were 
incubated for 20 min at room temperature as per the manufacturer’s 
instructions. 
8. Slides were washed as before (step 6) then 2-3 drops of ‘Label’ from the SS L-
D was added to each well. Care was taken to ensure the whole of the well was 
covered. The slides were incubated for 20 min at room temperature as per 
the manufacturer’s instructions. 
9. Slides were washed as before (step 6) then 2-3 drops of freshly prepared DAB 
reagent (2 drops of ‘Chromagen’ added to a 2.5 mL vial of ‘Substrate Buffer’ 
from the SS L-D) was added to each well. Care was taken to ensure the whole 
of the well was covered. The slides were incubated for 5 min at room 
temperature (optimum time ascertained by initial testing). 
10. Slides were then washed under running water for 2 min and counterstained 
with ‘Haematoxylin’ from the SS L-D for 5 min (optimum time ascertained by 
initial testing).  
11. Slides were then washed in running deionised water for 2 min, then 
dehydrated through graded alcohol baths and cleared in xylene (Sigma-
Aldrich, UK) before being mounted in XAM mounting medium. Slides were 
kept in the dark and horizontally for a day after mounting to prevent any 
movement of the mounting medium or coverslip before it was fully dry. 
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2.6.2  Stimulation of H400 cells prior to ICC 
Prior to staining, the cell culture medium was changed on day 4 post-seeding. Old 
medium was aspirated from the petri dish and discarded, and 15 mL of warmed fresh 
medium was pipetted into the dish with minimum disruption to the slide. In the case 
of cells being exposed to TiO2 NPs, cell culture medium containing 10 ppm anatase NPs 
(prepared as before) was substituted for plain medium. Cells were stained as per the 
above protocol on day 5 post seeding. 1 h prior to staining, cells were stimulated as 
indicated in the table below to activate NFκB nuclear translocation. 
E. coli LPS was purchased from Sigma-Aldrich, diluted to a stock concentration of 
1mg/mL, and stored in aliquots at -20°C prior to use.  
Condition Stimulant and concentration 
Control Warmed DMEM 300 µL into 15 mL in dish to mirror LPS or FN fluid addition 
LPS E. coli LPS (Sigma-Aldrich, UK) final concentration of 20 or 40 µg/mL  in cell 
culture medium 
FN Fusobacterium nucleatum (heat killed) at a multiplication of infection (MOI) of 
approximately 100 bacteria per epithelial cell (see Section 2.9.5) 
Table 2.12 - Concentrations of stimuli for H400 cells prior to immunocytochemistry staining 
2.6.3  Quantification of NFκB translocation 
Cell counts were performed using colour images captured by a Zeiss Primovert 
microscope and a Retiga camera (standard settings) and then analysed using FIJI 
(ImageJ) software 1.49k (National Institutes of Health, Bethesda MD, USA). 
Before cell counts were performed, the positive and negative control wells were 
studied to ensure they showed the expected results (Figures 2.10 and 2.11): 
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Figure 2.10 - Expected result showing positive control for immunocytochemistry (Ki67) well 
demonstrating DAB staining localised to the nucleus and minimal staining in surrounding 
cytoplasm. 
 
Figure 2.11 - Expected result showing negative diluent control demonstrating an absence of 
DAB staining when the primary antibody is omitted. 
Experimental slides were analysed by blinded cell counts as per the images below. 
Labelled folders of images were given pseudonyms by a third person before counts 
were performed. Sets of 50 cells taken from the top right of 10 randomly selected 
areas of the slides were counted and classified as positive or negative. These numbers 
were then plotted to form Hunting curves to determine how many sets of 50 cells 
needed to be counted to produce an accurate estimate of the percentage of cells 
activated. 
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Figure 2.12 - Control well from stained NFκB slide. DAB stained NFκB can be seen in the 
cytoplasm with minimal translocation to the nucleus. 
 
Figure 2.13 – E. coli LPS stimulated well from a slide. DAB stained NFκB can be seen 
translocated to the nucleus, meaning the blue haematoxylin counterstain is no longer clearly 
visible and nuclei are stained brown.  The DAB stain intensity in the cytoplasm is reduced. 
In situations where translocation was not clear, cells were counted as negative to 
minimise the incidence of false positives. Manual cells counts were performed to 
identify numbers of “positive” and “negative” cells. The number of fields that required 
cell counts to produce a representative indication of NFkB translocation was 
determined using Hunting curves.  
 
Negative result for 
NF-κB translocation 
(blue counterstained 
nucleus clearly 
visible, brown 
staining confined to 
cytoplasm) 
 
Positive result for 
NF-κB translocation 
(nucleus clearly 
stained brown 
visible, less intense 
brown staining in 
cytoplasm) 
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Hunting curves: 
An example of the Hunting curve produced is below. Each graph showed that a reliable 
mean of positively stained cells was reached after 10 counts of 50 cells. 50 cells were 
chosen as the number to count on each image. Where there were many more cells 
present, the 50 cells to the left of the image were counted. If there were fewer the 
image was discarded. 
 
Figure 2.14 – Hunting curve showing cell counts against cumulative mean of percentage of 
positively stained cells showing 10 counts of 50 cells is adequate for quantification of NFκB 
activation. This result was consistent between each condition (control and experimental wells).  
 
2.7   Immunofluoresence staining of cultured cells 
Indirect immunofluoresence (IF) works on the same principle as 
immunocytochemistry, however, the stain used is a fluorescent conjugate and 
visualised using fluorescence microscopy. This method was used to identify the 
presence of epithelial specific markers (cytokeratins) in tissue grown out from 
epithelial cell biopsies to ensure the outgrowth was epithelial and not mesenchymal in 
origin.  
The primary antibody chosen must be cross reactive with the species that the cells or 
tissue were derived from (e.g. anti-cytokeratin IgG produced in mouse). The secondary 
antibody must be specific to the primary antibody (e.g. goat anti-mouse IgG) and 
conjugated to a fluorescent label (e.g. FITC). 
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Figure 2.15 - Diagram of indirect immunofluorescence. 
 
1. Coverslips (#1.5 thickness, 13 mm diameter, Scientific Laboratory Supplies, 
Nottingham, UK) with attached cells were washed 3 times with PBS.  
2. Coverslips were fixed in neutral buffered formalin 10 % (Sigma-Aldrich, UK) for 
10 min at room temperature, then washed 3x with PBS as before.  
3. Coverslips were then washed 3 times with PBS BSA (1 %).  
4. A staining tray (large Petri dish, Corning, UK) was lined with a piece of 
Parafilm®M (Sigma-Aldrich, UK). 50 µL diluted primary antibody was placed on 
the film, and the coverslip inverted onto the droplet, cell side down. 
5. The coverslips were incubated at room temperature away from light for 1 h, 
then washed in PBS 3 times as before. 
6. 50 µL diluted secondary antibody was placed on fresh film, and a coverslip 
was placed cell side down onto the antibody drop.  
7. After incubating for 45 min at room temperature away from light, a glass slide 
was prepared by placing a drop of Fluoroshield® with DAPI mounting medium 
(Sigma-Aldrich, UK) onto the surface. The coverslip was washed 3 times in 
PBS, dried by gently blotting the edge of the coverslip onto tissue, and 
mounted onto the slide using Fluoroshield® mounting medium with DAPI 
Secondary antibody with 
fluorescent label (e.g. anti-
mouse IgG conjugated to 
FITC) 
Primary antibody specific to 
antigen (e.g. anti-
cytokeratin IgG produced in 
mouse) 
Cell / tissue substrate 
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(Sigma-Aldrich, UK). The slide was then stored in the dark until dry, and then 
at -20°C for longer term storage. 
 
2.8   Microscopy techniques 
The overall strategy for imaging epithelial cells was to use a variety of methods to 
image different potential interactions between TiO2 NPs and either H400 or primary 
oral epithelial cells. Simple light microscopy enabled visualisation of agglomerations of 
TiO2 NPs even following repeated washing of the cell monolayer, however any further 
visualisation of potential interactions by this method was limited. The capability of 
visualising interactions in the form of intracellularisation, membrane interactions, 
internal cell structure and the impact on cellular morphology cannot be provided 
through one technique alone. Transmission electron microscopy (TEM) was therefore 
used as a method of cellular imaging as it enables imaging of Sectioned cells, thereby 
allowing visualisation of intracellular structures. Confocal reflectance microscopy was 
also employed to locate agglomerations of nanoparticles associated either with the cell 
membrane or intracellularly. 
2.8.1  TEM  
TEM was used to investigate the appearance of epithelial cells both before and after 
exposure to Ti stimuli. TEM is a microscopy technique which uses an electron beam to 
pass through thin sample sections, and is capable of imaging at far higher 
magnification and resolution than light microscopy. The method however relies upon a 
complex sample fixation (which may introduce artefacts) and sectioning protocol, and 
is relatively time consuming to capture images of a good quality and quantity in the 
context of biological samples. It is necessary to find cleanly Sectioned cells which have 
not been creased or damaged during processing. However, this technique can 
successfully be used to visualise intracellular structures in detail. 
Cell fixation and processing prior to TEM 
1. Cells were cultured in appropriate cell culture treated plasticware as 
previously described. After stimulation with the selected Ti species for a 
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predetermined time, cell monolayers were washed with warmed PBS (Gibco, 
UK) 3x to remove as much loose Ti product as possible. 
2. Cells were then treated with trypsin-EDTA as previously described for 10 min 
at 37 °C and 5 % CO2 and gently agitated to detach from the plasticware. 
3. The resulting cell suspension was then transferred to a sterile universal 
container with an equal volume of warmed supplemented DMEM and 
centrifuged for 10 min at 1000 rpm. 
4. The supernatant was removed and discarded and the resulting cell pellet was 
re-suspended in an appropriate volume of freshly prepared chilled 2.5 % 
gluteraldehyde fixative (CEM, University of Birmingham). This was worked out 
at a ratio of 1 mL fixative per 1 x 106 cells. 
5. Cells were kept in fixative at 4°C until transported to the Centre for Electron 
Microscopy (CEM) at the University of Birmingham. The time in fixative can be 
between 1 h and several days. Where possible, the samples in this thesis were 
kept in fixative for less than 3 days. 
6. Samples were further processed by staff of the CEM according to the 
following protocol: 
a. Secondary fixation in 1 % osmium tetroxide for 1 h. 
b. Dehydration through graded alcohols – 50, 70, 90 and 100 % alcohols for 2x 
15 min each, followed by propylene oxide for 2x 15 min. 
c. Following dehydration, samples were embedded in propylene oxide: resin 
at a ratio of 1:1 on a rotator followed by pure resin for 1 h on a rotator. 
d. Samples were then positioned just under the surface of the resin in 
embedding moulds and placed in a vacuum for 30 min before allowing back 
to atmospheric pressure. 
e. The resin was then polymerised ay 60°C for at least 16 h. 
f. Sectioning of samples at a thickness of 50 – 15 nm was performed using a 
diamond blade and placed onto electron microscope grids (Formvar film 
with carbon coating). 
7. Following processing, TEM samples were stored in the dark at room 
temperature prior to examination using a Jeol 1200EX transmission electron 
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microscope (Jeol, USA) at a power of 80 keV and between x2,000–x10,000 
magnifications. 
2.8.2  Reflectance confocal microscopy 
This method of imaging uses a combination of light microscopy to capture a confocal 
stack of images through a sample and a reflectance mode which can image the 
reflectance of a specific target particle. In this case, TiO2 NP agglomerations were 
imaged using the reflectance mode. The light microscopy and reflectance images are 
then merged to provide a composite image allowing localisation of the target particle 
within a tissue. 
To obtain the reflectance image, TiO2 NPs were imaged in the absence of any cells in 
the reflectance mode, and the microscope was calibrated to the settings which would 
best visualise these agglomerations. A control cell monolayer was then imaged using 
the reflectance mode, and this background reflectance was subtracted from the 
subsequent images captured, therefore allowing visualisation of TiO2 NP 
agglomerations within a confocal stack of images. The same stack of images is then 
captured using light microscopy for orientation of where within the cell the TiO2 signal 
is captured. 
This technique requires cells to be adherent to a coverslip then fixed before 
visualisation. The method for culturing and fixing epithelial cells for this technique is 
listed below. 
1. H400s were cultured on sterile coverslips (#1.5 thickness, 13mm diameter, SLS 
UK) placed into the base of a 6 well cell culture plate. Cells were grown until 
near confluence, determined by using light microscopy.   
2. Cell culture medium was then removed and replaced with media containing 0, 
1, 10 or 100 ppm TiO2 NPs (<25nm diameter) prepared as described in Section 
2.1 and incubated for 0, 3, 6, or 9 h.  
3. Coverslips were then removed from media, washed 3 times in PBS to remove 
as much excess anatase as possible, and fixed as per the following protocol: 
a. Coverslips were immersed in formalin (Sigma-Aldrich, UK) at room 
temperature for 15 min. 
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b. The formalin was then neutralised with NH4Cl 50 mM (Sigma-Aldrich, UK) 
in PBS for 7 min. 
c. Coverslips were then washed with fresh NH4Cl 50 mM once and with room 
temperature PBS twice. 
d. The coverslips were inverted and mounted on plain glass microscope slides 
(Hedley Essex, UK) using one drop of Fluoroshield™ with DAPI (Sigma-
Aldrich, UK) and air dried in a dark drawer. The edges of the coverslips 
were then sealed with nail polish. 
Each sample was then examined using a confocal microscope (Carl Zeiss Microscopy, 
Oberkochen, Germany) using 488 nm and 543 nm lasers and an oil objective 
lens. Reflectance images were captured using an A1R inverted confocal microscope 
(Nikon Corporation, Tokyo, Japan). Cells were randomly selected and a point in the 
middle of the z-stack was chosen following identification of the nucleus to ensure 
images were truly intracellular. The resulting images were captured as TIFF files and 
analysed using FIJI (ImageJ) software 1.49k (National Institutes of Health, USA).  
2.9  ROS (Reactive Oxygen Species) production by neutrophils 
Neutrophils release ROS as part of their role in the innate immune system to protect 
the host from pathogenic bacterial challenge. Neutrophil responses can be measured 
in vitro by stimulating harvested neutrophils and measuring ROS release.  
Recruitment of neutrophils to the periodontal / peri-implant tissues occurs in response 
to molecular signals (chemokines) released at the site of injury. Historically it was 
thought that epithelial cells were simply a barrier cell, and that the sole function of 
epithelium was to provide a mechanical barrier to injury, be it physical or bacterial. 
However, there is a mounting body of evidence highlighting a role for epithelial cells to 
generate a pro-inflammatory response when stimulated, by releasing a variety of both 
pro and anti-inflammatory cytokines to signal to other cell types including neutrophils. 
Epithelial cells, specifically H400 cells, have been shown to produce specific cytokines 
(TNFalpha, IL-1beta, IL8, MCP-1/CCL2 and GM-CSF) (Milward et al., 2007) in response 
to a pathogenic challenge. IL8 in particular is important in the recruitment of 
neutrophils (Milward et al., 2007), therefore the hypothesis for this part of the work 
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was that cytokines may be produced by H400 cells in response to exposure to Ti 
products which could potentially promote an innate immune response via neutrophil 
recruitment.  
Primary neutrophils have an ex vivo life expectancy of up to 24 h (Ling et al., 2015) and 
are described as relatively fragile (Payne et al., 1994), therefore may not seem the 
ideal cell to use in vitro. However, some cell lines (such as HL60) have proven to 
inadequately respond in the same way as freshly isolated primary neutrophils so fail to 
offer a suitable model to study neutrophil responses. Therefore, this study used 
primary neutrophils harvested from donors to investigate cellular responses. However, 
it must be remembered that one of the issues with using cells harvested from human 
donors is the intra- and inter- donor variability in biological responses. 
The ROS production by neutrophils from healthy donors in response to various stimuli 
was investigated using luminescence assays. Luminol as a substrate produces a light 
output proportional to the total amount of ROS production by activated neutrophils 
and is a well-documented technique (Kopprasch et al., 2003) and is detailed in Figure 
2.16. Cell membranes are permeable to luminol, therefore both intracellular and 
extracellular ROS are detected. Isoluminol, a similar substrate to luminol, is also 
oxidised by ROS to form aminophthalate, but is less able to transverse cell membranes 
due to the position of the amino group within its structure when compared with 
luminol (Lundqvist and Dahlgren, 1996). Therefore, isoluminol detects extracellular 
ROS only. 
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Figure 2.16 – diagram of the ROS luminol/isoluminol based assay. 
For assays using isoluminol, supplementary horseradish peroxidase was added to 
amplify the chemilumnescence, and effectively replaces the intracellular 
myeloperoxidase which catalyses luminol during intracellular ROS detection. The 
principal ROS measured by luminol and isoluminol is HOCl, a downstream ROS from 
superoxide and hydrogen peroxide (Chapple and Matthews, 2007).  
2.9.1 Neutrophil isolation reagent preparation 
Percoll gradient preparation  
Percoll (GE Healthcare UK) densities were prepared as per Table 2.13 
 Density 1.079 Density 1.098 
Percoll (mL) 19.708 24.823 
H2O (mL) 11.792 6.677 
NaCl 1.5M (mL) 3.5 3.5 
Table 2.13 – Percoll densities 
6 mL of 1.079 density Percoll was carefully layered over 6 mL of 1.098 density Percoll 
in a 25 mL sterile universal tube (Fisher Scientific UK). These tubes were stored at 
room temperature for up to 2 h before neutrophil isolation commenced or 
refrigerated overnight at 4 °C then equilibrated to room temperature before use.  
 
3-aminopthalate 
ROS 
Luminol / Isoluminol (cyclic hydrazine 5/6-amino-2,3-
dihydo-1,4phthalazinedione)  
 
Light output 
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Lysis buffer preparation 
Lysis buffer was prepared as below and stored at 4 °C prior to use.  
NH4Cl (Sigma-Aldrich UK) 8.3 g 
KHCO3 (Sigma-Aldrich UK) 1.0 g 
EDTA 2H2O (Sigma-Aldrich UK) 0.04 g 
Bovine serum albumin (Sigma-Aldrich UK) 2.5 g 
Endotoxin free sterilised water (Versol, Aguettant UK) 1000 mL 
Table 2.14 – lysis buffer 
Neutrophil isolation protocol 
1. Blood was collected from volunteer donors who were not currently taking any 
anti-inflammatory or anti-microbial medication in 6 mL heparin anticoagulant 
vacutainers (Greiner UK). Ethical approval (number 10/H1208/48) was in place 
and all volunteers gave informed consent.  
2. 6 mL blood was layered gently over the prepared Percoll gradients using a 
Pasteur pipette. This was centrifuged for 8 min at 150 rcf followed 
immediately by 10 min at 1200 rcf (Hettich Universal 320R). 
3. Following centrifugation, the layers of separation are as below: 
 
 
Figure 2.17 – Diagram of Percoll blood separation tube following centrifugation indicating 
layers generated; notably the cloudy layer containing neutrophils. 
 
Clear plasma - 
discarded 
Cloudy layer 
containing neutrophils 
Red blood cell debris - 
discarded 
Percoll layer - 
discarded 
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The neutrophil containing layer was then transferred into a 50 mL centrifuge 
tube (Fisher Scientific UK) containing 30 mL lysis buffer. 
4. The tube was mixed gently and incubated at room temperature for 6 min or 
until the cloudy appearance had transformed into a non-turbid solution. 
5. The tube was then centrifuged at 500 rcf for 6 min. 
6. Following aspiration of supernatant, the resulting neutrophil pellet was re-
suspended in approximately 3 mL lysis buffer, mixed gently and incubated for 
5 min at room temperature before repeating centrifugation at 500 rcf for 6 
min. 
7. Following aspiration of the supernatant, the resulting cell pellet was re-
suspended in 2 mL PBS (as previously described) and centrifuged at 500 rcf for 
6 min in order to remove residual lysis buffer from the neutrophil suspension.  
8. Following aspiration of the supernatant, the resulting cell pellet was re-
suspended in 2 mL PBS and neutrophils were counted using a 
haemocytometer and viability determined using trypan blue dye exclusion as 
previously described (Section 2.2.2). 
2.9.2    ROS generation assay reagent preparation 
Luminol and isoluminol preparation 
A 30 mM stock solution of each reagent was prepared by dissolving 0.5 g luminol 
(Sigma-Aldrich UK) or isoluminol (Sigma-Aldrich UK) in 94.05 mL 0.1 M NaOH. These 
were stored at 4 °C in the dark prior to use.  
When required, a working solution was prepared by diluting 1 mL stock solution in 9 
mL PBS (as before) and adjusting the pH to 7.3 as necessary.  
Horseradish peroxidase (HRP) preparation 
A master stock solution was prepared by dissolving 1000 units HRP (Sigma-Aldrich UK) 
in 1.0 mL PBS (as before). This was stored at -20°C in aliquots of 105 µL. When 
required, an aliquot was defrosted and 945 µL PBS was added. 
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2.9.3   ROS assay protocol 
1. White, solid bottomed 96-well plates (Appleton Woods UK) were used to 
perform this assay. Both luminol and isoluminol were used in the same plate if 
required. Plates were pre-blocked with a 1 % BSA (Sigma-Aldrich UK) solution 
in PBS overnight at 4 °C to minimise neutrophils adhesion. 
2.  The plates were washed with fresh PBS before use using a microplate washer 
(BioTek ELx50). 
3. Reagents were added to wells as required. 
Reagent Luminol assay Isoluminol assay 
Luminol 30 µL - 
Isoluminol - 60 µL 
Glucose PBS 45 µL - 
Horseradish Peroxidase (HRP) - 15 µL 
Cell suspension (1 x 105 per well) 100 µL 100 µL 
Total volume: 175 µL 175 µL 
Table 2.15 – ROS assay protocol 
4. The cell suspension was added and the plate was placed into a luminometer 
(Berthold LB96v) at 37°C for 30 min. Readings were taken every 3 min to 
generate a background luminescence reading using Winglow software 
(Berthold Technologies, Bad Wildbad, Germany). This stage ensures any initial 
stimulation of neutrophils arising from handling and seeding into the plate 
does not adversely affect any stimulus response.  
5. 25 µL stimulus or PBS for negative controls was then added to each well to 
give a total volume of 200 µL. The luminescence was then read every 3 min 
for 2 h 30 min and the data collected as before or every 90 s if half a plate was 
used. If neutrophils were to be primed prior to stimulation 10 µL of primer 
was added after 30 min, and then neutrophils were stimulated after a further 
30 min. 
2.9.4    Preparation of bacterial stimuli  
A number of bacteria were cultured and prepared as neutrophil stimulants for the ROS 
assay and to investigate cellular responses in the presence of bacterial products.  
 79 
 
Fusobacterium nucleatum ssp Polymorphum (FN) 
FN is a Gram-negative periodontal pathogen (Settem et al., 2012, Roques et al., 2000), 
reported to activate neutrophils and epithelial cells via Toll Like Receptors (TLRs) 
(Kikkert et al., 2007), therefore was highly relevant in this work. Aliquots of heat killed 
FN (American Type Culture Collection [ATCC] 10953) were supplied as a gift from Dr 
Mike Milward at the University of Birmingham and stored until use at -20 ±1°C. 
Porphyromonas gingivalis (Pg) 
Pg is an important Gram-negative anaerobic periodontal pathogen associated with 
periodontal destruction (Hajishengallis et al., 2011) falling in to the red category of 
Socransky’s classification (Socransky et al., 1998). Pg (strain W83) aliquots were 
supplied as a gift from Dr Mike Milward at the University of Birmingham and stored 
until use at -20 ±1°C.  
Opsonised Staphylococcus aureus (Ops Sa) 
Sa is a Gram-positive bacterium commonly found on the skin and in the oral cavity of 
healthy individuals. Sa has however been isolated at higher levels from pockets of 
patients with aggressive periodontitis as opposed to chronic periodontitis (Fritschi et 
al., 2008), and Sa also elicits a strong neutrophil response (Brinkmann et al., 2004). Sa 
was opsonised to increase the neutrophil recognition of test bacteria (Voyich et al., 
2005). Sa (National Collection of Type Cultures 6571, Fisher Scientific) was cultured by 
inoculation of a mannitol salt agar plate (OXOID) and cultured overnight aerobically at 
37±1°C, 5% CO2. Bacterial colonies were then transferred to a sterile Pyrex bottle 
containing 500 mL sterile tryptone soya broth (OXOID) using a sterile plastic loop. The 
broth was cultured overnight (as before) and the resulting culture was divided into 10 
50 mL sterile centrifuge tubes (Fisher Scientific) before being subject to the following 
centrifuge and wash protocol: 
 10 min at 700 rcf then removal of the supernatant 
 Pellet was re-suspended in 20 mL sterile PBS (see 2.2.1) and vortexed to 
redistribute the bacteria 
 Resulting suspensions were pooled and centrifuged twice to produce two 
bacterial pellets 
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 The pellets were then re-suspended in 20 mL 10 % neutral buffered formalin 
(Sigma-Aldrich, UK) for 1 h at 22 ± 1°C 
 Centrifugation and re-suspension in PBS was repeated twice to remove the 
fixative 
 Bacterial concentration of the resulting suspension was measured by optical 
density using a spectrophotometer and a look-up table generated in house 
(Roberts et al., 2002) and diluted in PBS to achieve a concentration of 2.8 x 
107 bacteria per 50 mL tube. 
 To opsonise the bacteria, tubes were heat treated at 80°C for 20 min followed 
by the addition of Vigam at a concentration of 33 µL per 109 cells (a reagent 
containing active human IgG (Bio Products Laboratory) and incubated 
overnight on a shaker (Stuart Scientific S120H). 
 Following opsonisation bacteria were washed twice more and stored in 1 mL 
aliquots at -80 ± 1°C until use. 
 2.9.5  Chemotaxis assay 
Chemotaxis is defined as the movement of a cell or organism in response to a chemical 
stimulus gradient established in their local environment. Chemotaxis differs from 
chemokinesis, which is non-directional movement, while chemotaxis is a directional 
kinesis of a cell or an organism towards a chemoattractant along a chemical gradient. 
Neutrophils have been shown to be able to move in response to chemical stimuli in an 
in vitro situation, simulating the in vivo response whereby neutrophils are recruited 
from the peripheral blood supply to an area that is infected or colonised by bacteria. 
Neutrophils can then fulfil their role in phagocytosis and ROS production to eradicate 
invading micro-organisms. 
In order for neutrophils to produce this co-ordinated, directional cell movement, a 
number of criteria must be met: 
 The chemical stimulus (chemoattractant) can be a variety of substances 
(chemokines released from cells in the body e.g. IL8, bacterial products), but it 
has to be detected by the neutrophil. 
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 Internal signalling must take place within the neutrophil to signal formation of 
new pseudopods at the leading edge of the cell and retraction at the posterior 
edge of the cell. This also relies on the neutrophil having accurately identified 
the direction of the chemoattractant gradient to ensure movement occurs in 
the correct direction (Andrew and Insall, 2007).  
 Neutrophils have a number of transmembrane G-protein coupled receptors 
which are capable of detecting and activating a complex cascade of signalling 
leading to directional controlled movement towards a chemoattractant 
(Hirsch et al., 2000). 
 
Chemotaxis protocol 
The Insall chamber was used to visualise chemotaxis (Muinonen-Martin et al., 2010), 
see Figure 2.18. 
 
Figure 2.18 – Diagram and photograph of an Insall chamber. The photograph on the left shows 
the channels scribed into the chamber and the position of the coverslip is shown by the large 
white rectangle. The small white rectangle shows the detail of the chamber where a gradient 
of chemoattractant is formed, and the area of the chamber which is visualised in order to track 
neutrophil chemotaxis. Neutrophils are represented by the small grey circles and the 
chemoattractant gradient is represented by the grey gradient and highlighted by the blue 
arrow.  
N-formylmethionine leucyl-phenylalanine (fMLP) was used as a positive control as it is 
a well-established chemoattractant (Nagata et al., 2001, Heit et al., 2008) and would 
Chemoattractant into channel 
Chemoattractant  
No chemoattractant  
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indicate the ability of isolated neutrophils to undergo chemotaxis. The order of 
conditions was varied between experimental repeats, but data were only used when 
cells responded appropriately to the positive control.  
1. Neutrophils were isolated from healthy volunteers as described in Section 
2.9.2 and reconstituted to a concentration of 1 x 106 cells per mL in RPMI. 
2. A coverslip (22 mm, 1.5 thickness, VWR international) was washed in 0.2 M 
HCl and rinsed in two changes of RO water, dried and blocked with 400 µL 7.5 
% BSA (Sigma-Aldrich, UK). The BSA was then drained from the coverslip and 
400 µL cell suspension was added to the coverslip and incubated at room 
temperature for 20 min to allow the neutrophils to adhere slightly to the 
coverslip. 
3. The coverslip was then inverted, the excess neutrophil suspension was 
discarded, and the coverslip was placed onto the Insall chamber which had 
the inscribed channels pre-loaded with RPMI. Excess moisture was removed 
from the coverslip using filter paper to ensure the coverslip was adhered to 
the chamber slide by capillary force. 
4. The chemoattractant channel was then loaded from the loading bays (as 
shown by the large white arrow), ensuring the coverslip was not dislodged by 
overloading the channel with liquid. This produces a chemoattractant gradient 
in the area represented in Figure 2.19.  
5. Cell movement was recorded by capturing a frame every 30 s for 20 min using 
a Zeiss Primovert microscope at 20 x magnification (Carl Zeiss Imaging, USA) 
and a Q Imaging Retiga 2000R camera and QCapture Pro Software (QImaging, 
Canada). 
6. The frames captured were analysed using ImageJ by tracking 15 cells manually 
to give numerical co-ordinates which were used to calculate cell speed, cell 
velocity and Chemotactic Index (CI) per video as described by Roberts et al 
(Roberts et al., 2015).  
7. Statistical analysis was carried out using the CircStat tool in MATLAB 
(Mathworks, USA) to elucidate how significant the movement of the 
neutrophils was over time.  
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2.10   Enzyme linked immunosorbent assays (ELISAs) 
Commercially available ELISAs were used to determine concentrations of inflammatory 
markers in cell supernatants. Levels were quantified by measuring colour generation in 
a reaction which is directly related to target levels detected by target specific 
antibodies. Figure 2.17 summarises the experimental process underpinning ELISA 
assay. 
 
 
Step 1: 96-well clear 
plate coated with specific 
monoclonal capture 
antibody 
Step 2: After blocking, 
samples or standard 
added to wells and 
incubated to allow 
capture to antibody 
Step 3: After washing, 
monoclonal detection 
antibody added to wells 
Step 4: After washing, 
HRP conjugated antibody 
is added 
Step 5: After washing, 
TMB enzymatically 
activated detection 
agent is added and blue 
colour is allowed to 
develop proportional to 
the amount of bound 
immobilized HRP present 
Step 6: An acid stop 
solution is added to stop 
the reaction and a yellow 
colour is generated. The 
absorbance of the wells 
is then measured. 
Figure 2.19 – diagram illustrating sandwich ELISA process to detect target proteins within a 
sample. 
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2.10.1   ELISA protocol 
1. ELISAs were all performed using DuoSet ELISA kits (R&D systems, Bio-techne, 
USA) according to the manufacturer’s instructions. 
2. Plate preparation: Capture antibodies were diluted in protein free PBS and 
100 µL per well was incubated overnight at room temperature or at 4°C 
(target specific) in covered plates to prevent evaporation or contamination. 
Plates were then washed 3 times using PBS containing 0.05 % TWEEN-20 
(Sigma-Aldrich, UK) the excess blotted on clean paper towels. 
3. After washing, wells were blocked with 300 µL of either Reagent Diluent (RD) 
comprising Tris-buffered saline containing 0.05 % TWEEN-20 and 0.1 % BSA 
(Sigma-Aldrich, UK) or blocking buffer (PBS containing 1 % BSA) depending on 
the target. After 1 h, plates were washed following the same wash protocol as 
above. Plates were then used immediately or stored for up to 48 h at 4°C. 
4. Assay performance: Standards were diluted according to specific 
manufacturer protocol for each target. Cell supernatant samples were 
prepared as below using 6 well plates with H400 cells cultured to 70-80 % 
confluence before stimulating as below (Table 2.16). Supernatants were 
aspirated and centrifuged at 15000 rpm for 5 min (Geneflow SciSPin Micro). 
All standards and samples were brought to room temperature before use and 
stored long term at -20°C (standards at stock concentration) or -80°C 
(supernatants). 100 µL was added to each well and incubated in a covered 
plate for 2 h at room temperature. 
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Sample Cells TiO2 treatment Bacteria added 
1 Cell free - - 
2 H400 - - 
3 H400 24 h pre-treated 100ppm - 
4 Cell free - FN 100:1 for 1 h 
5 H400 - FN 100:1 for 1 h 
6 H400 24 h pre-treated at 100ppm FN 100:1 for 1 h 
7 H400 100 ppm with bacteria for 1h FN 100:1 for 1 h 
8 Cell free - PG 25:1 for 1 h 
9 H400 - PG 25:1 for 1 h 
10 H400 24 h pre-treated at 100ppm PG 25:1 for 1 h 
11 H400 100 ppm with bacteria for 1h PG 25:1 for 1 h 
Table 2.16 – H400 conditions prior to ELISA testing 
1.  After washing according to the previous protocol, Strepavidin conjugated to     
HRP was diluted according to the manufacturer’s instructions and 100 µL 
added to each well and incubated at room temperature in the dark for 20 
min.  
2. After 20 min, the plate was washed again according to the previous protocol. 
100 µL of a 50:50 mix of H2O2 and TMB (Tetramethylbenzidine) is 
recommended by the manufacturer, however in this work a TMB Liquid 
Substrate System for ELISA (Sigma-Aldrich, UK) was used due to its improved 
safety profile. The plate was incubated for up to 20 min in the dark, checking 
every 5 min to ensure wells were not becoming too blue. 
3. After an appropriate incubation time, 50 µL stop solution (1 M Sulphuric acid) 
was added to each well to stabilise the reaction, and the blue colour from the 
TMB changed to yellow. Absorbance was then read at 450 nm (absorbance at 
570 nm was subtracted to improve accuracy) using a plate reader (BIO-TEK 
Elx800, Bio-tek, USA).  
2.11    High Content Screening (HCS) sample preparation 
High content analysis (HCS) was carried out on H400 cells using a variety of assays and 
techniques by Imagen Therapeutics (formerly Imagen Biotech, Alderley Edge, UK). All 
experiments were carried out in sterile black walled, clear bottomed tissue culture 
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treated 96-well plates (Appleton Woods, UK). Live cells were used for some assays, and 
for others cells were fixed using paraformaldehyde prior to staining by Imagen Biotech.  
For the HCS work, all cells and reagents were supplied by the author and seeded into 
the appropriate well plates at Imagen Biotech’s laboratory in Alderley Edge. Due to the 
distance from Birmingham, H400 cells were transported at room temperature in a vial 
containing 1 x 106 cells in 1 mL culture medium in a cryovial, sealed with parafilm, as 
per established methods (Rainov et al., 2000). The following information describes the 
methods for HCS as a general technique, and the specific culture techniques, stimuli 
and protocols for each experiment will be described in the appropriate results in 
Chapter 5.  
2.11.1  HCS methods (general) 
H400 cells were fixed in 1 % formaldehyde and washed twice with PBS. Primary 
antibodies were diluted as appropriate according to the specific antibody used, and 
incubated with the cells in Digitonin (500 µL/mL, Sigma-Aldrich, UK) to induce 
increased membrane permeability. Primary antibodies were incubated for 1 h at room 
temperature (21 ± 2°C), following which the antibody was decanted and the plate was 
washed twice with PBS using a plate washer (Tecan UK Ltd, Reading, UK). Secondary 
antibodies were diluted as appropriate and again incubated for 1 h at room 
temperature in conjunction with Hoechst 3332 (Invitrogen, UK) to counterstain the 
nuclei. Following the second incubation the wells were again washed after removal of 
the secondary antibody mix. 100 µL of PBS was then added to each well for storage 
and visualisation. Immunoreactivity staining for biomarkers was performed in triplicate 
for each experiment and triplicate readings were pooled.  
HCS data capture and analysis 
Biomarkers of interest were visualised and the intensity quantified using Cellomics 
ArrayScan© HCS and INCELL Analyser© readers and Compartmental Analysis Bio-
Application (V2 Version, Thermo Scientific). Thermo Scientific Software was used for 
certain specific applications as appropriate (BioApplications). Images were captured of 
at least 5000 cells per well in > 8 images taken in a spiral pattern outwards from the 
centre of each well. Images were captured in three channels (386 nmEM, 488 nmEM and 
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549 nmEM). Each cell was analysed individually to identify the intensity of targets 
throughout different regions of the cell.  
 
Figure 2.20 – Diagram representing the different parameters which can be measured using 
HCS imaging techniques. Cytoplasmic and nuclear spot intensities can be measured using a 
threshold to count cells as positive or negative for the biomarkers investigated.  
2.12   Protein gel electrophoresis 
No. Preparation protocol Sample used 
1 IL8 in PBS 2000 pg/mL 
2a IL8 2000 pg/mL plus TiO2 1000 ppm in PBS incubated for 1 
h at room temperature then centrifuged at 150 x 100 rpm 
for 5 min (Geneflow SciSPin Micro) 
Supernatant  
2b TiO2 pellet washed in 
PBS and re-
suspended 
3a TiO2 1000 ppm in PBS incubated for 1hr at room 
temperature then centrifuged at 150 x 100 rpm for 5 min  
Supernatant 
3b TiO2 pellet washed in 
PBS and re-
suspended 
4 IL8 added at 2000 pg/mL in 20% human serum 
5a IL8 added at 2000 pg/mL in 20% human serum plus TiO2 
1000 ppm in PBS incubated for 1 h at room temperature 
then centrifuged at 150 x 100 rpm for 5 min  
Supernatant 
5b TiO2 pellet washed in 
PBS and re-
suspended 
Table 2.17 – Gel electrophoresis sample preparation 
Nucleus area 
(dashed line) 
Cytoplasmic 
area 
Membrane 
area measure 
Nuclear 
spots  
Cytoplasmic 
spots 
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For protein electrophoresis, 12% Bis-Tris protein gels (NuPAGE™ Novex™, Invitrogen, 
UK) were used. Samples were prepared as described in Table 2.17, then 500 µL of each 
preparation was concentrated using centrifuge filters (Amicon Ultra 0.5 mL 3K Ultracel 
membrane) and centrifuged at 14,000 rpm for 30 min. Samples containing TiO2 NP 
particles (2b, 3b, 5b) were treated with reducing agent, and all samples were heated in 
sample buffer for 70°C for 10 min prior to electrophoresis in MES buffer for 20 min (all 
as per the manufacturer’s protocol). Following electrophoresis, the gel was dyed using 
imperial protein stain (ThermoFisher Scientific, UK) for 1 h and washed in water twice. 
Images were captured using a digital camera (Canon S110 using standard settings). 
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Chapter 3  
Development and validation of in vitro models of 
oral epithelium 
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Synopsis 
To study interactions between Ti implant degradation products and oral epithelial 
cells, a reproducible and representative in vitro model system was required. 
H400 cell characterisation  
H400 cells were selected for potential use in a model system. The choice of this 
specific cell line is discussed, along with the characteristics and assessment techniques 
of normal H400 growth and replication. It is important to remember that H400 cells 
are a cancer derived cell line, and although they have been previously used as a model 
for bacterial challenge of oral epithelium, findings cannot necessarily be extrapolated 
to primary cells. The first part of this chapter documents the growth characteristics 
and morphological appearance of H400 cells, then subsequently the markers of 
epithelial cell characteristics, such as cytokeratin expression are compared with those 
of primary oral epithelial cells. Cell line reproducibility, ease of growing and consistent 
culture characteristics were the key advantages of using H400 cells when compared 
with primary cells 
Primary oral epithelial cell culture 
Given the limitations of cell lines it was also important to have access to primary oral 
epithelial cells to supplement data generated from H400 cells. Methods used for 
culture of primary oral epithelial cells and their outcomes are described. A 
characteristic of primary cells in culture is the inability to generate long term 
continuous cultures of epithelial cells, however short term cultures produced sufficient 
cells to allow the necessary experiments to be performed. Primary cells were 
compared with H400 cells both morphologically and for cytokeratin expression using 
PCR.  
Choice of Ti stimuli for model system 
Ti species have been identified within the body in a number of forms in areas both 
adjacent to and in the tissues surrounding implanted Ti devices (Addison et al., 2012). 
Addison et al., describe the variety of Ti species located within biopsies of inflamed 
tissues excised from around failing Ti percutaneous implants (Bone Anchored Hearing 
Aids, BAHAs), which was found to include particles from nm sized up to >100 µm. Ti 
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was found to be scattered throughout the sample in a radial pattern, with the highest 
concentrations being closer to the implant surface. These Ti particles included a variety 
of forms such as metallic particles and oxides (including rutile and anatase) as 
identified by X-ray absorption spectroscopy. This work alongside supplementary 
measurements (Section 1.4.3) informed the choice of the most appropriate Ti stimuli 
as Ti oxide. A panel of Ti species was used (e.g. viability, NF kappa B activation) but 
anatase was chosen as the primary stimulus to reduce material variables in the 
experimental designs.  
Potential interactions of nanoscale Ti products on known assays 
NPs possess high surface energies favouring biomolecular adsorption (Horie et al., 
2013) and whilst this is recognised in the literature, the impact upon data 
interpretation from NP exposure assays is frequently underestimated or ignored (Kroll 
et al., 2009). Therefore, it was important to identify whether established assays are 
affected by the presence of nanoscale Ti particles before they were used. Assays for 
cell viability and ELISAs were performed in the presence and absence of Ti. It was 
identified that a number of potentially useful experimental techniques such as ELISAs 
and certain viability assays were significantly confounded by the presence of Ti NPs, 
therefore highlighting the importance of validating each experimental technique in this 
model prior to use. 
3.1   H400 cell growth and morphology 
H400 cells are an epithelial cell line first described by Prime in 1990 (Prime et al., 
1990). H400s are derived from a moderately well differentiated stage II squamous cell 
carcinoma of the alveolar process in a 55-year-old female. H400 cells have been used 
as an epithelial cell model in the periodontal literature in the context of responses to 
Nickel (Wylie et al., 2010); responses to periodontal pathogens including activation and 
nuclear translocation of NFκB and associated downstream inflammatory pathways 
(Milward et al., 2013, Milward et al., 2007); and cytokine responses including TNFα and 
IL8 production (Grant et al., 2010a). The table below outlines the known similarities 
and differences between H400 and primary oral epithelial cells. 
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Similarities between H400 cells and primary 
oral epithelial cells 
Differences between H400 cells and 
primary oral epithelial cells 
Similar expression of EGF receptors to 
normal keratinocytes (Prime et al., 1994)    
H400 show a slightly increased sensitivity to 
epidermal growth factor (Prime et al., 1994) 
Similar production of TNFα to normal 
keratinocytes (Prime et al., 1994) 
H400 show a slightly lower number of EGF 
receptors compared with normal 
keratinocytes (Prime et al., 1994) 
Similar nuclear:cytoplasmic ratio to cells of 
origin (Prime et al., 1990) 
H400s are immortalised 
Similar morphology when examined under 
light microscopy 
H400 cells are all cloned therefore there will 
be no variability in DNA whereas primary 
oral epithelial cells will exhibit donor-donor 
variation 
Similar cytokeratin expression to normal 
keratinocytes (Prime et al., 1994, Prime et 
al., 1990) 
 
Table 3.1 – similarities and differences between H400 cells and primary oral epithelial cells 
(keratinocytes).  
3.1.1  H400 morphology assessment 
Epithelial cells have a consistent, characteristic appearance, exhibiting: 
 regular polygonal shape;  
 tight junctions to other cells; 
 growth in either islands, originating from a single cell or outwards from an 
established mass of cells.  
When culturing primary epithelial cells from a tissue biopsy, cultures can become 
contaminated with connective tissue cells (mainly fibroblasts) which have a very 
different morphological appearance to epithelial cells: 
 bi-polar or multi-polar;  
 elongated shape; 
 may not have regular tight junctions with other cells but can grow in more of a 
mass pattern with spaces between cells.  
Light microscopy was used to assess the morphology and growth characteristics of 
H400 cells. The rate and pattern of H400 cell growth under standard culture conditions 
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was studied. Cells were cultured according to the methods detailed in Section 2.2 and 
seeded onto tissue culture treated plastic and incubated at 37 ± 1°C in 5% CO2. Cell 
counts were performed daily until H400 cells reached full confluence when viewed at 
x20 magnification by light microscopy (Primo Vert, Zeiss, Germany).   
H400 growth quantification  
Cell counts were carried out under standard growth conditions to quantify cell growth 
characteristics. As cell counts must be known to standardise data reporting, it was 
important to assess not only the growth characteristics of this cell line but also to 
verify cell count methods which can be used in experimental protocols and when re-
seeding cells into cell culture vessels. Experimental protocols may involve cells being 
examined on an individual basis, for example to identify potential interactions with Ti 
products via microscopy techniques. Other methodologies required cells to be in a 
monolayer such as histocytochemistry. Experiments where H400 cells were exposed to 
Ti products were largely performed with H400 cells in a near confluent monolayer as 
previously discussed. Also the exposure of cells to Ti products will alter if cells are in 
single cell suspension compared with a monolayer, as cells grown to a confluent 
monolayer or within a tissue will have a reduced surface area expressing receptors 
than will cells that have been released from the substrate following trypsinisation. 
Cell counting methods 
Cell counts were performed after trypsinisation of the cell monolayer to produce a 
single cell suspension (see Section 2.2). A modified Neubauer haemocytometer was 
used for all cell counts. Cell counts were carried out prior to seeding into 12 x 25 cm2 
flasks, then each day 3 randomly selected flasks were trypsinised (Section 2.2) and cell 
counts performed.  
To count H400 cells in-situ, an eyepiece graticule fitted inside the microscope was 
employed to count cells at 10x magnification (Figure 3.2) using an inverted light 
microscope (Primo Vert, Zeiss, Germany). 25 cm2 flasks (Corning, UK) were inoculated 
with 1 x 105 H400 cells in 5 mL supplemented DMEM as previously described, and 
incubated at 37°C 5% CO2 for 4 days. Cell counts were performed in triplicate on 3 
different flasks for both the above and below methods at the same time each day. 
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Figure 3.1 – Diagram representing a section of a modified Neubauer haemocytometer 
quadrant of 16 squares. To perform a cell count, four of these quadrants (16 small squares as 
shown) were counted and a mean cell count per quadrant was generated. This mean cell count 
per quadrant equates to the cell count x 104 per mL within the sample examined. Cells 
positioned on a line were included in the box either to the left or below to ensure counts were 
not duplicated. 
                
Figure 3.2 – Diagram showing eyepiece graticule superimposed over cells in situ (not to scale) 
The number of cells visible was counted and this was then multiplied to give an 
approximate cell count in the cell culture vessel. To achieve reliable estimations of cell 
counts, Hunting curves were performed for each of the above methods in order to 
0.2 mm 
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establish the minimum number of counts which would give a valid approximation of 
cell number. Figure 3.6 shows the Hunting curves generated from each method.  
3.1.2  H400 morphology assessment – results 
 
 
Figure 3.3 – Light microscopy images illustrating H400 cell growth from 1-4 days post seeding 
showing increasing growth to confluence. Note that as cells are confluent they become slightly 
compressed, appearing smaller than those on days 1-3 inclusive. This Figure is representative 
of the typical growth pattern of H400 cells as cultured according to the protocol in Section 2.2. 
A number of epithelial characteristics of growth are evident including outward growth from 
cell islands, regular non stellate shape, and formation of a confluent monolayer. No 
morphological changes were observed in cells from P4-P30. 
 
Day 4 Day 3 
Day 2 Day 1 
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Figure 3.4 – H400 cells showing morphological features of epithelial cells. a=regular 
cobblestone appearance b=growth outwards from cell islands c=tight cell-cell junctions 
d=cuboidal, non-stellate shape (4 days post seeding). 
 
 
 
 
 
 
Figure 3.5 – Hunting curves for single cell suspension count using a haemocytometer (a) and 
in-situ count using an eyepiece graticule (b) showing that approximately 16 counts was 
adequate for both methods to achieve a reliable mean cell count. 16 was taken as a suitable 
number of counts for consistency. 
 
a 
b 
c 
d 
(a) 
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Figure 3.6 – Cell counts of single cell suspension using haemocytometer (a) and cell counts of 
in-situ cells within a monolayer using an eyepiece graticule (b) showing an exponential pattern 
of growth from each method up to 4 days post seeding when confluence was reached. n=3, 
mean and SD shown. 
From Figure 3.6, it can be seen that both methods of cell counting identified the same 
pattern of growth, but the numbers of cells reported to be in each flask differed: the 
maximum cell count reached by day 4 was approximately 20 x 105 cells per flask using 
the trypsinised method and approximately 40 x 105 in the in-situ method.  
Exponential growth patterns were identified using both methods. Cells were grown to 
4 days as they were confluent at this time-point within the culture flasks, so continued 
culture would have required passage and re-seeding.  
(a) 
(b) 
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Two important factors to consider when accounting for the differences in cell numbers 
generated by the two methods are that trypsinising cells and counting them was likely 
to underestimate the number of cells in a flask, due to the fact that not all of the cells 
are detached from the cell culture surface. Trypsin is a proteolytic enzyme which 
breaks down the proteins responsible for cell attachment, but must be deactivated to 
prevent damage to cell surface proteins which could affect cellular function (Huang et 
al., 2010). A balance must be achieved between leaving the trypsin in the flask for 
sufficiently long to assist cellular dissociation from the culture treated surface and 
other cells in the monolayer, and avoiding leaving the trypsin in the flask so long that it 
adversely affects cell surface proteins. Flasks were trypsinised for the minimum 
possible time to prevent cellular damage whilst detaching the majority of adherent 
cells. The efficiency of this process is also dependent upon temperature and agitation, 
so trypsin solution was pre-warmed and flasks were kept in the incubator during 
detachment and were gently manually agitated halfway through trypsinisation.  
The in-situ method may over-estimate viable cell counts, as areas at the edges of the 
flask are likely to be less confluent (confirmed by light microscopy), as well as the fact 
that any non-viable but still adherent cells are not excluded. However, cell viability 
cannot be assessed using cell counts in-situ, whereas it can be done using the trypsin 
method and Trypan blue staining as detailed previously. 
3.1.3   Conclusions from H400 growth characterisation and cell counts 
Figures 3.3 and 3.4 above confirmed that H400 cells had an epithelial appearance, and 
were simple to culture aseptically under the conditions described (Section 2.2). The 
approximate length of time between seeding density and confluence was established 
and served to inform future experimental methods.  
H400 cells were reliably cultured under the conditions and seeding density described 
in Section 2.2, grew exponentially to confluence (approximately 4 days post seeding) 
and appeared to show the expected morphological features of epithelial cells when 
examined by light microscopy.  
Once H400 cells have reached confluence on the available tissue culture treated 
surface, the rate of replication will slow. This is due to cells having no more available 
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space into which to divide. If culture medium is not refreshed then exhaustion of 
nutrients in the medium and acidification may occur, inhibiting cellular growth and 
division. When confluence is reached, if the flask is not trypsinised and cells re-seeded 
into a new vessel, the cells will become over confluent, leading to a lack of cell division 
and a higher percentage of non-viable cells. This happens at varying time points (>24 
h) following confluence depending on the volume of the medium in a vessel and the 
cell count, however all exposure experiments reported in this study were carried out 
prior to cells reaching confluence.  
3.2   Primary oral epithelial cell isolation and culture  
It is accepted that H400 cells are an immortal cell line and their responses to stimuli 
and cellular behaviour in vitro may differ from epithelial cells in vivo. The literature 
indicates that cell lines and primary cells have differences, e.g. proteomic phenotype 
of hepatocytes (Pan et al., 2009) and phenotype of endothelial cells (Unger et al., 
2002). However, it has also been highlighted that under the right conditions and with 
appropriate controls, immortalised cell lines can retain properties of the cells of origin 
(Masters, 2000). The H400 cell line was established with the use of a 3T3 cell feeder 
layer, with early passages being cytotoxic to mitomycin C-treated 3T3 cells, but in later 
passages the cells were not mesenchymal dependent (Prime et al., 1990). Normal 
(non-malignant) epithelial cells were shown to senesce at passages 3-4, highlighting 
the difficulty in establishing and successfully culturing primary epithelial cells.  
 
H400 cells were compared with primary epithelial cells grown from either waste tissue 
from surgery or from biopsy samples taken as part of a clinical trial. Tissue samples 
were stored in transport media (Ham’s F12 DMEM supplemented with 10% Fetal Calf 
Serum and 100 U/mL penicillin, 0.1 mg/mL streptomycin, Sigma-Aldrich, UK) for up to 
24 h at 4°C as necessary before use. Primary epithelial cell culture was attempted using 
two methods. the first involved a “feeder layer” of 3T3 cells and the second used a 
direct explant method. The resulting cells were compared with H400 cells in terms of 
morphology and cytokeratin expression in order to establish the validity of H400s as an 
epithelial cell line in this work and also to establish a protocol for the use of primary 
oral epithelial cells. 
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3.2.1  Primary epithelial cell culture methods 
Primary oral epithelial cell isolation and culture – “feeder layer” method 
The use of a 3T3 cell feeder layer has been shown to facilitate the growth of primary 
epithelial cells (Gray et al., 1983, Taylor-Papadimitriou et al., 1977). A feeder cell layer 
was employed as epithelial cells in culture are thought to require growth factors 
produced by other cells in vivo (e.g. fibroblastic cells in this in vitro model). This 
protocol uses 3T3 cells to grow to approximately 1/3 confluence, then treated to arrest 
cell division, and for the epithelial biopsy to then be cultured alongside the non-
dividing fibroblasts (see Section 2.4). 
Primary oral epithelial cell isolation and culture – “explant” method 
The explant method for isolating primary epithelial cells requires no feeder layer. This 
method has been described in detail in the literature (Groger et al., 2008) and is a less 
complex protocol with fewer stages where errors could be made. The protocol for the 
explant method is described in Section 2.4.2.  
3.2.2  Results of primary epithelial cell culture 
Initial cells cultured using the feeder layer method appeared to exhibit epithelial 
morphology when viewed under light microscopy.  
 
Figure 3.7 -Appearance of epithelial cells growing out from biopsy tissue on a 3T3 fibroblast 
feeder layer before passaging and reseeding. 
Epithelial 
appearance 
primary cells 
Feeder layer 
cell 
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Figure 3.8 -Mixed epithelial and fibroblastic appearance of primary epithelial cells grown on a 
3T3 feeder layer following cell passage 
On following the protocol for passage and re-seeding of these epithelial cells (see 
Section 2.2), the morphology of the resulting re-seeded cells appeared to be 
fibroblastic as well as epithelial (Figure 3.8) with stellate shaped cells also present. This 
mixed morphology continued following re-seeding into a new culture vessel and until 
the vessel became confluent with mixed cells.  
When the explant method was used,  50% of the tissue samples set up as described in 
Section 2.4.2 showed signs of growth at 21 days (n=20).  
Figure 3.9 shows typical images taken on days 5 and 7 following inoculation of tissue 
samples into culture plasticware containing cell culture medium as described in 
chapter 2. 
 
Fibroblastic 
appearance 
cell 
Epithelial 
appearance 
primary 
cells 
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Figure 3.9 – Light microscopy images showing explanted oral epithelial tissue exhibiting 
epithelial appearance of primary cells growing outwards in a “cobblestone” formation from a 
tissue biopsy at 5 and 7 days post placement into a culture flask.  
Day 7 
Day 5 
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Within 15 – 21 days, a confluent area of cells exhibiting epithelial morphology can be 
seen (Figure 3.10). 
 
Figure 3.10 – Typical light microscopy image showing cells cultured from explanted epithelial 
tissue. A confluent area of cells exhibiting epithelial appearance can be seen 15 days post 
initial seeding of the explant.  
 
However, similar issues to the feeder layer method arose in that the morphology 
appeared to shift to a more fibroblastic phenotype following initial cell passage. 
Despite repeated efforts, this shift in phenotype was a consistent finding. Figure 3.11 
shows the morphology of cells 14 days after initial passage. 
 104 
 
 
Figure 3.11 - Primary oral cells 14 days post passage showing a mixed morphology of epithelial 
and fibroblastic appearance 
3.2.3  Conclusions from primary oral epithelial cell culture 
The appearance of the cells cultured following the feeder layer method casts doubt 
over whether these cells are truly epithelial in nature. It was proposed that this was 
either due to fibroblastic contamination from the initial tissue sample, or that the 3T3 
cells were not sufficiently inhibited from dividing and were contaminating the culture. 
This process was repeated 3 times with the same outcome.  
The explant method seemed to produce a similar number of cells in a similar time to 
the “feeder layer” method, but with the convenience of not needing to prepare and 
culture fibroblast cells. However, there was a lower success rate for the explant 
method in terms of successful cell outgrowth from tissue of approximately 50% of 
biopsies from the explant method compared to approximately 80% for the feeder layer 
biopsies.  
 The same issue occurred using both methods in that initial outgrowth had the 
morphological appearance of epithelial cells, but on examining the outgrowth 
following first cell passage this morphology did not remain consistent.  
Epithelial 
appearance 
Fibroblastic / 
mesenchymal 
appearance 
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 For this reason, it was decided to characterise the cells that grew initially 
outwards from the tissue biopsy before passage, and to compare them to 
both H400 cells and fibroblasts.  
3.2.4  Characterisation of explant cellular outgrowth 
To validate the primary cell phenotype, indirect immunofluorescence (IF) (see Section 
2.7 for methods) and RT-PCR (see Section 2.5 for methods) were used.  
Indirect immunofluorescence staining of cellular outgrowth from biopsy tissue 
Cytokeratins are proteins which form part of the filamentous protein structure in 
epithelial cells (Henzen-Logmans et al., 1987), and are considered to be phenotypic 
markers of epithelial cells. Vimentin is a filamentous protein which is expressed in 
mesenchymal and fibroblastic cells (Eckes et al., 1998), but not in epithelial cells. To 
characterise the cellular outgrowth from biopsy tissues, cells were stained using 
indirect immunofluorescence for vimentin and cytokeratin expression. A pan 
cytokeratin antibody (Monoclonal Anti-Cytokeratin PCK-26 produced in mouse, Sigma-
Aldrich, UK) and anti-vimentin antibody (Monoclonal Anti-Vimentin VIM-13.2 
produced in mouse, Sigma-Aldrich, UK) were used as primary antibodies, then 
secondary antibodies conjugated to FITC were used according to the protocol 
described in Section 2.7. 
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Figure 3.12 – Representative image of tissue outgrowth stained for cytokeratin expression 
(green) (Blue is DAPI) confirming that epithelial outgrowth has occurred from the biopsy. There 
is no stain for vimentin (red), therefore it can be concluded that the tissue has a significant 
epithelial component, in line with the PCR results shown in Section 3.3.4. 
 
RT-PCR to assess cytokeratin and vimentin expression profiles for H400 cells, primary 
epithelial outgrowth from biopsies and fibroblasts  
RT-PCR was performed on RNA extracted from half of the cell pellet from primary cells 
which were cultured as in Section 3.2.5, RNA was extracted and cDNA was synthesised 
(see Section 2.5).  
Following synthesis of cDNA, RT-PCR was performed using primers for cytokeratins 1 
and 5, which have been shown to be expressed in oral gingival epithelial cells 
(Mackenzie et al., 1991) and vimentin, a fibroblastic / mesenchymal cell marker. 
Primary epithelial cells (1°E) were compared with H400 cells (H) and primary fibroblast-
like cells (1°F) (cells cultured to 6 passages post explant growth and more fibroblastic 
in appearance), and neutrophils (N) were included as a control cell as they should 
contain minimal amounts of cytokeratin and vimentin.  
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     H       1°E     1°F     N                                        H      1°E     1°F      N 
                       
Cytokeratin 1 expression (28 cycles)     Cytokeratin 5 expression (28 cycles) 
     H       1°E     1°F     N                                      H      1°E     1°F      N   
                         
  Vimentin expression (25 cycles)            GAPDH normalisation gel (28 cycles) 
Figure 3.13 – Images of agarose gel showing expression of cytokeratins and vimentin in H 
(H400), 1°E (primary epithelial appearance), 1°F (primary fibroblastic appearance and N 
(neutrophil) cells.  
These results clearly show that the primary epithelial cells express cytokeratins 1 and 
5. The signal for vimentin expression from the fibroblastic cells appeared to be low, 
however following normalisation after further RT-PCR using a primer for 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), vimentin expression was 
shown, as was expected. 
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Figure 3.14 – Expression of vimentin in different cell types H400; primary (primary epithelial 
appearance cells), fibroblast (primary fibroblastic appearance cells) and neutrophil 
(neutrophils), adjusted for background expression of GAPDH, n=1. This result was consistent 
with previously published findings (Mackenzie et al., 1991).  
3.2.5 Conclusions of characterisation following culture of epithelial cells from 
gingival tissues 
It can be concluded that: 
 H400 cells can be readily cultured and exhibit an exponential growth pattern 
until reaching confluence; 
 H400 cells exhibit a classical epithelial morphology and cytokeratin expression 
profile; 
 Early outgrowth from donor tissue initially produces well characterised 
epithelial cells using either the explant method or feeder cell layer method;  
 The early outgrowth from donor tissue shows strong cytokeratin 1 and 5 
expression and limited vimentin expression along with characteristic epithelial 
cell morphology, suggesting an epithelial cell phenotype; 
 However, these primary epithelial cells lose their epithelial morphology and 
markers after the first passage, suggesting a loss of epithelial phenotype; 
 Primary oral epithelial cells can be successfully isolated but long term culture 
and obtaining a reliable supply of these cells in the numbers required is 
problematic. There will also be inherent variability in cells from different 
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donors which will potentially compromise experimental design and 
subsequent results; 
 For these reasons it was decided to use H400 cells for initial experimentation 
and then whenever possible verify results by using primary epithelial cells. 
Based on the findings of initial studies it was decided to harvest primary epithelial cells 
via the “explant method” and use these cells for verification of H400 responses. The 
choice of the “explant method” for epithelial cell harvest was driven by the reduced 
time required and the lack of need for a feeder layer. Data generated in this study have 
highlighted the unreliability of extracting epithelial cells following passage with either 
of these techniques, therefore primary cells were grown out from explanted tissue and 
used immediately in experiments rather than following cell passage as the data 
demonstrated that passaged cells have a non-epithelial cytokeratin profile and also 
express vimentin. 
3.3 Potential interactions of Ti NPs with known assays 
The in vitro methods reported in published studies involve exposure of cells to a 
defined concentration of NPs within suspension. Given that NPs are insoluble and 
show a strong propensity for aggregation (Zhang, 2014), the exposure of each 
individual cell to NPs will not be uniform. Attempts to mitigate this have used 
sonication of suspensions as described by Taurozzi et al., prior to cell challenge 
(Taurozzi et al., 2013), however visual examination of samples after a few hours shows 
that agglomeration still occurs. For this reason, the sonicated powder was kept in 
water at stock concentration and added to the cell culture medium as required. When 
the stock suspension had been prepared for >48 h, it was re-sonicated to disperse any 
settled TiO2 NPs (visual inspection showed settling of some powder in water after this 
time). Section 2.1.1 contains details of the sonication protocol used. 
Conventional assays are commonly used to measure a range of outcomes such as cell 
viability, pro-inflammatory gene transcription factor activation and cytokine 
production. Many of these assays are multi-well plate-based assays and use a variety 
of chemistries to deliver a colour change or fluorescent signal which is in proportion to 
the quantity of specific analyte present. Conventional assays such as luminescent ATP 
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assays, MTT assays and LDH assays have been used to determine cell viability when 
exposed to NPs (Barillet et al., 2010, Gerloff et al., 2012, Fisichella et al., 2012). 
However, issues concerning the use of some of these assays in the presence of NPs 
have been highlighted (Kroll et al., 2009), and specific interactions between TiO2 NPs 
and the MTT assay have been established (Holder et al., 2012). It is essential to ensure 
that NPs do not interfere with the chemistry of an assay system so that it can be 
reliably used in an experimental model. 
3.3.1  Cell Titer-Glo® verification with TiO2 
Cell Titer-Glo® is an indirect luminescence assay which measures “viability” indirectly 
by quantifying the ATPase activity in a sample of cells. ATP is required for the 
conversion of the reagent into the end product, a process which produces light that 
can be quantified by a luminometer (see Section 2.3.1 for detail). This commercial 
assay is designed to work by being added to a sample of cells in serum supplemented 
medium, which will then be lysed and results in the generation of light proportional to 
the amount of ATP present in the sample. It is therefore more accurately a measure of 
metabolic activity as opposed to true cell viability. All experimental samples must be 
compared with control samples. Due to the number of steps involved in the assay, it is 
possible that the presence of TiO2 NPs within the system may disrupt the assay 
chemistry and inhibit light production resulting in inaccurate results.  
CellTiter-Glo® was used as detailed in Section 2.3.1. In cell free conditions, no 
interaction between TiO2 NPs and RLU output were found at levels of 0-1000 ppm TiO2 
NPs.   
3.3.2  MTT ([3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide]) Assay 
This is a colourmetric assay for assessing cell metabolic activity, as the reduction of the 
reagent to the product formazan is dependent upon the presence of NAD(P)H. This 
means that MTT is reduced in the mitochondria of living cells, therefore the amount of 
formazan present in a well following reduction should be proportional to the cell 
viability within that sample (Liu et al., 1997). Formazan has a purple colour, so the 
amount of end product can be determined by the quantification of light absorbance at 
a wavelength of 570 nm. The MTT assay has been used in the literature as a measure 
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of epithelial cell viability in the presence of TiO2 NPs (Huang et al., 2009, Barillet et al., 
2010). However due to the fact that it is a colourmetric assay it is reasonable to 
assume that assay output may be directly affected by the presence of TiO2 NPs, not 
least because of TiO2 being used widely as a pigment.  
The MTT assay was tested under cell free conditions in the presence of up to 1000 
ppm TiO2 in cell culture medium as described in Section 2.1.1 and compared with wells 
containing media and H400 cells cultured under standard conditions. This was to 
assess if there was a significant interaction between TiO2 NPs and the colour change as 
measured by the absorbance of the resulting solution at 570nm.  
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Figure 3.16 – Absorbance (Relative Absorbance Units) for cell culture media (M) containing 0-
1000 ppm TiO2 NPs and H400 cells (n=3). There appears to be a dose dependent interference 
from TiO2 under cell free conditions, therefore this would potentially alter readings from cell 
containing wells. The asterisk shows a significant difference from media only when statistically 
tested using a one way ANOVA (p<0.001).  
MTT assay verification – conclusions 
From the data presented, there is a clear interaction between TiO2 NPs at 
concentrations that will be used in this work and the MTT assay making it unsuitable to 
measure cell viability/metabolic activity in the model system. The interaction (Figure 
3.16) is to be expected due to the fact that TiO2 is widely used as a pigment. Although 
* 
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many other investigators have used the MTT assay with NPs, it was not used further in 
this experimental model and other measures of cell viability were investigated. 
3.3.3  LDH assay 
The LDH assay is a colourmetric assay used to determine cell viability. This assay uses 
cell supernatant to quantify levels of LDH. The assay measures the reduction of NADH 
via the conversion of lactate to pyruvate. Diaphorase then uses NADH in the reduction 
of the reagent to a red formazan product which can be measured. LDH is only present 
in cell culture medium if cells within the sample have damaged membranes, therefore 
are non-viable. LDH assays have been suggested to be unreliable when used in the 
presence of TiO2 NPs (Chan et al., 2011), therefore it was essential to verify the assay 
in the context of the methods described in Chapter 2. 
LDH assay verification – method 
The CytoTox-ONE™ assay was used in this work and is a commercially available LDH 
assay kit. Cell free wells of a 96-well plate contained a range of TiO2 NP concentrations 
from 0 to 1000ppm (see Section 2.2.2). 100 µL supernatant was removed from the 
wells and placed into a black, opaque bottomed plate for the LDH assay to be carried 
out (see Section 2.3.2). Known concentrations of LDH (positive control from CytoTox-
ONE™ kit) were added to wells in order to assess the effect of the presence of TiO2 
NPs in the system. 
 
Figure 3.17 – Absorbance (RAU) of samples containing known concentrations of TiO2 NPs and 
LDH. Interactions were not noted up to 887 mU/mL LDH and 1000 ppm TiO2. n=1.  
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The initial data shown in Figure 3.17 suggest that the LDH assay is not significantly 
affected by the presence of TiO2 NPs in the method described in Section 2.6.2. Further 
work to verify the LDH assay in terms of its sensitivity and other potential issues in the 
model system can be found in Section 5.1.2.  
3.3.4       CaspaseGlo® 3/7 assay  
The caspase enzymes are a group of enzymes essential for cellular apoptosis. Caspases 
3 and 7 are effector caspases, which cleave proteins within a cell to initiate apoptosis. 
CaspaseGlo 3/7 is a commercially available luminescence assay which detects the 
presence of caspases 3 and 7 within a sample containing a cell population. The 
substrate is cleaved in the presence of caspases 3 and 7 to produce a substrate for 
luciferase used in the production of light (aminoluciferin). The reagent lyses the cells 
within a sample, and the amount of caspases 3 and 7 is proportional to the amount of 
light emitted, therefore indicating the proportion of cells within the sample which are 
apoptotic when compared with the control. It has been reported that TiO2 NPs are 
capable of inducing apoptosis in a variety of human cells including human 
keratinocytes (Shukla et al., 2011a), human epidermal cells (Shukla et al., 2011b), 
human lung cancer line A549 (Srivastava et al., 2013), human embryonic kidney cells 
(Meena et al., 2012), cultured BEAS-2B cells (Park et al., 2008) and human liver cells 
(Shukla et al., 2013).   
Cell free wells containing H400 cell culture medium as described in Section 2.2 with up 
to 1000ppm TiO2 NPs were tested alongside wells containing control cells cultured 
according to the standard protocol (see Section 2.2.2) to investigate any interference 
between the TiO2 NPs and the mechanism of action of the assay. As caspases are likely 
to be released over time, a selection of time-points up to 30 h was tested. No 
significant effect of the presence of up to 1000ppm TiO2 NPs in a cell free system on 
the generation of light signal was observed. 
3.3.5  Conclusions from assay verifications 
It was concluded from this Section of work that cellular “viability” of H400 cells 
cultured as per the standard protocol and exposed to up to 1000 ppm TiO2 (anatase, 
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<25 nm) may be assessed using the following assays; Cell Titer-Glo, LDH assay and 
CaspaseGlo 3/7. 
It was decided not to use the MTT assay due to clear interference from the presence of 
TiO2 in a cell free system. The results in general highlight the importance of validating 
known assays in a protocol involving nanoscale Ti products, and emphasise the need to 
validate each experimental protocol before interpreting any data produced.  
3.4   Chapter conclusions 
The conclusions from the work in this chapter which now lead on to further work are: 
 H400 cells can be readily and reliably cultured according to the methods 
outlined in chapter 2. 
 H400 cells are not completely representative of primary epithelial cell 
responses as they are an immortalised cell line, however they show good 
characterisation in terms of morphology, cytokeratin expression and growth 
characteristics in order to be used as an oral epithelial cell model to examine 
interactions between TiO2 NPs and epithelial cells. 
 While it was possible to culture primary epithelial cells from tissue in at least 
two ways, subsequent passage and reseeding of these cells produces a cell 
population with a reduced epithelial phenotype. The characterisation of these 
cells shows that epithelial markers are present in the initial outgrowth, 
however subsequent cell passages appear to show a more fibroblastic profile 
of markers. It was therefore decided to use initial outgrowth primary 
epithelial cells from biopsied tissue in experiments to ensure they are as pure 
a population of epithelial cells as possible. This in turn limits the availability of 
primary epithelial cells, therefore not all work was able to be carried out on 
both H400s and primary cells. It was decided that H400 cells would be used as 
the main cell model, and any significant findings validated by the use of 
primary oral epithelial cells where possible.  
 TiO2 NP dispersion in water produces a relatively homogenously dispersed 
suspension, however on adding to cell culture medium, some settling out of 
TiO2 occurs. This means that the concentrations of TiO2 NPs added into each 
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system will be variable and hard to measure accurately. In addition, the actual 
local concentration adjacent to each cell is likely to vary considerably. 
However, this somewhat mimics the in vivo situation and was therefore 
acceptable in the model system used. 
 The reported data have shown that TiO2 NPs have potential to interact with a 
number of assays, so careful verification is required prior to use to ensure the 
validity of any results obtained. CellTiter-Glo®, CytoTox-ONE™ and 
CaspaseGlo® 3/7 all show insignificant confounding effects from the addition 
of TiO2 NPs into the cell free model system.  
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Chapter 4  
Imaging of interactions between TiO2 NPs and oral 
epithelial cells 
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Synopsis 
This chapter investigates the interactions between both H400 and primary epithelial 
cells with TiO2 nanoparticles (TiO2 NPs). Imaging potential interactions between 
epithelial cells and TiO2 NPs is challenging, as conventional microscopy techniques (i.e. 
light microscopy) are limited in their ability to visualise NP agglomerations or individual 
NPs due a lack of resolution. In addition, conventional microscopy provides limited 
information on the 3D localisation of TiO2 NPs in relation to epithelial cells i.e. are they 
located on the cell surface or intracellularly. Initially, light microscopy was used to 
gather an overview of features such as cell surface binding or intracellularisation of 
TiO2 NPs by H400 cells. Subsequently TEM and reflectance microscopy were used to 
further elucidate how these particles associate with epithelial cells. 
4.1  Light microscopy findings 
 
 
 
 
 
 
Figure 4.1 – A representative image of H400 cells cultured in a 25cm2 cell culture flask without 
addition of TiO2 NPs (a) and after the addition of 100 ppm TiO2 NPs to cell culture medium for 
24 h (b) showing potential association of NP agglomerations with cells but no apparent 
inhibition of growth at this stage (48 h post seeding) from a qualitative visual examination. 
 
 
 
NP 
agglomerations 
a b 
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Figure 4.2 – A representative image of H400 cells cultured in a 25cm2 cell culture flask without 
addition of TiO2 NPs (a), and after the addition of 100 ppm TiO2 NPs to cell culture medium for 
48 h (b) showing potential association of NP agglomerations with cells and possible inhibition 
of growth at 72 h post seeding. Image (a) shows confluent cells while (b) shows an inconsistent 
monolayer with agglomerations of NPs visible.  
 
Light microscopy suggested no clear inhibition of H400 cell growth at 24 h following 
the addition of TiO2 NPs to the growth medium. At 48 h following TiO2 NP addition, 
agglomerations of NPs were clearly visible in the flasks and appeared to prevent cells 
from adhering to the cell culture plate. Smaller agglomerations were associated with 
individual cells, potentially bound to the cell surface membrane or being intracellularly 
located. These features were consistent across multiple images. Complementary 
imaging techniques were performed to establish whether NPs were bound to cellular 
membranes, loosely associated with cell membranes or intracellularly located.  
4.2  Transmission Electron Microscopy (TEM)  
TEM was conducted on sectioned cells to confirm and add to the information gained 
from light microscopy. TEM provides a higher resolution than standard light 
microscopy due to the shorter equivalent wavelength of electron beams compared 
with that of visible light. Images can be acquired with subcellular resolution which is 
more suited to the investigation of NP interactions with cells and cellular 
substructures. 
Sample preparation for TEM involves fixation of a sample in a solid matrix then 
sectioning into ultrathin (50 µm) sections.  Sectioning allows intracellular structures to 
a b 
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be visualised, thereby enabling the location of intracellular agglomerations to be 
discerned from those associated with the cell membrane. 
                                      
Figure 4.3 - a Section through a detached (trypsinised) and fixed H400 cell viewed using TEM. 
Labels are G= Golgi apparatus, L = lysosome, N1 = nucleolus, N2 = Nucleus, M= mitochondria 
and V = vacuole.  
Cells for examination using TEM microscopy were prepared as per the protocol 
(Section 2.8.1) following culture and stimulation using a variety of conditions as listed 
below (all using H400 cells): 
 Control cells: H400 cells cultured to 80-90% confluence under standard 
conditions (see Section 2.2); 
 Washed with 100ppm medium: H400 cells cultured to sub confluence as in 
Section 2.2 then rinsed for <1 min with cell culture medium containing 
100ppm TiO2 NPs; 
 Cultured for 24 h with 10 ppm TiO2 NPs H400 cells cultured to 24 h prior to 
sub confluence then medium containing 10 ppm TiO2 NPs added for 24 h; 
 Cultured for 24 h with 100 ppm TiO2 NPs: H400 cells cultured to 24 h prior to 
sub confluence then medium containing 100ppm TiO2 NPs added for 24 h; 
 Cultured for 24 h with 1000 ppm TiO2 NPs: H400 cells cultured to 24 h prior to 
sub confluence then medium containing 1000ppm TiO2 NPs added for 24 h. 
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Figure 4.4 – Control (not exposed to TiO2 NPs) H400 cells imaged using TEM. The non-uniform 
appearance of the cells is due to cell-cell variation and the level of sectioning through the cell 
which will alter the visible area of organelles. See Figure 4.3 for more organelle structure 
detail. Scale bar = 5 µm. 
 
 
 
 
 
 
Figure 4.5 – H400 cells washed (<1 min) with cell culture media supplemented with 100ppm 
TiO2 NPs to determine if NP agglomerations adhere to the cell membrane. Results indicated 
that no NP agglomerations were seen suggesting that immediate surface adherence is not a 
mechanism by which NP interact with H400 cells. Scale bar = 5 µm. 
 
 
 
 
 
 
Figure 4.6 – H400 cells cultured with 10 ppm TiO2 NPs in medium for 24 h showing varying 
numbers of NP agglomerations as marked by arrows seen as black or white features (charging 
in EM) associated with cells. Microscopic qualitative assessment showed that 30-50% cells had 
visible NPs agglomerations either intracellularly or associated with the cell membrane. The NP 
agglomerations appeared to be of the order of 0.5-2 µm diameter and within the cell 
cytoplasm. Scale bar = 5 µm. 
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Figure 4.7 – H400 cells cultured for 24h in growth media containing 100ppm TiO2 NPs. Results 
showed varying numbers of TiO2 NP agglomerations associated with cells. 30-50% of cells 
appeared to have agglomerations visible intracellularly or associated with the cell membrane. 
The visible TiO2 NP agglomerations visible appeared to be grouped into larger collections than 
at lower concentrations (10 ppm), with groups of agglomerations nearing 5 µm in diameter 
seen. Vesicle type structures appear in some images. TiO2 NPs appear generally as 
agglomerations as opposed to being scattered throughout the cell. Scale bar = 5 µm. 
 
 
Figure 4.8 – H400 cells cultured with 1000ppm TiO2 NP containing medium for 24h showing 
varying numbers of NP agglomerations associated with cells. 30-50 % of cells appeared to have 
NP agglomerations visible intracellularly or associated with the cell membrane from a 
qualitative visual assessment. The TiO2 NP agglomerations appeared to be grouped into 
collections ranging from 0.5 µm to nearing the whole cell diameter (approx. 30 µm) in a non-
uniform distribution. Scale bar = 2 or 1 µm. 
 
This series of images demonstrates TiO2 NP agglomerations. The amount of 
agglomerated NP within the cells increased with the exposure concentration; however 
accumulation was not consistent throughout the population of cells; 50-70 % cells 
appeared not to contain intracellular TiO2 NPs. Higher exposure concentrations 
resulted in very large groups of agglomerations occupying a substantial proportion of 
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the cytoplasm of some cells, while other cells within the same sample appeared to 
have no visible intracellular agglomerations.  
NPs have been shown to be present intracellularly in human lung epithelial cells (Singh 
et al., 2007) following exposure to ultrafine TiO2 particles (using TEM and X-ray 
methods). TEM images from Singh et al., (Singh et al., 2007) showed small 
agglomerations of particles within lamellar bodies in lung epithelial cells as well as 
agglomerations of ultrafine particles within membrane bound vacuoles consistent with 
findings in this study. Singh et al., also noted a lack of uniformity in the intracellular 
number and location of ultrafine particles and proposed the uptake mechanism to be 
endocytosis (Singh et al., 2007).  Polystyrene NP uptake into HeLa cells has also been 
reported (Dausend et al., 2008). Endocytosis is a process where cells actively uptake a 
molecule, particle or agglomeration by engulfing it within a membrane bound vesicle. 
Nanoparticle uptake into HeLa cells has been shown to occur, (Smith et al., 2012), and 
this intracellularisation was shown to be reduced but not entirely stopped by inhibition 
of the clathrin-mediated endocytosis pathway. These findings suggest that clathrin-
mediated endocytosis is one mechanism of intracellularisation of carboxylate-modified 
polystyrene NPs into HeLa cells, but that multiple mechanisms may exist therefore 
accounting for some residual uptake once clathrin mediated endocytosis has been 
inhibited. Alternative mechanisms may include diffusion through pre-existing or 
induced perforations within the plasma membrane of the cell. From the findings of 
Smith et al., it is plausible that (clathrin mediated) endocytosis is one mechanism 
involved in the uptake of TiO2 NPs into H400 cells.  
4.2.1                    Limitations of TEM imaging 
Although these images appear to show intracellular agglomerations of TiO2 NPs, there 
are alternative explanations which need to be ruled out before claiming that 
intracellularisation has occurred. 
1. The particles may have been dragged during processing and may be 
superimposed over the cell sections rather than being located intracellularly. 
This is unlikely as the images appear to show membrane like structures 
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around agglomerations of nanoparticles, however it is not possible to exclude 
this scenario from these images alone. 
2. The sample preparation for TEM imaging is complex, therefore some form of 
agglomeration of the nanoparticles may have arisen via mechanisms which 
are unrelated to epithelial cells themselves.  
Therefore, the following two strategies were adopted to definitively identify whether 
the H400 cells contained intracellular TiO2 NP agglomerations, and to further assess 
the TiO2 NP agglomerations following alternative fixation methods.  
1. To confirm endocytosis as a mechanism leading to TiO2 NP intracellularisation, 
an endocytosis blocking agent was used to investigate whether this affected 
the apparent TiO2 NP uptake. 
2. In addition, an alternative imaging method (confocal microscopy) was used to 
confirm intracellular accumulation of TiO2 NPs. Confocal microscopy enables 
visualisation of agglomerations within a cell without the need for cell 
sectioning and uses a less complex fixation protocol, mitigating the possibility 
of agglomerations being either caused by or introduced by the fixation and 
processing required for TEM.   
Furthermore, reflectance confocal microscopy also allows visualisation of 
agglomerations and their association and distribution between cells to further 
investigate the non-uniform cell distribution.  
 
4.2.2   Treatment with an endocytosis inhibitor 
Dynasore hydrate is a cell permeable dynamin 1 and 2 GTPase activity inhibitor, and 
blocks endocytosis, which is dependent on dynamin for clathrin coated vesicle 
formation. Serum within cell culture medium is known to inhibit dynasore hydrate. For 
studies using dynasore, H400 cells were cultured in standard medium until just sub-
confluent, then gently rinsed in warmed PBS and a serum free medium added (Section 
2.2.1) with or without TiO2 NPs as appropriate. To assess the effect of treating 
epithelial cells with dynasore hydrate, H400 cells were cultured with dynasore hydrate 
at a concentration of 80µM for 24 h in the presence of 100 ppm TiO2 NPs. Control cells 
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were cultured with 0.1% DMSO (the vehicle for dynasore hydrate) and 100 ppm TiO2 
NPs.  
    
    
Figure 4.9 – H400 cells cultured with (a) 100 ppm TiO2 NP containing medium for 24 h and 
0.1% DMSO showing varying numbers of NP agglomerations associated with cells. 
Agglomerations are seen intracellularly in the size range of <1 µm to groups of agglomerations 
totalling >5µm. There was an enhanced amount of NP debris surrounding cells due to a 
number of possible reasons; either omission of serum means NPs will be more likely to 
associate with proteins within the cell membrane, or the protein corona which forms 
surrounding NPs in the presence of serum may make them more susceptible to washing off the 
monolayer prior to fixation. (b) Shows H400 cells cultured with 100 ppm TiO2 NP containing 
medium for 24 h with 80 µM Dynasore Hydrate showing reduced numbers of NP 
agglomerations associated with cells as judged qualitatively by visual inspection. The 
agglomerations of NPs visible in the dynasore treated cells were smaller, and there appeared 
to be a higher proportion of cells with no visible NPs than in the control DMSO group although 
this cannot be reliably quantified in the sample size imaged. Scale bar = 5 µm. 
TEM images showed a reduction in intracellular agglomerations of TiO2 NPs, however 
subjective analysis of a limited number of cells did not enable quantification of any 
reduction in uptake. Some apparent intracellular TiO2 NPs were still observed in 
dynasore treated cells and suggest that clathrin-mediated endocytosis was involved in 
uptake but that other mechanisms may also be operative and was consistent with 
previous findings (Smith et al., 2012).  
 
a 
b 
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4.3   Reflectance confocal microscopy 
Reflectance confocal microscopy allows the visualisation of intracellular structures and 
was used to confirm intracellular agglomeration of TiO2 NPs. For reflectance confocal 
microscopy, H400 cells were cultured on a glass coverslip and fixed using 4% 
paraformaldehyde before imaging. DAPI was used as a nuclear stain to enable cell 
visualisation in the fluorescence mode and to aid orientation. H400 cell preparation is 
detailed in Section 2.8.2. 
For imaging, five randomly chosen areas on each coverslip were selected. The areas 
imaged were discounted if there were no visible cells present or if the cell layer 
appeared to have been damaged during fixation and mounting. The confocal stack of 
microscopy images was captured along with the reflectance confocal images of NP 
agglomerations. Images were analysed using FIJI (ImageJ, U. S. National Institutes of 
Health, Bethesda, Maryland, USA) software to maximise the visibility of organelles and 
to falsely colour the reflectance signal to enable location of the NP agglomerations 
within cells. Figures 4.10-12 show selected slices from the confocal stack of light 
microscopy images overlaid with the corresponding reflectance signal. These Sections 
were selected to include organelles to ensure they are intracellular images, and to 
exclude, as far as possible, surface associated agglomerations of NPs. 
 
Figure 4.10 – H400 cells cultured with 1 ppm TiO2 NPs for 0, 3, 6 and 9 h then fixed (Section 
2.8.2) and viewed under reflectance microscopy. The violet colour was due to TiO2 NPs 
overlaid on mid stack images from light microscopy images. A fairly broad scatter of violet 
points across the cell monolayer was observed, but due to the small size of agglomerations, 
visualisation of any specific agglomerations from these images is problematic. 
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Figure 4.11 – H400 cells cultured with 10 ppm TiO2 NPs for 0, 3, 6 and 9 h then fixed (Section 
2.8.2) and viewed under reflectance microscopy. The violet colour was due to TiO2 NPs 
overlaid on mid stack images from light microscopy images. Images show larger 
agglomerations found intracellularly with increasing time than in the 1ppm exposure sample 
shown in Figure 4.10. A non-uniform distribution of NP agglomerations within the cell 
population was observed. 
 
 
Figure 4.12 – H400 cells cultured with 100 ppm TiO2 NPs for 0, 3, 6 and 9 h then fixed (Section 
2.8.2) and viewed under reflectance microscopy. The violet colour was the signal from TiO2 
NPs overlaid on mid stack images from  light microscopy images. Images show an increase in 
both the number of agglomerations over time and the size of these agglomerations within the 
cell monolayer when compared with lower concentrations of NPs. Again a non-uniform 
distribution was observed with certain cells producing a high signal from intracellular NPs 
compared with others showing very little or no signal at all.  
 
Figures 4.10 – 4.12 demonstrated intracellular agglomerations of TiO2 NPs from mid 
stack images. The magnitude of accumulation of intracellular TiO2 NPs appears to be 
both dose and time dependent, and the agglomerations increase in size with higher 
exposure concentrations. A non-uniform distribution of uptake was seen at all 
exposure concentrations. The numbers of cells (approximately 34 cells per image) 
within 5 randomly selected images exhibiting NP agglomerations was quantified and 
correlated with time and exposure conditions (Figure 4.13). 
 
0h 9h 6h 3h 
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Figure 4.13 – Graph showing % cells with visible TiO2 NP agglomerations following exposure to 
0-100 ppm TiO2 NPs for 0-9 h. Shows minimal differences in % cells with agglomerations, but 
images demonstrate that the agglomerations seen are larger at higher doses. n=5 images 
analysed, approximately 34 cells per image and 170 cells total. A two way ANOVA revealed no 
significant difference in the number of cells with TiO2 NP agglomerations between the 
different exposure concentations (p>0.05).  
As the exposure concentration increased, the proportion of cells with visible 
intracellular agglomerations of NPs using reflectance microscopy did not increase 
significantly. Up to approximately 30% of cells exhibited visible agglomerations even 
when exposed to higher doses of NPs for longer time periods, and the images clearly 
demonstrated that the distribution of agglomerations was far from uniform within the 
cell population examined. Extended exposure time points (>9 h) were not performed 
due issues with cell confluencey.  
4.4   Imaging of TiO2 NP accumulation in primary oral epithelial cells 
The images of agglomerations of intracellular TiO2 NPs in H400 cells suggest that this 
cell line has the capacity to intracellularise TiO2 NPs. Reflectance microscopy was 
determined to be an efficient method to study TiO2 NP accumulation and was 
employed to identify whether primary oral epithelial cells mirrored the pattern of 
uptake seen in the H400 cell line. 
Primary epithelial cells were grown using the explant method and prepared (Sections 
2.8.1 / 2.8.2) for imaging with both TEM and reflectance confocal microscopy. Due to 
the limitations of the isolation and culture of primary epithelial cells the numbers of 
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cells examined was lower than that for H400 cell imaging. As the adherence of primary 
cells to the culture glassware was less robust, cells were trypsinised prior to fixation for 
reflectance microscopy, and exhibited the more rounded appearance when compared 
with the images of the adhered confluent H400 cells seen previously. This was an 
experimental finding when growing primary epithelial cells on coverslips, often the 
primary cell monolayer was lost upon washing, compared with H400 cells, where the 
washing and fixing process did not seem to compromise the integrity of the cell layer. 
Therefore, it was decided to trypsinise and detach the primary cells from the cell 
culture surface prior to fixation, and to pipette the resulting suspension onto coverslips 
in order to prevent sample loss. 
   
Figure 4.14 – TEM images showing primary human gingival epithelial cells exposed to TiO2 100 
ppm for 6 h. There is clear non-uniform intracellularisation in a similar manner to H400 cells, 
and NP agglomerations are visible intracellularly with a size range of 0.5 – 5 µm diameter.  
 
Figure 4.15 – Reflectance microscopy images of primary human gingival epithelial cells (clump 
of 7 cells plus single cell) exposed to 10ppm TiO2 NPs for 6 h.  Prepared after trypsinisation to 
increase ease of orientation on microscope compared with a monolayer. Images from cell 
surface, mid stack and base of stack showing clear intracellular NP agglomerations. As before 
violet false colour represents reflectance signal from TiO2 NPs. 
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Figure 4.16 – Reflectance microscopy images of primary human gingival epithelial cells (clumps 
of cells plus single cells) exposed to 10 ppm TiO2 NPs for 9 h.  Prepared after trypsinisation to 
increase ease of orientation on microscope compared with a monolayer. Images from cell 
surface, mid stack and base of stack showing clear intracellular NP agglomerations. As before 
violet false colour represents reflectance signal from TiO2 NPs.  
Figures 4.15 and 4.16 show TiO2 NP uptake in primary human oral epithelial cells. 
Although limited conclusions regarding the pattern of uptake can be drawn from these 
images due to the limited number of cells present, the presence of TiO2 NPs within 
primary oral epithelial cells is evident. 
Previously published work on the uptake of NPs by cancer cell lines (such as H400) and 
comparison with primary cells of a similar type is limited. Hepatoyctes have been 
shown to take up NPs in both cancer cell lines and primary rat hepatocytes in similar 
amounts, but the uptake was highly dependent upon NP size and shape rather than 
simply cell type (Johnston et al., 2010). The specific uptake of NPs appears to depend 
upon both the NP studied (its coating, composition and shape) as well as the specific 
cell type involved and there are likely to be different uptake rates between cell lines 
and primary cells under certain conditions (Albanese et al., 2012). Again, multiple 
mechanisms of uptake are identified as being relevant in the uptake of polystyrene 
NPs by human alveolar epithelial cells including clathrin-mediated endocytosis (Kuhn 
et al., 2014). Surface charge also affects the likelihood of uptake by cells and through 
tissues; Bannunah et al., demonstrated positively charged NPs are more likely to be 
internalised by human colon epithelial cells than negatively charged NPs, a finding 
consistent across two sizes of NP examined (50 nm and 100 nm diameter) (Bannunah 
et al., 2014). It can be concluded that uptake of NPs by cells is a complex process which 
likely involves multiple mechanisms. Further work is required to fully characterise the 
processes involved. 
 130 
 
4.5  Conclusions from cell imaging and justification for further investigation 
A similar picture of intracellularisation and agglomeration of TiO2 NPs appeared in 
primary gingival epithelial cells and H400 cells, therefore it can be assumed that the 
H400 model of interactions in this biological context has validity. The conclusions that 
can be drawn from the reported imaging work thus far are: 
 Both H400 cells and primary epithelial cells appear to have the capacity to 
take up agglomerations of TiO2 NPs in a dose and time dependent manner. 
 Cells that have been exposed to larger doses of TiO2 appear to take up larger 
amounts of TiO2 NPs. 
 TiO2 NP uptake was not uniform across a cell population, and some cells 
remain free from visible agglomerations while others have significant 
amounts of TiO2 NPs intracellularly. 
 Cells which had intracellular agglomerations did not appear morphologically 
changed when compared with those without. This was supported by no 
apparent loss of viability in previously reported work (see chapter 3) at the 
above doses and timescales. 
4.6   Synchrotron micro-focussed X-ray Fluorescence (SR-XRF) 
2 dimensional micro-focussed SR-XRF is a method that can be used to measure 
concentration of elements at trace levels within a sample at a high spatial resolution. 
SR-XRF has been extensively used for biological imaging (Bacquart et al., 2007, Betz et 
al., 2007, Petibois et al., 2009) and Ti is an element in particular which can be imaged 
readily using this approach as its X-ray absorption energy (4.965 KeV) is distinct from 
native elements found in tissues (Mountjoy et al., 1999). Here SR-XRF was used to 
quantify, proportionally the number of cells within a sample exposure population that 
become associated with TiO2 NPs. The proportion of cells within an exposure 
population actually interacting with the insoluble TiO2 NPs stimulus will have a direct 
bearing on the interpretation of biological assays in the following chapters. SR-XRF has 
the capability to detect much smaller amounts of TiO2 NPs than other imaging 
methods used to date in this work, alongside the far greater resolution of images.  
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4.6.1   SR-XRF methods 
Sample preparation 
H400 cells were cultured as previously described (Section 2.2.2) and exposed to TiO2 
NPs of varying concentrations (0 – 1000 ppm) for 0 – 24h. Following exposure, the cell 
monolayer was washed 3 times with warmed PBS and trypsinised to produce a cell 
suspension (see Section 2.2.2) and an equal volume of cell culture medium added to 
counteract the trypsin. The resulting cell suspension was then transferred aseptically 
to a sterile tube and centrifuged for 10 min at 1000 rpm. The resulting cell pellet was 
then re-suspended in ice cold methanol (-20 ± 2°C) to fix the cells, immediately mixed 
and pipetted at a relevant density (calculated from a cell count of the suspension 
before centrifugation) onto silicon nitride windows (membrane size 5.0 x 5.0 mm or 
3.0 x 3.0 mm, Membrane thickness 500 nm, Silson, UK ). Once air dried they were 
dipped into distilled water to remove crystalline artefacts from cell culture medium 
before being stored in a desiccator until use (up to 10 days). The above method for 
sample preparation is in line with current literature (Carter et al., 2010). The 
experimental samples produced were: 
 Control cells – H400s cultured to just sub confluence then media changed for 
fresh medium for 24 h. 
 10 ppm - H400s cultured to 80-90% confluence then media changed for fresh 
medium containing 10 ppm anatase <25 nm as before for 24 h. 
 100 ppm - H400s cultured to just sub confluence then media changed for 
fresh medium containing 100 ppm anatase <25 nm as before for 24 h. 
SR-XRF methods 
2D SR-XRF was performed on the beamline ID21 at the European Synchrotron 
Radiation Facility (ESRF, Grenoble France) using an incident energy of 5.7 KeV and a 
beam footprint of 0.2 x 0.7 µm2 and a 0.5 µm step-size. Detection limits for Ti were <1 
parts per million.   
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4.6.2    Rr-XRF results 
 
Figure 4.17 – Images showing relative fluorescence of Potassium, Calcium and Titanium in 
control H400 cells. The cells are not completely separated due to incomplete trypsinisation.  
 
 
Figure 4.18 – A representative image of fluorescence of S or K, Ca and Ti in H400 cells exposed 
to TiO2 10 ppm for 24h. Ti is seen within the confines of the cells in the area mapped . The 
white spots in all three signals are due to saturation of the signal from the large deposits of Ti 
leading to a loss of signal from the detector. 
These initial results demonstrate a large accumulation of Ti present within the cell 
samples examined by SR-XRF in cells exposed to TiO2 NPs when compared with control 
cells. There is saturation of the detector present (white spots) indicating that the 
actual concentration of Ti is higher than can be accurately recorded in some areas.  
The results also seem to show that Ti is present in agglomerations, concurrent with the 
other microscopy methods described in this chapter, and again that the distribution of 
Ti is non-uniform across the cell population.  
To quantify the number of cells associated with Ti and in which manner, table 4.1 was 
constructed by counting the number of cells present, and recording if each cell was 
20µm 20µm 20µm 
20µm 20µm 20µm 
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associated with no Ti, “small” particles of Ti or “larger” particles of Ti. This table was 
produced using 10 ppm and 100 ppm exposed cell data. This was a qualitative 
assessment based on interpretation of images, where “small” particles were quantified 
as being signal spots <2 µm in diameter. 10 and 100 ppm data was included together 
to increase the amount of data and previous work has shown a lack of uniformity of 
association regardless of exposure concentration (see Section 4.2). 
Cell count 
within image 
Number associated 
with no Ti 
Number associated with 
small particles of  Ti 
Number associated with 
large agglomerations of 
Ti 
27 8 13 6 
12 2 3 7 
3 0 1 2 
15 5 5 5 
6 3 1 2 
3 1 0 2 
6 2 2 2 
5 2 2 1 
22 7 9 6 
16 6 1 9 
14 6 2 6 
Totals: 
129  
 
42 (33 %) 
 
39 (30 %) 
 
48 (37 %) 
Table 4.1 – table showing quantification of H400 cells associated with no Ti, small and large 
agglomerations. Approximately 2 out of 3 cells had some association with Ti after exposure to 
TiO2 at 10 or 100 ppm for 24 h. 
Co-localisation between Ti and Calcium (Ca) 
A number of these images seem to show some co-localisation between Ti and Ca: 
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Figure 4.19 – X-ray fluorescence of Ca and Ti two groups (a and b) of H400 cells exposed to 
TiO2 10 ppm for 24 h. The Ca and Ti signals from this group appear to show similar locations.  
The potential co-localisation of Ca and Ti may be associated with the role Ca plays in 
lysosome formation, as Ca2+ has been reported to be essential for fusion of lysosomal 
membranes during uptake of target molecules (Luzio et al., 2007).  
4.7   Chapter conclusions 
 Intracellularisation of TiO2 NPs by oral epithelial cells was clearly 
demonstrated. 
 A variety of different imaging methods have shown an association of TiO2 
agglomerations with H400 epithelial cells. Further investigation shows that 
these agglomerations are indeed intracellular.  
 Intracellularisation is not uniform within a cell population, and is dose and 
time dependent.  
20µm 20µm 
20µm 20µm 
a a 
b b 
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 There are no observable gross morphological changes in epithelial cells 
associated with TiO2 NP intracellularisation.  
 A similar pattern of intracellularisation was evident in primary oral epithelial 
cells in comparison to the H400 cell line. 
 The lack of uniformity of uptake may be due to the lack of uniformity in local 
exposure to TiO2 NPs of each cell. It has been shown that TiO2 does 
agglomerate in cell culture medium. However, this is likely to be 
representative of the situation in vivo. 
 Clathrin mediated endocytosis is partly, but not wholly, responsible for TiO2 
NP uptake by oral epithelial cells.  
Further questions raised by this work include: 
 Is this uptake of TiO2 dependent on the cell cycle stage, thus accounting for 
the fact that only some cells in a population are seen to have agglomerations 
within them? 
 What implications does TiO2 NP intracellularisation have on epithelial cell 
biological responses both directly and on their interactions with other cell 
types? 
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Chapter 5 
Effects of interactions between TiO2 NPs and oral 
epithelial cells on cell viability, growth and 
immune responses 
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Synopsis 
In Chapter 4 it was demonstrated that exposure of both H400 epithelial cells and 
primary oral epithelial cells to TiO2 NPs leads to intracellular accumulation of 
agglomerations of particles after co-incubation. This chapter studies the consequences 
of these interactions on cell viability and on known inflammatory pathways within oral 
epithelial cells such as NFκB expression.  
Epithelial cell viability has previously been reported to be affected by exposure to TiO2 
NPs. HaCaT (immortalised human keratinocytes) have been shown to internalise TiO2 
NPs and inhibition of HaCaT cell growth has been reported at TiO2 NP concentrations 
of 10 – 300 ppm (Chan et al., 2011). Human A549 (lung epithelial cells) have been 
shown to produce an inflammatory response to TiO2 NPs, including increased IL8 
release alongside TiO2 NP internalisation (Singh et al., 2007). The viability of other 
human cell types has been shown to be affected by the presence of TiO2 including a 
monoblastoid cell line (Vamanu et al., 2008) and human embryonic kidney cells 
(Meena et al., 2012). In this chapter the effects on oral epithelial cell viability of 
exposure to a variety of concentrations of TiO2 NPs is studied by conventional assay 
methods and high throughput techniques. Subsequently, the effects of TiO2 NPs on 
epithelial cellular pathways (including NF kappa B activation, known to be important in 
inflammatory responses to pathogenic challenge) are investigated both in the 
presence and absence of microbial stimuli to simulate and identify any modification to 
normal oral epithelial cell responses to bacterial challenge from the oral microflora. 
5.1  Conventional cell viability assays 
As discussed in Section 3.6, and demonstrated by other investigators (Holder et al., 
2012, Kroll et al., 2009) interactions between the insoluble TiO2 NPs and a number of 
biological assays have been demonstrated. In this chapter assays employed were 
previously validated (see Section 3.6) for use in the presence of TiO2 NPs. The 
suitability of each assay used is discussed alongside summary of findings from the 
combined assays in Section 5.1.4. 
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5.1.1   ATP activity measured by CellTiter-Glo® 
CellTiter-Glo® (Promega, Wisconsin, USA) measures the ATP activity within a cell 
population and therefore measures viability indirectly (see Section 2.3.1). 
H400 cells were cultured in 96-well plates (Section 2.2). TiO2 NP dispersions were 
added to give final stimulation concentrations of 0 – 1000 ppm. After 0, 3, 6 and 24 h, 
plates were removed from the incubator and CellTiter-Glo® assays were performed 
(Section 2.3.1). Figure 5.1 shows the data for control cells compared with those 
treated with 1, 10, 100 and 1000 ppm TiO2 NPs. 
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Figure 5.1 – CellTiter-Glo® luminescence (RFU) for H400 cells treated with 0, 1, 10, 100 and 
1000 ppm TiO2 NPs for 0, 3, 6 and 24 h (n=3, all data shown). ATPase activity is seen to be 
increased at 3 h and 6 h when compared with 0 h for all conditions. No reduction in ATPase 
measurement following exposures of up to 1000 ppm TiO2 NPs was seen when compared with 
the respective controls.  
CellTiter-Glo® assays showed an increase in the measured ATPase activity in all 
conditions at 3 and 6 h when compared with 0 h suggesting an overall increase in 
metabolic activity of the sampled H400 cell populations. Cells exposed to higher levels 
of TiO2 NPs exhibited the greatest increases in ATPase activity at 3 and 6 h in 
particular, which may be attributable to an increased metabolic activity associated 
with their internalisation (or other interactions) with the Ti stimulus. Although there 
was no loss of ATP activity at any time point when compared with 0 h, the stimulation 
with TiO2 NPs in comparison with a soluble stimulus is inhomogeneous and only a 
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proportion of the population become exposed. It is conceivable that the net measured 
ATPase activity is a combination of cells increasing in activity and possibly others 
reducing. The assay itself is not able to discriminate such behaviours and one indirect 
measurement of cell viability cannot be relied upon to give a true picture of the 
viability of a cell population. The results from using a conventional plate system and 
CellTiter-Glo® assay showed no loss of “viability” at the concentrations and timepoints 
tested, however the literature does report that epithelial cell death (apoptosis) as a 
result of exposure to TiO2 NPs occurs (see also Table 1.5). To more robustly exclude 
cytotoxic effects of TiO2 NPs on H400 cells in this system at varying time-points, 
additional assays and methods were used as detailed below.  
5.1.2  LDH concentration measured by CytoTox-ONE™ 
The CytoTox-ONE™ assay detects LDH released extracellularly into cell culture medium 
due to cellular necrosis (Section 2.3.2).  
Further verification of LDH assay 
The LDH assay was verified for use in the presence of TiO2 NPs in Chapter 3 (see 
Section 3.6.3), showing that the presence of up to 1000 ppm TiO2 NPs did not affect 
the performance of this assay. To assess whether LDH remained stable in supernatant 
stored for a period of time, experiments were carried out to establish if any LDH 
released by cells could degrade over time. Figure 5.2 shows the stability of LDH 
(positive control from CytoTox-ONE™ Assay kit) in cell culture medium necessary for 
H400 growth and division stored for up to 42 h at room temperature (21 ± 2°C). The 
findings established acceptable storage parameters prior to assays being conducted. 
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Figure 5.2 – Fluorescence (RFU) generated using CytoTox-ONE™ assay of known LDH 
concentrations (represented by each colour) added to cell free culture medium plotted against 
the time stored for at room temperature (23 ± 2°C) on the x axis. The differences between 
each concentration remain stable over time, therefore indicating that storage of medium for 
LDH quantification of multiple samples at one time would be a viable experimental design. 
To establish the relationship between LDH release and H400 cell necrosis, cells were 
allowed to become over-confluent and the medium to become exhausted. As a result, 
there was increased H400 cell death due to lack of nutrition and acidification of the cell 
culture medium. To achieve a variety of degrees of confluence, a suspension 
containing 5 x 104 H400 cells in 200 µL was obtained and diluted with cell culture 
medium to achieve a range from 0 – 100 % (see Figure 5.3). DH levels in supernatant, 
caspase levels (as detected by CaspaseGlo 3/7, see Section 3.6.4) and staining with 
trypan blue (see Section 3.1.2) were all endpoints gathered from the same samples 
(n=3).  
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Figure 5.3 – LDH levels, Caspase 3 and 7 levels and percentage of cells positive for trypan blue 
stain within a 96-well plate (n=5, mean and SD shown) following incubation for 24 h. The data 
show that increased LDH levels were detected in cell populations containing higher 
proportions of non-viable cells, and the caspase levels appeared generally constant, indicating 
that necrotic H400 cells will release LDH at measurable levels. These data have been corrected 
for the cell counts present.  
Allowing cells to become over-confluent was chosen as a mechanism of initiation of 
cell death as it does not rely on cytotoxic agents such as DMSO or heat, both of which 
were shown to interfere with the LDH assay in this application. Heat will denature the 
proteins present in LDH as it is an enzyme (Korzeniewski and Callewaert, 1983). It was 
concluded that the LDH assay was suitable for use in this experimental system, would 
detect necrosis of H400 cells within a population, and that the assay could be 
performed on supernatant removed from flasks and stored for up to 42 h. 
Furthermore, it was concluded that the main mechanism of cell death by over-
confluence was necrosis, as there was a positive correlation between cells positively 
stained for Trypan blue and the LDH levels detected in the cell culture medium. 
5.1.3   CaspaseGlo® 3/7 
It has been reported that TiO2 NPs are capable of inducing apoptosis in a variety of 
human cells (Shukla et al., 2011a, Srivastava et al., 2013, Meena et al., 2012, Park et 
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al., 2008, Shukla et al., 2013). Caspase-Glo® is an assay system designed to detect 
levels of caspase 3 and 7 within a cell population (see Section 2.3.3), and an increase in 
concentration of caspases 3 and 7 indicates that more apoptosis is occurring within a 
sample when compared with controls.  
5.1.4   Cell viability results from conventional assays 
Assays were performed in parallel to gain an overall view of the likely levels of viability, 
necrosis and apoptosis present in H400 samples exposed to up to 5000 ppm TiO2 NPs. 
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Figure 5.4 – Conventional viability assays performed at time-points up to 24 h on H400 cells 
exposed to up to 5000 ppm TiO2 NPs (n=3, all data shown). (a) CellTiter-Glo®, (b) CaspaseGlo® 
3/7, (c) CytoTox-ONE™. Plots show maintenance of ATPase activity following an initial peak at 
3-6 h up to 1000 ppm (a) and an increase in both caspase activity (b) and necrosis (c) up to 24 
h post exposure to TiO2 NPs but the magnitude of changes over time appeared small. Figure (a) 
is a repeat of earlier data shown for comparison.  
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Figure 5.4 shows minimal differences in the measured responses of cell populations 
treated with 0-5000 ppm TiO2 NPs using three different conventional assays. Key 
observations include: 
 There is an apparent increase in metabolic activity shown by the increase in 
signal at 3-6 h from the CellTiter-Glo® data. This suggests there may be some 
increase in activity within the cells present, as a significant increase in the 
number of cells present within the well to account for this increased signal is 
unlikely.  
 After the initial peak in Figure 5.4 (a), ATPase activity levelled off and 
remained constant in conditions up to 1000 ppm TiO2 NP exposure, above 
which there was a reduction in the measurement of ATPase activity after 6 h. 
 There was an apparent gradual increase in apoptotic markers over 24 h 
(Figure 5.7 (b)), but limited increase in the necrosis marker (LDH, Figure 5.4 
(c)). The increases were not distinguishable from the control conditions. 
Overall there is some evidence from the conventional assays of a minor loss of viability 
of H400 cells exposed to TiO2 NPs. ATPase activity appeared reduced in H400 cells after 
6 h following exposure to 1000 ppm and 5000 ppm concentrations of TiO2 NPs when 
compared with controls, and there appeared to be an increase in Caspase activity and 
in the LDH concentration in medium after 6 h. However, the differences appeared 
small, and no assay showed a large reduction in cell ‘viability’ at the concentrations 
tested up to 24 h of co-culture with TiO2 NPs. It is important to note that limitations of 
the assays conducted include: 
 As concluded in Chapters 3 and 4, not all H400 cells in a population are 
exposed to an equal concentration of TiO2 NPs. Therefore, the overall change 
in a light signal across an entire well of cells may be very small. It may 
therefore be that there are subtle changes in viability which are not identified 
using the assays described in this Section. 
 The mechanism of cell death induced by TiO2 NP exposure within epithelial 
cells is likely to be apoptosis, as published in the context of TiO2 NPs and 
kidney cells (Park et al., 2008), human lung epithelium (Srivastava et al., 2013) 
and human liver cells (Shukla et al., 2013). If apoptosis is occurring in a small 
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subset of the population of H400 cells examined using these conventional 
assays, this may be in response to ROS activation, which will be discussed 
further. 
 The issues surrounding using a nano-scale, insoluble stimulus means the local 
concentration of TiO2 each cell is exposed to may vary widely. This in turn 
could mean that changes in the viability state of an overall population may be 
small but the effects on a number of individual cells may be significant.  
 Changes in behaviour of individual cells may also affect the responses of 
neighbouring cells due to alterations in cell signalling mechanisms. These 
changes may be important but are not detected by the conventional assays 
above, and will be studied further in chapters 6 and 7. 
5.1.5  Sytox® green staining 
Sytox® green is a nucleic acid stain with a high affinity to DNA, which will readily stain 
the DNA content within the nuclei of non-intact cells. It can be used in two ways, firstly 
by measuring the amount of light output in a sample, for instance in a well plate 
seeded with cells of a known density, or by direct visualisation of a cell population. The 
method for staining H400 cells in this context is described in Section 2.3.4. The use of 
direct visualisation as opposed to quantifying light output was chosen due to the 
potential interferences discussed in Section 5.2. 
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Figure 5.5 – Exemplar images showing Sytox® green stained cells in a population of H400 cells 
co cultured with TiO2 NPs at concentrations of 0-1000 ppm and the proportion of positively 
stained cells within a number of images counted (n=3 image fields, approx. 250 cells per field). 
Asterisk shows significant increases in non-viable cells at 1000 ppm using one-way ANOVA 
(p<0.05) using total cell counts. The dark artefacts visible are TiO2 NP agglomerations. This 
appears to show a dose dependent increase in non-viable cells from the images although only 
the largest concentration exposure was significant.  
Figure 5.5 shows a significant increase in non-viable cells at exposure levels of 1000 
ppm TiO2, and there appears to be a correlation between the areas of TiO2 NP 
100ppm 
1000ppm 
10ppm 
Control 1ppm  
* 
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agglomeration and the non-viable cells. It is possible that there is therefore some 
effect on cell viability which is not clearly seen from the use of assays which average 
outputs across the entire cell population. 
5.2  High Content Screening (HCS) 
Ideally a homogeneous distribution of TiO2 NPs would be achieved within a sample to 
ensure all cells encounter the same local TiO2 NP concentration. Due to agglomeration 
of TiO2 NPs, the localised concentration of TiO2 NPs adjacent to each cell within a 
sample could differ largely within the experimental methods used for co-incubation. 
Therefore, HCS was used as an alternative method of assessing the cell population. The 
principles are the same as for conventional assays (reagents are added to cells which 
will generate light output or colour change in response to the generation or detection 
of a target molecule). However, the outcome is determined by the computer aided 
identification and analysis of relevant markers. This means that individual cells are 
labelled or stained for a particular target, then high numbers of cells are able to be 
individually analysed for a potentially large number of parameters depending on the 
markers used. The rationale for using this technique is that it may potentially 
overcome the limitations of conventional assay techniques in the experimental model 
used in this work and summarised below: 
 Due to the issues surrounding the use of an insoluble stimulus which has been 
seen to agglomerate in cell culture medium, the individual exposure of each 
cell to TiO2 NPs will potentially vary widely. Local concentration exposure of 
one cell may be in the multiples of thousands if adjacent to agglomerations, 
while other cells may experience no local exposure. Therefore, measuring the 
responses of a larger number of cells may show results which are so diluted in 
a small sample that they are not seen using conventional techniques. 
 Viability assays using the conventional assays described in Section 5.1 rely on 
sacrificing a sample at each time-point or removing the supernatant from the 
sample. This is a limitation as it means continuous monitoring of the viability 
of the same cell population is not possible. 
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 A larger amount of data is gathered efficiently when using HCS when 
compared with conventional assays and allows for more robust statistical 
analysis.  
All samples for processing by HCS were processed at Imagen Therapeutics (formerly 
Imagen Biotech, Alderley Edge, UK). H400 cells were cultured as described in Section 
2.2 and stimulated and analysed as described by the specific protocol outlined in each 
section. 
HCS assays 
The following HCS assays were performed: 
 Cell viability and cell death using DraQ7™ (Biostatus, UK) 
 Cell count using Hoechst 33342, Trihydrochloride, Trihydrate - 10 mg/mL 
Solution in water (ThermoFisher Scientific, UK) 
 Cell morphology using CellMask™ Green Stain (ThermoFisher Scientific, UK) 
 Cell cycle markers using a histogram profile and computerised gate on 
Hoescht stained cells  
 NFkappaB translocation using NFκB2 p100/p52 (18D10) Rabbit mAb (Cell 
Signalling Technology, Massachusetts, USA). 
5.2.1   Cell viability using HCS 
Draq7™ (Biostatus, UK) was used to assess the viability of cells using HCS. Draq7 is a 
red dye which will readily enter non-intact cells and hence stain the nuclei of non-
viable cells. It is non-toxic to intact cells (Akagi et al., 2013). Draq7™ therefore has the 
advantage that it can be used repeatedly on the same sample to monitor viability over 
a time-course as opposed to using separate replicated wells to achieve an 
approximation of viability time. Draq7™ has been extensively tested to ensure 
compatibility with multi-stain experiments and for long term analysis (Akagi et al., 
2013).  
H400 cells were cultured as described previously. 24-48 h after seeding, cells were 
examined using light microscopy and 70-80 % confluent TiO2 NPs were added as 
stimuli (Section 2.1.2) at a range of concentrations from 0-1000 ppm.  
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Generic HCS methods  
Following exposures, H400 cells were fixed in 1 % formaldehyde and washed twice 
with PBS. Primary antibodies were diluted as appropriate according to the specific 
antibody used, and incubated with the cells in Digitonin (500 µL/mL, Sigma-Aldrich, 
UK) to allow membrane permeabilisation. Primary antibodies were incubated for 1 h at 
room temperature (21 ± 2°C), following which the antibody was decanted and the 
plate was washed twice with PBS using a plate washer (Tecan UK Ltd, Reading, UK). 
Secondary antibodies were diluted as appropriate and again incubated for an hour at 
room temperature in conjunction with a Hoechst 3332 (Invitrogen, UK) to counterstain 
the nuclei. Following the second incubation the wells were again washed after removal 
of the secondary antibody mix. 100 µL of PBS was added to each well for visualisation. 
Immunoreactivity staining for biomarkers was performed in triplicate for each 
experiment and triplicate readings were pooled.  
HCS data capture and analysis 
Biomarkers of interest were visualised and the intensity quantified using Cellomics 
ArrayScan© HCS reader: Compartmental Analysis Bio-Application (V2 Version, Thermo 
Scientific). Images of at least 5000 cells per well were captured in > 8 images taken in a 
spiral pattern outwards from the centre of each well. Each image was analysed 
through bio-application analysis protocols to identify the immunoreactivity 
fluorescence intensity for areas of interest for each individual cell. Areas of the cell 
were analysed along with sites within the cell depending on the specific area of 
interest (e.g. morphology scans assessed perimeter, area of cytoplasm and nucleus 
while NFκB assay collected data on regions within the cell cytoplasm).  
Within the relevant area of interest, threshold values were used to identify the sum of 
or mean intensity of areas showing fluorescence. The intensity was designated as 
relative light units (RLU). Cells which were immuno-positive for fluorescence values 
greater than the set thresholds were counted and reported as a percentage positive (% 
positive) relative to all those examined within the population.   
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Figure 5.6 – Selected images showing cell viability 6 days following addition of TiO2 NPs at 
concentrations shown. Draq7™ positively stained cells are shown in red, cell nuclei are shown 
in blue. There appears to be an increased number of non-viable cells with an increase in TiO2 
NPs ppm from control to 1000 ppm. Lower concentration images were not made available 
from Imagen BioTech.   
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1000 ppm 300 ppm 
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5.2.2  Cell count and cell death 
(A) 
 
  
(B)
 
Figure 5.7 – Percentage cell death (A) and cell count of the whole population (B) as measured 
by HCS over 7 days (n=2, mean and SEM shown as supplied by Imagen Biotech. There is a clear 
dose dependent increase in percentage cell death at 300 ppm and 1000 ppm after 72 h, and a 
dose dependent reduction in cell count over time. However, the results may be influenced by 
the fact that the medium within the wells may well become exhausted at 72 h leading to an 
increase in cell death in all conditions, and a relative plateau of cell replication. 
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5.2.3  Cell morphology 
As discussed in chapter 4, accurate measurements of cell size, shape and alterations in 
morphology following incubation with TiO2 NPs have not been possible using TEM and 
light microscopy. Images captured using CellMask™, a fluorescent dye which will stain 
the plasma membrane, therefore representing the shape of the entire cell are shown 
in Figure 5.8. Cell nuclei are counterstained with DAPI (blue). 
 
 
Figure 5.8 - H400 cells stained with CellMask plasma membrane stain (left), DAPI nuclear stain 
(centre) and combined image (right) at 6 days post exposure to 1000 ppm TiO2 NPs (a) and 
control cells (b). The images show clear differences in cell morphology with H400s exposed to 
1000 ppm TiO2 NPs showing brighter plasma membrane signal and appearing more elongated 
in shape.  
5.2.4  Further work informed by HCS results 
High content screening generated some different results to the conventional assays 
described in Section 5.1. The HCS results are likely to be more robust as they use a 
higher number of samples, and therefore may be more representative. The initial 
results appear to show an increase in cell death and reduction in cell growth in 
response to an increase in TiO2 NP ppm. There are also potential morphological 
(a) 
(b) 
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changes seen within cell populations associated with higher concentrations of TiO2 NP 
exposures.  
5.2.5  Cell cycle as examined using HCS 
As discussed in Section 4.5, there was a non-uniform uptake of TiO2 NPs within the 
populations of both H400 and primary oral epithelial cells examined. All methods used 
to image epithelial cells so far (light microscopy, TEM, FTIR techniques and confocal 
reflectance microscopy) showed the same pattern, namely that a sub-set of the cell 
population shows a large amount of associated NP agglomerations, while other cells 
within the population appear to not be associated with TiO2 NP agglomerations. The 
pattern of association of agglomeration with cells may be due to non-uniform 
distribution within cell culture medium, but also could be affected by the cell cycle 
stage of each cell when exposed to TiO2 NPs. According to the literature, endocytosis 
can occur at a variety of stages of the cell cycle, but may be more likely during G1 
phase. Endocytosis is arrested at mitosis (Tuomikoski et al., 1989, Fielding et al., 2012). 
It has been shown that the concentration of NPs within a cell population varies, and 
that nanoparticles were present in higher concentrations at Gap 
2/Mitosis>Synthesis>Gap 0/1 (Kim et al., 2012). It is therefore reasonable to expect 
that the cell cycle stage, which will be mixed within a growing cell population, may 
affect NP uptake in an epithelial cell population. What is also unknown is whether the 
cell cycle will be altered by the uptake of NPs into an epithelial cell. It has been shown 
that NPs are divided between daughter cells in A459 human lung epithelial cells (Kim 
et al., 2012), but that no dis-regulation of either viability markers or cell cycle stages 
were detected following NP internalisation in this particular study.  
The stage of cell cycle was investigated using HCS. Conventional methods of cell cycle 
investigation, such as flow cytometry, were not used due to concerns that there could 
be potential interactions or issues with introducing nanoparticles into a flow cytometry 
system. The HCS system used was a similar methodology to those described in 
previous Sections, in that Hoersct stained fixed cells were imaged using a 
computerised histogram profile which ‘gates’ each phase.  
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Figure 5.9 – Cell cycle diagram. Endocytosis is most likely to occur in the G1 phase of cell cycle 
(Quintart et al., 1979). Published data on endocytosis of nanoparticles in epithelial cells 
regarding cell cycle status the cell population are limited.  
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Figure 5.10 – HCS analysis of cell populations exposed to differing concentrations of TiO2 NPs 
showing % cell population in a certain cell cycle point (y-axis) against time (x-axis). Figure 5.10 
shows potential small alterations in cell cycle stages, therefore it can be assumed that the cell 
cycle stage, while it may initially determine which cells will uptake TiO2 NPs, is unlikely to be 
affected by the presence of up to 1000 ppm TiO2 NPs within the culture system.   
5.2.6  Conclusions from HCS viability and initial assays 
Alongside the differences discussed in Section 5.2.4, there are some similarities 
between the findings from conventional assays and HCS techniques when looking at 
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markers of viability within the H400 cell population when exposed to TiO2 NPs. Both 
techniques show a potential dose dependent increase in cell death with increasing 
concentrations of TiO2 NPs, however the magnitude of this appeared larger in HCS. 
HCS techniques have also shown a number of features of TiO2 NP interactions which 
were not identified by conventional methods. These were: 
 Reduced cell counts in populations exposed to higher TiO2 NP concentrations 
(over a longer time-course than examined by conventional methods)  
 Potential morphological changes at higher concentrations as shown by the 
CellMask™ stain 
 Minimal effects on cell cycle following incubation with TiO2 NPs.  
The HCS findings reinforce that conventional assay methods may not be the best way 
to examine cell populations where a non-homogeneous distribution of stimulus and 
potentially therefore heterogeneity in response is anticipated. It may be that 
conventional assays are not sensitive enough to distinguish the responses of a subset 
of cells in a population from the overall responses of the well as a whole when 
measures such as luminescence and fluorescence are used as end-points. Imaging 
techniques appear to give truer representation of epithelial cellular responses to TiO2 
NPs in this model system. It is therefore important to consider the use of HCS 
techniques in conjunction with conventional techniques wherever possible. The use of 
primary cells was not possible for HCS methods due to the number of cells required.  
5.3  Effects of TiO2 NPs on NFκB activation 
It has been demonstrated that H400 epithelial cells will show an inflammatory 
response when challenged with relevant pathogenic stimuli (Milward et al., 2007). In 
the peri-implant situation, epithelial cells will interact not only with any implant 
derivatives present but also with peri-implant pathogens. Therefore, an important 
aspect of this work was to investigate how the interactions seen between epithelial 
cells and TiO2 NPs could potentially influence cellular pathways known to be important 
in the response to pathogenic challenges.  
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5.3.1 Activation of Nuclear Factor kappa-light-chain-enhancer of activated B 
cells (NFκB) in H400 cells 
Translation of NFκB from within the cytoplasm to the nucleus of epithelial cells is a 
characteristic feature of cells showing an inflammatory response. NFκB is a complex of 
proteins which are involved in the control of DNA transcription, cytokine production 
and cell survival and is found in most mammalian cell types (Makarov, 2000, Silverman 
and Maniatis, 2001). NFκB release is considered to be a key initial event in the 
inflammatory processes, particularly in chronic inflammatory conditions such as 
periodontitis (Milward et al., 2007, Milward et al., 2013), and potentially therefore 
peri-implantitis. NFκB is initially activated by stimuli such as oxidative stress and 
pathogenic challenge (Zhang and Ghosh, 2001). Once activated, the protein complex is 
not irreversibly bound within the nucleus, but can be moved back into the cytoplasm 
(Hayden and Ghosh, 2004) in its inactive form. Once bound within the nucleus, NFκB 
will activate transcription of DNA, production of cytokines to form an inflammatory 
response, and regulate cell survival. The recycling of NFκB can continue repeatedly, but 
it serves to ensure that the activation of NFκB is only transient within a cell. This 
mechanism is key in both acute and chronic inflammatory conditions.  
The method used for staining H400 cells to show activation of NFκB is described in 
Section 2.6.1 and is a conventional staining approach where manual counts of stained 
cells were undertaken.  
   
Figure 5.11 – H400 cells stained for the identification of NFκB translocation. Control cells (a) 
show the counterstained blue nucleus to be fairly free of the brown stained NFκB, while the 
activated cells (b) exposed to E.coli LPS 20 µg/mL for 1 h show translocation of NFκB to the 
nucleus.  
a b 
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The conditions for stimulation of H400 cells are explained in detail in Section 2.6.2, and 
quantification is described in 2.6.3.  
Firstly, it was investigated whether TiO2 NP exposure on H400 cells would lead to 
activation of NFκB. Figure 5.12 shows the percentage of activated cells within a 
population when exposed to a variety of Ti products along with a table detailing each 
stimulus. A wider panel of Ti species in the fine and ultrafine scale was used to assess 
the potential for other Ti stimuli to be pro-inflammatory to H400 cells by way of 
measuring NFκB translocation, and assess the relative inflammatory response to TiO2 
NPs as used before when compared with other potentially biologically relevant Ti 
products. 
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Name Stimulus Particle size  Concentration 
in medium 
Supplier and code 
Control - - -  
Anatase 10 TiO2 (anatase) <25 nm dia 10 ppm 637254 Sigma-Aldrich,  
Anatase 100 TiO2 (anatase) <25 nm dia 100 ppm 637254 Sigma-Aldrich,  
Rutile 10 TiO2 (rutile) ~ 50 nm dia 10 ppm 1317802 Sigma-Aldrich,  
Rutile 100 TiO2 (rutile) ~ 50 nm dia 100 ppm 1317802 Sigma-Aldrich,  
Metal 10 Ti metal ~ 5 µm dia 10 ppm Gift from Dr S Kalra 
Metal 100 Ti metal ~ 5 µm dia 100 ppm Gift from Dr S Kalra 
LPS 20 E.coli LPS  - 20 µg/mL L2630 Sigma-Aldrich  
Figure 5.12 – graph showing activation of H400 cells exposed to the stimuli listed in the below 
table for 1 h (n=2, data and mean shown). This shows a limited activation of NFκB in H400 cells 
in response to Ti products using a conventional staining technique but a clear activation to the 
E.coli LPS as expected.  
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A HCS methodology was used in conjunction with the conventional assay above, where 
TiO2 as anatase of 0-1000 ppm was used as the stimulus to investigate if there was an 
altered response in NFκB activation of H400 cells. The HCS assay measured a number 
of features of each cell, not just the translocation of NFκB as a “positive” or “negative” 
outcome as was recorded in the conventional assay. Due to the fact that the images 
where NFκB was stained were captured digitally and analysed using specific software, 
the amount of NFκB in the cytoplasm and the nucleus could be recorded. This was 
used to generate a nuclear:cytoplasmic ratio of NFκB within cells, with a higher 
number indicating a higher amount of activated NFκB. The other main difference in 
this technique compared with the conventional technique is that the HCS was carried 
out over a longer time period, allowing the investigation of the potential cycling of 
NFκB into and back out of the nucleus of cells, a mechanism which may be important 
in chronic inflammatory conditions such as periodontitis and potentially peri-
implantitis.  
 
Figure 5.13 – Nuclear:cytoplasmic intensity of NFκB stained with a flurophore of H400 cells 
exposed to 0-1000 ppm TiO2 NPs (anatase, <25nm diameter). The higher the number, the 
more NFκB is present in the nucleus. This appears to show a dose dependent suppression of 
background NFκB activation post 72 h. An increase in background NFκB activation would be 
expected in all conditions over time due to acidification of the medium eliciting a stress 
response within H400 cells. 
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The pattern of the control response over time in Figure 5.13 is as expected: An initial 
rise in NFκB activation as the cells are responding to being disturbed by a change in 
medium then a reduction as the cells are left to settle and grow normally, before a rise 
as the medium becomes exhausted. However, this pattern becomes disordered by the 
presence of TiO2 NPs in a dose dependent manner to have an initial drop then less of a 
rise after medium exhaustion. This suggests that the presence of TiO2 inhibits the 
activation of NFκB, possibly by binding to the NFκB or inhibiting its transport into the 
nucleus, or by blocking the receptors needed to activate the NFκB translocation.  
 
5.4  TiO2 NPs as a potential modifier of epithelial responses to bacteria 
Responses of epithelial cells may be affected by the presence of TiO2 NPs in a culture 
system. In the peri-implant environment in vivo, there will be exposure of the oral 
epithelial cells adjacent to an implant surface to a bacterial challenge. While it has 
been shown in this work that the exposure of oral epithelial cells (both H400s and 
primary epithelial cells) of TiO2 NPs at up to 1000 pm concentration does not cause 
widespread viability changes in a population, it may be that the interactions between 
TiO2 NPs and epithelial cells could impact on responses to bacterial challenge.  
5.4.1 NFκB responses of oral epithelial cells to bacterial LPS with and without 
pre-treatment with TiO2 NPs – method 
Given that NFκB is a known pathway involved in the response of H400 cells to bacterial 
challenge (Milward et al., 2007), the effects of TiO2 NPs as a co-exposure factor along 
with a pathogen on the activation of NFκB in response to bacteria was investigated. 
The method for NFκB activation detection is detailed in Section 2.6.1. The stimulus 
conditions were as follows: 
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Control cells H400s cultured on glass slides in standard medium (see Section 2.2.2) until 
just sub confluent 
LPS 20 mg/mL H400 cells as control then stimulated with 20 mg/mL E.coli LPS for 1 h 
LPS 40 mg/mL H400 cells as control then stimulated with 40 mg/mL E.coli LPS for 1 h 
TiO2 H400 cells as control then cultured with TiO2 NPs 10ppm for 18 h 
TiO2 LPS 
20mg/mL 
H400 cells as control then cultured with TiO2 NPs 10ppm for 18 h then 
stimulated with 20 mg/mL E.coli LPS for 1 h 
TiO2 LPS 
40mg/mL 
H400 cells as control then cultured with TiO2 NPs 10ppm for 18 h then 
stimulated with 40 mg/mL E.coli LPS for 1 h 
Table 5.1 – H400 cell preparation prior to staining.  
Triplicate slides were prepared and 500 cells counted from each condition. 
 
5.4.2 NFκB responses of oral epithelial cells to bacterial LPS with and without 
pre-treatment with TiO2 NPs – results and discussion 
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Figure 5.14 –NFkB activation in response to 20 mg/mL LPS when pre-treated with TiO2 (n=10, 
mean and SD of counts shown) and  LPS 40 mg/mL. Cells were either pre-treated for 18 h with 
10 ppm TiO2 or not. LPS was added for 1 h prior to washing and fixing. 
The results from the conventional approach to staining show that there was a 
statistically significant down regulation in NFκB activation in cells pre-treated with TiO2 
however the effect size was small. This could be due to potential binding of LPS protein 
to TiO2 NPs therefore reducing the effective concentration. Further investigation in this 
area is warranted. 
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5.4.3 Co-stimulation of H400 cells with heat killed Fusobacterium nucleatum 
and TiO2 NPs 
H400 cells were cultured on glass slides as in Section 2.2.2 and the staining protocol for 
NFκB activation is detailed in Section 2.6.1. Cells were stimulated as follows: 
Control cells H400s cultured on glass slides in standard medium (see Section 2.2.2) until 
just sub confluent 
FN  H400 cells cultured in standard medium until just sub confluent then 
stimulated with heat killed FN at a concentration of 1 x 109/mL for 1 h  
TiO2 then FN H400 cells cultured in standard medium until approx. 24 h prior to 
becoming just sub confluent then exposed to TiO2 10ppm for 24 h then 
stimulated with heat killed FN at an MOI of 1 x 109/mL for 1 h 
 
FN/TiO2 H400 cells cultured in standard medium until just sub confluent then 
stimulated with TiO2 10ppm and heat killed FN at an MOI of 1 x 10
9/mL for 
1 h concurrently. 
Table 5.2 –H400 co-culture conditions prior to staining. 
Triplicate slides of each condition were prepared and 500 cells were counted from 
each condition.  
 
Figure 5.15 -The % activated H400 cells exposed to heat killed FN for 1 h +/- TiO2 10 ppm for 24 
h previously or exposed to FN and TiO2 concurrently for 1 h (n=5, mean and SD shown). A 
reduction in NFκB activation in response to FN when H400 cells have been previously exposed 
to TiO2 compared with concurrent exposure or exposure to FN alone was observed. 
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5.4.4 Co-stimulation of H400 cells with heat killed Fusobacterium nucleatum 
and TiO2 NPs –discussion 
The results in Figure 5.15 suggest that pre-exposure to TiO2 (a low concentration of 10 
ppm) for 24 h seems to reduce the activation of NFκB in response to heat killed FN. 
TiO2 NP itself has not been shown to stimulate NFκB translocation when measured by 
the same technique (see Section 5.3.1), therefore it is unlikely to be due to competitive 
stimulation of the epithelial cells. The fact that TiO2 NPs have the capacity to modify 
epithelial responses to bacteria could be important clinically as epithelial cells are likely 
to be in contact with Ti species chronically. Therefore, potential inhibition of responses 
to bacteria would be an important in vivo consequence of the presence of Ti species in 
tissues adjacent to implants. To further investigate this potential modification of NFκB 
activation, HCS techniques were used. 
5.4.5 HCS investigation of NFκB responses to bacteria with and without TiO2 
NPs- method 
H400 cells were cultured according to Section 2.12 and after 24 h settling in wells, 
medium was changed for medium containing 0-100 ppm TiO2 and cultured for a 
further 24 h. At this point, 10 µL of stimulus was added to each well, containing either 
heat killed FN (1x109/mL), heat killed PG (1x109/mL), E.coli LPS (20 mg/mL) or PBS 
(control). After 1 h incubation under standard cell culture conditions, cells were 
stained as appropriate, imaged, and analysed as appropriate (see also Section 5.2.1). 
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5.4.6 HCS investigation of NFκB responses to bacteria with and without TiO2 
NPs- results 
 
 
Figure 5.16 – Nuclear:cytoplasmic intensity ratio of fluorophore conjugated to NFκB in oral 
epithelial cells when stimulated with FN (Fusobacterium nucleatum), LPS (E.coli LPS) and PG 
(Porphyromonas gingivalis) over time. A small increase in activation of NFκB in cells pre-
treated with TiO2 was seen compared with those not pre-treated but the differences were 
small. 
 165 
 
 
 
Figure 5.17 – Example images showing fluorescent signal from DAPI (left, nuclear stain), NFκB 
linked fluorophore (centre) and combined false colour image (right, DAPI blue and NFκB green) 
in H400 cells 1 h after being treated with PBS (control) showing minimal translocation of NFκB. 
  
  
Figure 5.18 – Example images showing fluorescent signal from DAPI (left, nuclear stain), NFκB 
linked fluorophore (centre) and combined false colour image (right, DAPI blue and NFκB green) 
in H400 cells pre-treated with TiO2 NPs at 10ppm for 24 h, 1 h after being treated with PBS 
(control) showing minimal translocation of NFκB. 
DAPI NFκB Composite 
DAPI NFκB Composite 
DAPI NFκB Composite 
DAPI NFκB Composite 
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Figure 5.19 – Example images showing fluorescent signal from DAPI (left, nuclear stain), NFκB 
linked fluorophore (centre) and combined false colour image (right, DAPI blue and NFκB green) 
in H400 cells 1 h after being treated with FN showing a degree of translocation of NFκB. 
 
Figure 5.20 – Example images showing fluorescent signal from DAPI (left, nuclear stain), NFκB 
linked fluorophore (centre) and combined false colour image (right, DAPI blue and NFκB green) 
in H400 cells pre-treated with TiO2 NPs at 10ppm for 24 h, 1 h after being treated with FN 
showing a degree of translocation of NFκB. 
DAPI NFκB Composite 
DAPI NFκB Composite 
DAPI NFκB Composite 
DAPI NFκB Composite 
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5.4.7 HCS investigation of NFκB responses to bacteria with and without TiO2 
NPs- discussion 
Conventional staining and light microscopy showed only limited consequences of the 
presence of TiO2 NPs on the NFκB translocation in H400 cells in the absence of other 
stimuli. However, when investigating the effects of the presence of TiO2 NPs on NFκB 
translocation within cells in a co-stimulation model or using TiO2 NP as a pre-
treatment, there appeared to be small but statistical modifications in behaviour.   
The results from the HCS investigation appear to show a different pattern to the 
conventional assay technique, in that there is a minimal difference in NFκB expression 
in H400 cells pre-treated with TiO2 and those not pre-treated. There is a non-uniform 
distribution of TiO2 within the cellular population due to insolubility and agglomeration 
within the cell culture system as previously discussed, so it may be that the HCS 
technique gives a truer picture of responses than the conventional approach to 
staining for NFκB which is limited to smaller sample numbers. HCS samples analyse at 
least 5000 cells in triplicate, so far higher numbers of cells are imaged and analysed 
than using conventional methods. Also using algorithms in the analysis of images in 
HCS means that cells are counted as positive or negative for certain parameters, as 
opposed to light output from a well as a whole being taken as a result. This means that 
it is less likely to have a dilution of positive cells in a sample.  
5.5  Chapter conclusions 
The direct effects on H400 cells following interactions with TiO2 NPs are limited. 
Conventional assays showed an increase in ATPase activity at approximately 6 h, 
indicating cells are metabolically more active at this time-point, which ties in with the 
timescales of intracellularisation of NP agglomerations shown in Chapter 4. However 
conventional assays demonstrated only a small reduction in viability up to 24 h and 
with exposure concentrations ranging up to 1000 ppm TiO2. Sytox green staining 
appeared to show an increase in the number of non-viable cells and these non-viable 
cells appeared to be located adjacent to NP agglomerations. There is evidence to show 
some reduced viability in longer term cultures at increasing concentrations from HCS 
data.  
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Known pathways in response to bacterial challenges such as NFκB appear to be 
unaffected by pre-treatment with TiO2 NPs when investigated using HCS techniques, 
however conventional staining appeared to show a small reduction in NFκB activation 
in response to pre-treatment. The differences in results between HCS and 
conventional methods are likely to be due to the fact that each cell is not equally 
exposed or affected by the presence of TiO2 NPs in this system. A number of factors 
which are important in both the in vitro and in vivo situations are relevant: 
 TiO2 is insoluble and agglomerates in cell culture mediums, therefore the local 
concentration in the immediate environ of each cell will not be uniform across 
the cell population.  
 HCS techniques will reduce background noise, as cells are labelled individually 
as opposed to results being pooled across a whole cell population. 
 It is possible that cell cycle stage of the cells determines whether or not an 
interaction is seen, however attempts to elucidate this using HCS techniques 
were inconclusive. 
There appears to be a slight morphological change in H400 cells when stained with 
CellMask post TiO2 NP exposure. LPS contamination is unlikely to be a significant issue 
in this model system, and any contamination may in fact be more representative of the 
clinical situation. 
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Chapter 6 
Effects of interactions between TiO2 NPs and oral 
epithelial cells on gene expression 
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Synopsis 
In Chapters 3 and 4 it was demonstrated that H400 cells and primary oral epithelial 
cells interact with TiO2 NPs leading to NP intracellularisation. At concentrations of 1000 
ppm of TiO2 NPs and higher, a reduction in H400 viability was identified using 
conventional assays. A dose dependent reduction in cell viability and cell count was 
identified using HCS techniques. NFκB translocation in response to pathogenic stimuli 
was inhibited by the presence of TiO2 NPs. Interactions such as intracellularisation and 
altered viability suggest that the responses of epithelial cells to TiO2 NPs are likely to 
be complex and involve multiple cellular pathways and functions. In this chapter the 
gene expression profile of human oral epithelial cells when exposed to TiO2 NPs is 
compared with non-exposed cells of the same type, and is investigated using DNA 
microarray and PCR techniques. Furthermore, relevant pathogenic stimuli are 
introduced into the co-culture model and their effects on gene expression and 
therefore potentially proteins expressed by oral epithelial cells are explored in the 
presence and absence of TiO2 NPs.  
6.1  DNA microarray 
A DNA microarray is a device for a high throughput technique where a panel of DNA 
probes are presented to a DNA sample. In a microarray chip there are often many 
thousands of probes presented to the sample. Due to the specific sequences of the 
probes, complementary sections of DNA within the sample will bind to the probes, 
which are labelled with a reporter molecule. A higher signal from the specific label 
correlates with a greater expression of the target DNA sequence within that sample.  
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Figure 6.1 – Illustration of a DNA microarray chip. 
DNA for the microarray assay is synthesised from RNA extracted from cells or tissue. 
The protocol for RNA extraction from epithelial cells grown in culture vessels is 
reported in Section 2.5.1. A DNA microarray approach was chosen as it is a non-
presumptive technique, and the expression levels of thousands of genes can be 
generated, thus potentially allowing identification of novel genes that will enable a 
better understanding of the mechanisms underpinning the cellular effects of TiO2 NP 
exposures. The interactions between oral epithelial cells and TiO2 NPs have been 
shown to vary within cell populations, and involve a number of physiological 
processes. The objective was therefore to use a DNA micro-array approach as a 
screening tool with subsequent validation of findings performed using targeted and 
presumptive PCR techniques. 
The Affymetrix Human Gene 1.0 ST Array was employed, which covers 36,079 total 
transcripts and 21,014 RefSeq (Entrez) genes, covering a wide range of potential 
cellular responses. Entrez Gene is a national database for gene-specific information, 
and records information from sequenced genomes (Maglott et al., 2011) and 
generated specific identifiers for genes known as GeneIDs. This allows quick 
identification of genes and the full Entrez Gene report allows access to a variety of 
gene specific information.  
Fixed probes on microarray 
chip 
Labelled target linked to fixed 
probe  
Labelled 
target 
within 
sample 
Microarray chip  
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6.1.1  Affymetrix GeneChip methods   
The microarray data using the Affymetrix GeneChip was generated at the University of 
Birmingham Institute of Cancer Sciences, as an assay service. 
RNA sample preparation 
H400 cells were cultured in 25 cm2 cell culture treated flasks using standard growth 
conditions (Section 2.2.2). When the flasks had reached approximately 80 % 
confluence, determined visually using light microscopy, the growth medium was 
changed and supplemented with TiO2 NPs according to the methods specified in 
Section 2.2.2. Subsequent to supplementation of the growth medium with TiO2 NPs, 
flasks were incubated as described in Section 2.2.2. The culture medium was then 
removed and the cell monolayer was washed with warmed (37 ± 1°C) PBS three times. 
Flasks were then processed as described in Section 2.5.1. The process was completed 
three times on separate days to create full biological triplicates of each sample 
number. Samples were then processed separately and not pooled to enable sample 
comparison within conditions. 
Sample number Final concentration of TiO2 NPs 
in culture medium 
Time from 0 h  
1 0 6 h 
2 0 24 h 
3 100 ppm 6 h 
4 100 ppm 24 h 
Table 6.1 – H400 RNA sample preparation 
The time points of 6 h and 24 h were chosen as intracellularisation was clearly evident 
in TEM images of H400 cells, 6 h post-TiO2 NP exposure, and at 6 and 24 h post 
exposure a different set of genes may be activated. Gene expression changes have also 
been previously reported in H400 cells 24 h post-stimulation with periodontally 
relevant bacteria (Milward et al., 2007). Longer term cultures were avoided to reduce 
the risk of media exhaustion influencing cell responses. Shorter term cultures (< 2 h) 
were avoided to minimise the risk of disruption to cells from media supplementation 
affecting gene expression. The potential for TiO2 NP interference with the microarray 
was minimised by avoiding high (> 100 ppm) TiO2 NP exposures. The avoidance of 
higher TiO2 NP concentrations may not have been necessary, but given the previously 
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reported effects of high TiO2 NP concentrations with certain assays, a lower 
concentration was selected to reduce the risk of interference. This however, inevitably 
reduces the proportion of cells within the sample population that are directly exposed. 
Sample preparation and microarray protocol 
RNA samples were prepared (Section 2.5.1) and transferred to the Institute of Cancer 
Sciences (now the Institute of Cancer and Genomic Sciences) microarray service for 
processing. The processing briefly consisted of: 
1. Synthesis of double stranded cDNA from RNA 
2. Purification of double stranded cDNA 
3. Synthesis of biotin labelled cRNA 
4. Purification of biotin labelled cRNA  
5. Fragmentation of cRNA 
6. Target hybridisation and probe array wash and stain/label. 
Following staining, arrays were scanned and analysed. 
6.1.2  GeneChip data analysis 
Images of microarray chips were scanned and then analysed using the Affymetrix 
GeneChip Command Console. The data analysis was completed by Dr Wenbin Wei at 
the University of Birmingham as part of the microarray service provided by the 
Institute of Cancer and Genomic Sciences. Probe level quantile normalisation (Bolstad 
et al., 2003) and robust multi-array analysis (Irizarry et al., 2003) was performed on the 
raw CEL files. The multi-array analysis was performed using the “Affy” package of the 
Bioconductor (http://www.biocondutor.org) project and custom Computable 
Document Format (cdf) HUGENE10ST_Hs_ENTREZG (version 17) (Dai et al., 2005). 
Gene annotation was based on the NCBI gene database downloaded on June 7, 2013. 
Differentially expressed genes were initially identified using Limma software 
(Bioconductor 3.3 open source software), with a fold change >1.5 and p < 0.01 (Smyth, 
2004). Significance levels were not adjusted for multiple hypothesis testing.  
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6.1.3  GeneChip results - DNA microarray data  
The tables below summarise the down-regulated and up-regulated genes at 6 h 
following TiO2 NP exposure compared with 6 h control H400 cells. The fold changes at 
a significance of p< 0.01 are listed.  
Symbol  Description  Fold 
Change  
ID2  inhibitor of DNA binding 2, dominant negative helix-loop-helix 
protein  
-8.44  
SNORD116-8  small nucleolar RNA, C/D box 116-8  -2.82  
ID1  inhibitor of DNA binding 1, dominant negative helix-loop-helix 
protein  
-2.53  
ID3  inhibitor of DNA binding 3, dominant negative helix-loop-helix 
protein  
-2.14  
SCARNA4  small Cajal body-specific RNA 4  -2.00  
LOC100996467  metastasis-associated lung adenocarcinoma transcript 1-like  -1.95  
BMI1  BMI1 polycomb ring finger oncogene  -1.86  
MIR1247  microRNA 1247  -1.85  
ANKRD36BP1  ankyrin repeat domain 36B pseudogene 1  -1.83  
RHOBTB3  Rho-related BTB domain containing 3  -1.83  
HIST1H2AH  histone cluster 1, H2ah  -1.78  
TRAPPC2P1  trafficking protein particle complex 2 pseudogene 1  -1.73  
RPL22  ribosomal protein L22  -1.71  
RPSAP52  ribosomal protein SA pseudogene 52  -1.70  
LSP1P3  lymphocyte-specific protein 1 pseudogene 3  -1.67  
COX7B  cytochrome c oxidase subunit VIIb  -1.65  
HIST3H2BB  histone cluster 3, H2bb  -1.63  
HOXC13  homeobox C13  -1.58  
RNU5B-1  RNA, U5B small nuclear 1  -1.58  
TRGV3  T cell receptor gamma variable 3  -1.57  
ORM1  orosomucoid 1  -1.53  
GCNT4  glucosaminyl (N-acetyl) transferase 4, core 2  -1.52  
CIITA  class II, major histocompatibility complex, transactivator  1.50  
KRTAP5-5  keratin associated protein 5-5  1.51  
ADAMTSL2  ADAMTS-like 2  1.54  
FLJ44790  uncharacterized FLJ44790  1.54  
NEDD9  neural precursor cell expressed, developmentally down-
regulated 9  
1.54  
USP32P2  ubiquitin specific peptidase 32 pseudogene 2  1.55  
TUBB8  tubulin, beta 8 class VIII  1.57  
ZRSR2  zinc finger (CCCH type), RNA-binding motif and 
serine/arginine rich 2  
1.57  
HBB  hemoglobin, beta  1.57  
LOC145757  uncharacterized LOC145757  1.68  
OR10G9  olfactory receptor, family 10, subfamily G, member 9  1.68  
MIR134  microRNA 134  1.74  
IGKV1D-12  immunoglobulin kappa variable 1D-12  1.75  
XAGE-4  XAGE-4 protein  1.93  
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ANAPC1P1  anaphase promoting complex subunit 1 pseudogene 1  2.00  
FLJ45248  FLJ45248 protein  2.15  
INS-IGF2  INS-IGF2 readthrough  2.25  
Table 6.2 – Genes showing altered expression at 6 h in H400 cells exposed to TiO2 NPs 
compared with control cells (fold change >1.5 and p < 0.001). 
 
Symbol  
Description  Fold 
Change  
ID2 inhibitor of DNA binding 2, dominant negative helix-loop-helix 
protein 
-8.03 
ID3 inhibitor of DNA binding 3, dominant negative helix-loop-helix 
protein 
-3.42 
AKR1B10 aldo-keto reductase family 1, member B10 (aldose reductase) -2.50 
FABP4 fatty acid binding protein 4, adipocyte -2.19 
C10orf99 chromosome 10 open reading frame 99 -2.03 
RHOBTB3 Rho-related BTB domain containing 3 -1.95 
IGKV1D-12 immunoglobulin kappa variable 1D-12 -1.95 
CLDN8 claudin 8 -1.91 
KRTAP20-1 keratin associated protein 20-1 -1.82 
ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix 
protein 
-1.80 
RIPK4 receptor-interacting serine-threonine kinase 4 -1.74 
MGC21881 uncharacterized locus MGC21881 -1.70 
TPTE2P6 transmembrane phosphoinositide 3-phosphatase and tensin 
homolog 2 pseudogene 6 
-1.69 
RFPL4AL1 ret finger protein-like 4A-like 1 -1.67 
TMPRSS11E transmembrane protease, serine 11E -1.66 
PTENP1 phosphatase and tensin homolog pseudogene 1 -1.65 
TGM5 transglutaminase 5 -1.61 
APOL1 apolipoprotein L, 1 -1.61 
SNORA60 small nucleolar RNA, H/ACA box 60 -1.61 
PSCA prostate stem cell antigen -1.57 
CYP4F3 cytochrome P450, family 4, subfamily F, polypeptide 3 -1.56 
KRT4 keratin 4 -1.55 
HOXC13 homeobox C13 -1.54 
AQP3 aquaporin 3 (Gill blood group) -1.54 
LY6D lymphocyte antigen 6 complex, locus D -1.53 
POU5F1 POU class 5 homeobox 1 -1.52 
OR1F2P olfactory receptor, family 1, subfamily F, member 2 -1.52 
ANKRD32 ankyrin repeat domain 32 1.50 
ZNF443 zinc finger protein 443 1.50 
MMS22L MMS22-like, DNA repair protein 1.50 
DEPDC1 DEP domain containing 1 1.51 
TPRG1 tumor protein p63 regulated 1 1.51 
FANCB Fanconi anemia, complementation group B 1.51 
CDCA7 cell division cycle associated 7 1.53 
CENPK centromere protein K 1.53 
CEP128 centrosomal protein 128kDa 1.54 
HNRNPA3 heterogeneous nuclear ribonucleoprotein A3 1.54 
BRIP1 BRCA1 interacting protein C-terminal helicase 1 1.54 
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HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) 1.54 
LYRM1 LYR motif containing 1 1.55 
TNC tenascin C 1.55 
HELLS helicase, lymphoid-specific 1.55 
CDC7 cell division cycle 7 1.56 
FAM111B family with sequence similarity 111, member B 1.57 
SNORD42B small nucleolar RNA, C/D box 42B 1.57 
IL1A interleukin 1, alpha 1.57 
CCL5 chemokine (C-C motif) ligand 5 1.58 
WDHD1 WD repeat and HMG-box DNA binding protein 1 1.59 
XRCC2 X-ray repair complementing defective repair in Chinese 
hamster cells 2 
1.61 
TRIM51 tripartite motif-containing 51 1.62 
STC2 stanniocalcin 2 1.62 
CENPH centromere protein H 1.62 
CLSPN claspin 1.63 
MND1 meiotic nuclear divisions 1 homolog (S. cerevisiae) 1.63 
BRCA2 breast cancer 2, early onset 1.64 
MYBL1 v-myb myeloblastosis viral oncogene homolog (avian)-like 1 1.64 
MAD2L1 MAD2 mitotic arrest deficient-like 1 (yeast) 1.67 
HSPA6 heat shock 70kDa protein 6 (HSP70B') 1.67 
ATAD5 ATPase family, AAA domain containing 5 1.68 
B4GALT6 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, 
polypeptide 6 
1.68 
ALG10B ALG10B, alpha-1,2-glucosyltransferase 1.69 
NT5E 5'-nucleotidase, ecto (CD73) 1.69 
DDX11L2 DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 like 2 1.71 
OCM2 oncomodulin 2 1.77 
ANAPC1P1 anaphase promoting complex subunit 1 pseudogene 1 1.98 
CXCL10 chemokine (C-X-C motif) ligand 10 2.06 
TPPP3 tubulin polymerization-promoting protein family member 3 2.30 
PDIA3 protein disulfide isomerase family A, member 3 2.65 
TRAV8-3 T cell receptor alpha variable 8-3 2.73 
ALG10B ALG10B, alpha-1,2-glucosyltransferase 1.69 
NT5E 5'-nucleotidase, ecto (CD73) 1.69 
DDX11L2 DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 like 2 1.71 
OCM2 oncomodulin 2 1.77 
ANAPC1P1 anaphase promoting complex subunit 1 pseudogene 1 1.98 
CXCL10 chemokine (C-X-C motif) ligand 10 2.06 
TPPP3 tubulin polymerization-promoting protein family member 3 2.30 
PDIA3 protein disulfide isomerase family A, member 3 2.65 
TRAV8-3 T cell receptor alpha variable 8-3 2.73 
Table 6.3 - Genes showing altered expression at 24 h in H400 cells exposed to TiO2 NPs 
compared with control cells (fold change >1.5 and p < 0.01). 
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6.1.4 GeneChip results - DNA microarray data interpretation and discussion - 
Ontological grouping 
Ontological grouping was used to manage the complex data sets generated by 
microarray techniques. Ontological grouping can be useful to identify potential causes 
of certain genes being up- or down-regulated, as genes are grouped according to 
cellular functions. The technique takes lists of genes showing altered expression and 
databases provide information on the functions of these genes (if known), to produce 
groups of genes relevant to defined cellular processes. For the datasets in Figures 6.2 
and 6.3, the PANTHER classification system was used (Mi et al., 2010, Mi et al., 2013) 
and the PANTHER tool used for generating outputs (Thomas et al., 2006). The 
molecular function of each gene showing altered expression was matched to the 
categories within the Panther GO-Slim molecular function database of 20972 genes 
and 14830 function hits. The parent categories were: 
 antioxidant activity  
 binding  
 catalytic activity  
 channel regulator activity  
 receptor activity 
 signal transducer  
 structural molecule activity  
 translation regulator activity  
 transporter activity 
Each parent category consists of a number of child categories which are listed where 
relevant. 
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Figure 6.2 – diagrams showing ontological grouping by function of genes with altered 
expression as labelled in H400 cells exposed to TiO2 NPs 100 ppm for 6 h compared with a 
control cell sample. Generated using PANTHER tool (Mi and Thomas, 2009). The largest 
changes were observed in “binding” genes. 
Binding 
Transporter activity 
Transcription regulator activity 
Structural molecule activity 
Receptor activity 
 
Ion channel activity 
Enzyme regulator activity 
Catalytic activity 
Control cell 
Binding (2 nucleic acid, 2 protein binding) 
Structural molecule activity 
(cytoskeleton) 
Protein binding TF activity 
Nucleic acid binding TF activity 
Enzyme regulator activity 
Catalytic activity (hydrolase) 
6h up-regulated genes 
Structural molecule activity (ribosome) 
Binding (7 nucleic acid, 1 protein binding) 
Nucleic acid binding transcription factor (TF) 
 activity 
Catalytic activity (hydrolase, ligase, 
transferase) 
6h down-regulated genes 
Total genes 14, function hits 10 
Total genes 11, function hits 10 
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Figure 6.3 – diagrams showing ontological grouping by function of genes with altered 
expression as labelled in H400 cells exposed to TiO2 NPs 100 ppm for 24 h compared with a 
control cell sample. Generated using PANTHER tool (Mi and Thomas, 2009). Shows transporter 
genes are down-regulated at 24 h, possibly following intracellularisation of TiO2 NPs.   
Binding (4 nucleic acid, 1 protein binding) 
Transporter activity (carbohydrate,  
lipid and transmembrane) 
Signal transducer activity  
Catalytic activity (hydrolase, 
oxidoreductase, transferase) 
Structural molecule activity 
Receptor activity 
24h down-regulated genes 
Binding (6 protein, 6 nucleic acid, plus 
calcium and chromatin binding) 
Structural molecule activity 
Nucleic acid binding 
 transcription factor activity 
Catalytic activity (helicase, hydrolase, 
isomerase, lyase and transferase activity) 
24h up-regulated genes 
Binding  
Transporter activity 
Transcription regulator activity 
Structural molecule activity 
Receptor activity 
 
Ion channel activity 
Enzyme regulator activity 
Catalytic activity 
Control cell 
Total genes 26, function hits 24 
Total genes 38, function hits 30 
Total genes 17298, function hits 
19242 
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Up-regulated and down-regulated genes common in both 6 h and 24 h exposures to 
TiO2 NPs were in the ontological group ‘binding’. These genes fall into a variety of sub- 
categories, and mainly demonstrate that nucleic acid binding genes are down-
regulated and both protein binding and some nucleic acid binding genes are up-
regulated. Both nucleic acid and protein binding are complex gene groups with a large 
number of functions. Therefore, the information presented here is inadequate to gain 
a comprehensive understanding of the specific alterations to cell processes in response 
to TiO2 NP exposures. However, there are indications that intracellularisation is 
occurring by endocytosis at or before 6 h (as discussed in chapter 4) in that transporter 
activity is down-regulated at 24 h. Cytoskeleton reorganisation is also likely to be 
occurring due to the changes in regulation of structural protein coding genes specific 
to the cytoskeleton. These findings are discussed further in Section 6.1.5.  
6.1.5 GeneChip results - DNA microarray data interpretation and discussion – 
Common genes between 6 h and 24 h samples 
To identify if there was a consistent elevation or downregulation due to the exposure 
of TiO2 NPs to H400 cells, results were analysed to identify genes that were in common 
as being up- or down-regulated in both the 6 h and 24 h data sets when compared 
with their respective controls (fold change >1.5 and p < 0.01).  
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Figure 6.4 – Venn diagrams showing down-regulated, up-regulated and altered expression of 
genes in H400 cells at 6 h (blue) and 24 h (yellow) TiO2 exposure at 100 ppm compared with 
respective control cells as detected by the AffyChip.  
ID1, ID2, ID3: 
These helix-loop-helix (HLH) transcription factors are three of a family of four genes. 
ID1, ID2 and ID3 were all significantly downregulated in both conditions with the 
biggest fold change being for ID2 (>-8.00 fold change). ID1, ID2 and ID3 genes codes for 
ID1, ID2 and ID3 proteins, respectively. All ID proteins are thought to play a role in 
negatively regulating cell differentiation; therefore, suppression of these proteins 
could lead to an increase in cell differentiation. 
Transcription factors can be broadly categorised into: 
Superclass I  – those containing basic domains 
Superclass II  – those containing zinc co-ordinated DNA binding domains 
Superclass III  – those containing helix-turn-helix domains 
Superclass IV  – those containing β-scaffold factors. 
Common element – 
ANAPC1P1 
Common elements – ID1, ID2, 
ID3, RHOBTB3, HOXC13 
Common elements - ID2, ID1, ID3, 
RHOBTB3, HOXC13, IGKV1D-12, 
ANAPC1P1 
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Superclass I can be divided further into subcategories depending on the specific motifs 
present (e.g. basic HLH or bHLH). bHLH transcription factors all share a highly 
conserved HLH region which mediates protein-protein interactions, and also a basic 
DNA binding region (Forrest and McNamara, 2004). The ID class of HLH proteins are 
dominant-negative regulators of class I and class II bHLH proteins (Benezra et al., 
1990). ID proteins probably mediate communication between pathways that regulate 
cellular growth and differentiation, and ID expression is upregulated after mitosis 
triggering. 
Inhibition of any of the ID genes is sufficient to inhibit fibroblastic proliferation 
stimulated by serum (Barone et al., 1994). Physiological processes ID proteins (IDs) are 
known to be involved in include, the regulation of cyclin-dependent kinase (cdk) 
inhibitors (which regulate the cell cycle). ID2 specifically appears to inactivate the 
retinoblastoma protein (pRb), promoting cellular growth (Lasorella et al., 2000). 
IDs can also act as cellular differentiation inhibitors; therefore, downregulation would 
imply an inhibition of the prevention for cell differentiation. Ectopic ID expression 
inhibits cell differentiation in epithelial cells, and expression of ID genes is significantly 
reduced on terminal differentiation of different cells. It has been suggested that ID1 
renders cells refractory to differentiation signals and receptive to growth signals by 
inactivating one or more basic HLH proteins that co-ordinate growth and 
differentiation in the mammary epithelium of mice (Desprez et al., 1995). The ID 
proteins are also thought to play a role in vascular lesion formation (Forrest and 
McNamara, 2004). 
ID1, 2 and 3 are expressed in multiple tissues during murine embryological 
development and tissue morphological changes, but thereafter ID2 is the only member 
of this family expressed in epithelium, while ID1 and ID3 are found in the surrounding 
mesenchyme (Coppe et al., 2003). This family of proteins is also often over-expressed 
in malignancy. ID1 can facilitate the phenotypic transition from resting, sessile 
keratinocytes to mobile, migrating and proliferating keratinocytes during wound 
healing (Schaefer et al., 2001). There is evidence to suggest that different ID proteins 
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can play opposing roles in the same tissue, as well as the same ID playing a different 
role in a different tissue. 
Cell lines derived from squamous cell carcinomas (SCCs), such as H400 cells, express ID 
123 mRNA at high levels. Cell lines derived from head and neck SCCs have shown high 
expression of ID1. Knockdown of ID1 inhibits the metastatic potential of breast cancer 
cells (Fong et al., 2003). It is therefore not surprising that high levels of ID genes are 
present, but each sample exposed to TiO2 NPs was compared with the respective 
control, therefore the change in expression remains valid, and ID genes should not be 
discounted as being falsely elevated in cell line samples. 
ID1 and TiO2 NPs 
Lee et al., (Lee et al., 2009) reported that ID1 was down-regulated in lung cancer cells 
exposed to TiO2 NPs (15-350 nm diameter), while cells exposed to extracellular ID1 
appeared to undergo less apoptosis and proliferated more. They hypothesised this was 
due to ID 1 modulating an intracellular signalling pathway and protecting against 
apoptosis as well as enhancing proliferation. It is possible that ID1 plays a role in the 
TiO2 induced repression of cell viability. IDs 1-3 are unlikely to be relevant proteins in 
the process of intracellularisation of TiO2 NPs, and the altered expression of the IDs are 
more likely to be due to effects of TiO2 NPs on the cell. Changes in motility, 
proliferation and apoptosis are likely to be occurring due to the downregulation of 
these genes and apparent reduction in levels of the ID proteins in affected cells. 
HOXC-13 
HOXC-13 was downregulated in all samples (>-1.54 fold change). HOXC-13 codes for 
the protein HOXC13, which belongs to the homeobox family of genes, a highly 
conserved family of transcription factors which play an important role in 
morphogenesis in all multicellular organisms. There are four gene clusters: HOXA, 
HOXB, HOXC and HOXD. HOXC13 is in a cluster of HOXC genes located on chromosome 
12 and may have an important role in keratin production. 
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RhoBTB3 
RhoBTB3 was downregulated in all samples (>-1.83 fold change). RhoBTB3 codes for 
the RhoBTB3 protein which is a member of a family of Rho GTPases and is localised to 
the trans-golgi network. Knockout mice have been shown to exhibit a decreased body 
length and males had abnormal tooth morphology. RhoGTPases are key regulators of 
the actin-based cytoskeleton, and RhoBTB3 has also been shown to interact directly 
with Rab9 GTPase to function in protein transport from endosomes to the Golgi 
network (Espinosa et al., 2009). RhoBTB3 interacts with other proteins (TIP47) on 
membranes, and it is hypothesised that its function may be to release this cargo 
selection protein from vesicles to allow fusion at the Golgi (Espinosa et al., 2009). It is 
therefore possible that the down-regulation of RhoBTB3 may be associated with the 
intracellularisation of TiO2 NPs via clathrin-mediated endocytosis (see also Section 
4.2.2). 
ANAPC1P1 
ANAPC1P1 codes for a protein involved in promotion of anaphase. Its function is not 
yet well characterised. 
IGKV1D-12  
IGKV1D has not been well characterised yet.  
Overall the number of genes that are up- or down-regulated is small, implying minimal 
changes within the gene expression of H400 cells when exposed to 100 ppm TiO2 NPs 
for 6 and 24 h respectively. There is no strong trend from the data to suggest any 
specific ontological groups are altered compared with any others. The overall 
conclusions of this work will be discussed at the end of this chapter. 
6.1.6 GeneChip results - DNA microarray data interpretation and discussion – 
robustness of microarray data 
To validate the microarray data, confirmatory PCR was performed (see Section 6.2). 
Samples were analysed according to their agreement between replicates; an example 
graph of this is shown in Figure 6.5. 
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Figure 6.5 – Example graph of the levels of expression of ID1 in each sample replicate. Samples 
were not pooled in order to eliminate errors in one replicate altering the overall data. The 
graph above shows good trend replication in each set of samples. 
 
6.2  Confirmatory PCR 
To confirm the accuracy of the microarray data, PCR was performed. A selection of 
genes was chosen including those significantly up-or down-regulated according to the 
microarray results. 
6.2.1  Confirmatory PCR – methods 
Confirmatory semi quantitative PCR was performed (Section 2.5.6) on duplicate H400 
RNA samples generated at the same time as those used for the microarray. 
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6.2.2  Confirmatory PCR – results and conclusion 
 
                
 
 
                        
 
 
Figure 6.6 – Images of agarose gels showing agreement of up- or down- regulation between 
PCR and microarray data on a selection of genes. Although the degree of change is different in 
most samples, PCR is only semi-quantitative, therefore the fold changes are unlikely to be 
numerically accurate. 
These data demonstrate that the microarray data appeared to be representative of 
gene expression changes in H400 cells as described in this chapter.  
6.2.3 Confirmatory PCR – Primary oral epithelial cells –aim and methods 
The same methods as described in Section 2.5.6 were used to perform semi 
quantitative PCR on primary oral epithelial cells, to establish if H400 cells are likely to 
be an appropriate model for the behaviour of oral epithelial cells in this context. Due 
to issues outlined in chapter 3, PCR was only performed on a small selection of genes.  
 
ID1 
ID2 
ID3 
Control  
6 h 
Control 
24 h 
TiO2    
24 h 
TiO2    
6 h 
CXCL10 
RHOB-
TB3 
Agreement with 
microarray?  
Yes 
Yes 
Yes 
Yes 
Yes 
 187 
 
6.2.4 Confirmatory PCR – Primary oral epithelial cells –results and conclusions 
 
Figure 6.7 - Primary epithelial cell semi-quantitative PCR data showing a down-regulation of 
ID1 and 3 in cells exposed to TiO2 for 6h and an up-regulation of ID2 (n=3, error bars show SD). 
This was in contrast to data from H400 cells where ID1, ID2 and ID3 were all downregulated. 
Therefore, H400 cells may not be an accurate model for ID gene expression in epithelial cells.  
Primary cells showed a different gene expression profile to H400 cells when stimulated 
with TiO2 NPs. This implies that the microarray data may not be translatable to oral 
epithelial cells in the clinical situation. 
Immortalised cells such as H400 cells are, as discussed in chapter 3, used as a 
substitute for primary cells in many experiments. In the microarray data presented 
here, H400 cells were used for the following reasons: 
 Availability of cells to ensure a good quantity of high quality RNA was 
produced; 
 Consistency, as multiple donors would potentially have been needed in order 
to produce a sufficient number of epithelial cells. This intra-donor variation in 
cell phenotype may have led to a lack of clarity of gene expression changes as 
each donor’s cells may have produced different baseline gene expressions; 
 Financial – each microarray assay is expensive, so it was not feasible to run 
microarrays on multiple samples. Ideally, multiples of paired control-matched 
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microarrays would have been performed on primary cells from a set of 
donors, and the results combined and analysed. 
The results described above gives an indication of the gene expression changes within 
immortalised epithelial cells, and the PCR data in Figure 6.7 indicates that these 
responses may not be applicable to primary oral epithelial cells. However, the 
magnitude and number of changes in gene expression shown by the microarray is 
lower than was anticipated; for instance Milward et al., (2007) noted significantly 
altered expression of upwards of 400 genes when examining the interactions between 
H400 cells and periodontal pathogens (Milward et al., 2007). While the response of 
H400 cells to TiO2 NPs is likely to be far less inflammatory than the response to 
pathogenic bacteria, it seems surprising that the microarray data did not disclose 
higher magnitude fold changes in more genes. The possible reasons for this are 
discussed in Section 6.4.  
6.3  Co-stimulation qPCR (Quantitative Real Time PCR) 
6.3.1  Co-stimulation qPCR - aims 
Sections 6.1 and 6.2 demonstrated minimal effects of exposure to TiO2 NPs in isolation 
on the gene expression profile of H400 cells at 6 h or 24 h. In the clinical situation, 
there is likely to be a bacterial challenge present in the peri-implant tissues. It is 
therefore relevant to investigate whether previous exposure to, or coincident 
exposure to TiO2 NPs alongside pathogenic bacteria may produce an altered cellular 
response to a purely pathogenic stimulation. This was examined using qPCR (Section 
6.3.2). 
6.3.2  Co-stimulation qPCR - methods 
H400 cells were cultured in 6-well plates as described in Section 2.2.2. Once cells were 
judged to be just sub-confluent by light microscopy, samples were exposure to 
bacteria (heat killed FN or Pg, see Section 2.9.5) with or without TiO2 NPs as a modifier 
(Table 6.4) 
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Sample TiO2 NP exposure Bacterial exposure 
Control None none 
TiO2 1 h 100 ppm 1 h none 
TiO2 24 h 100 ppm 24 h none 
FN 1 h None FN (MOI 100:1) for 1 h 
TiFN 1 h 100 ppm 1 h coincident with bacteria FN (MOI 100:1) for 1 h 
Ti 24 h FN 1 h 100pm 24 h pre-treatment prior to bacteria FN (MOI 100:1) for 1 h 
PG 1 h None PG (25:1) for 1 h 
TiPG 1h 100 ppm 1 h coincident with bacteria PG (25:1) for 1 h 
Ti 24h PG 1h 100pm 24 h pre-treatment prior to bacteria PG (25:1) for 1 h 
Table 6.4 – H400 plating conditions prior to qPCR 
Following exposures (or control conditions), samples were washed three times using 
warmed PBS to remove bacteria and TiO2 NPs. Subsequently samples were trypsinised 
and prepared for RNA extraction (Section 2.5.1). Following RNA extraction, cDNA was 
synthesised using the protocol described in Section 2.5.4. qPCR was performed as 
detailed in Section 2.5.7. 
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6.3.3  Co-stimulation qPCR - results 
 
 
 
Figure 6.8 – Histograms showing ID1 (a), ID2 (b) and ID3 (c) expression using qPCR of H400 
samples (n=4, mean data and SD shown). Graphs show a reduction in ID 1, 2 and 3 expression 
following TiO2 NP treatment, as seen in the microarray data. 
6.3.4  Co-stimulation qPCR - discussion 
(a) 
(b) 
(c) 
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Co-stimulation qPCR showed that the addition or pre-treatment of H400 cells with TiO2 
in conjunction with bacteria significantly changes the expression of ID genes when 
compared with stimulation with bacteria alone. This suggests that TiO2 has the 
potential to act as a modifier to H400 responses to bacteria. In ID1, 2 and 3 the 
expression of the gene is reduced markedly under conditions where cells were 
exposed to TiO2 prior to exposure to bacteria as well as, to a lesser degree, when the 
cells were stimulated by bacteria and TiO2 concurrently. Published work on the 
possible link between TiO2 and the ID genes is scant, however Lee et al., highlighted 
that ID1 expression “attenuates the degree of TiO2 induced cytotoxicity in lung cells” 
(Lee et al., 2009), a statement which may also be true for oral epithelial cells.  
6.4  Chapter conclusions 
This chapter has demonstrated that  a DNA microarray is a robust method of 
examining gene expression changes in H400 cells when exposed to TiO2 NPs, as 
confirmed by both PCR and qPCR. The gene expression profile of H400 cells in 
response to TiO2 NPs at 100ppm for 6 h and 24 h did not change as much as 
anticipated; there are a number of factors which may be important in explaining this 
finding: 
 As shown in previous work, only a minority of cells will interact with TiO2 NPs 
(see also Chapter 4). There will therefore be a “dilution” effect of cells 
showing potentially altered gene expression by other cells that may exhibit an 
unchanged gene expression profile due to the heterogeneous response of the 
cell population. 
 TiO2 may simply have a minimal effect on the gene expression of H400 cells at 
all time-points, or 6 h and 24 h may miss peaks in gene expression changes 
that occur at different time-points. 6 h and 24 h should however show 
intracellularisation as demonstrated by other microscopy methods (see 
chapter 4) and 24 h should show some effects on cell viability (see chapter 5).  
 As reported in Chapter 4, H400 cells take up TiO2 NP agglomerations by 6 h. 
There may be minimal changes occurring after this intracellularisation. 
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However, more genes show altered expression at 24 h, suggesting there may 
be further changes later on in the exposure time-course. 
 There is some crossover in H400 gene expression changes at 6 h and 24 h, 
mainly in a family of genes important in cell differentiation and replication (ID 
genes). 
 Primary cells appear to show a different expression pattern of ID genes 
compared with controls than H400 cells, therefore H400s may not offer an 
accurate model of epithelial gene expression in the context of interaction with 
TiO2 NPs and examination by microarray. 
 TiO2 NPs appear to have the potential to act as a modifier in gene expression 
changes in H400 cells when responding to bacterial challenges. 
The subsequent chapter will investigate cell to cell interactions involving epithelial cells 
in the presence and absence of TiO2 NPs.  
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Chapter 7 
Effects of the presence of TiO2 NPs on cell to cell 
signalling processes 
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Synopsis 
In chapters 4 to 6, TiO2 NPs were shown to interact with oral epithelial cells in culture, 
becoming intracellularised and leading to alterations in cell morphology. TiO2 NP 
exposures had some effects on oral epithelial cell viability and led to changes in gene 
expression and potentially functional changes in response to pathogenic bacteria. The 
overall effects on the cell population in terms of viability were however limited.  
It has been established that epithelial cells (including oral epithelium) play an 
important role in a number of cell-cell signalling pathways, particularly in the presence 
of a pathogenic challenge, producing signalling molecules to recruit other cell types 
and initiating and propagating an immune response (Yilmaz et al., 2003, 
Krisanaprakornkit et al., 2000, Milward et al., 2007). Many of the pathways by which 
oral epithelial cells interact with other cell types in response to a pathogenic challenge 
have been well characterised. Based on preliminary findings in previous chapters it was 
hypothesised that oral epithelial cells exposed to TiO2 NPs may exhibit perturbed 
responses to known stimuli. The effect of TiO2 NP exposures on the NFκB intracellular 
signalling pathway was previously investigated and a potential reduction in NFκB 
activation was demonstrated with increasing concentrations of TiO2 NPs when co-
stimulated with a bacterial pathogen. Following on from this observation, this chapter 
investigates whether TiO2 NPs can also impact upon extracellular signalling involved in 
epithelial cell responses, including ROS production as a downstream consequence, 
cytokine expression and interactions with polymorphonuclear leukocytes (neutrophils) 
cells. 
7.1 Cytokine release from H400 cells as detected using ELISAs  
ELISAs offer a sensitive method of detecting and quantifying cytokine release from 
cells in culture. A broad panel of ELISAs for the detection of relevant proteins of 
acquired immune responses and also inflammatory processes were chosen to 
investigate cytokine release from H400 cells in culture in the presence and absence of 
TiO2 NPs. Specific antibodies are attached to a surface to bind a target antigen. An 
enzyme is then linked to the antibody-antigen complex and a colour changing reporter 
enzyme substrate is added. The degree of subsequent colour change reflects the 
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concentration of the target antigen within the sample. In this work a sandwich ELISA 
was employed. In a sandwich ELISA, a specific antibody is bound to the substrate 
surface and any non-specific binding sites are blocked. The sample and any target 
antigen contained within will bind to the antibody on the surface. The specific enzyme 
linked antibody is then applied prior to the reporter substrate. The term “sandwich” is 
used as the target is between the antibody on the ELISA plate surface and the enzyme-
linked antibody. The sandwich ELISA system is described further in Section 2.10.  
ELISAs (IL8 (CXCL8)), Interferon-gamma (IFN- γ), Interleukin 1-Beta (IL-1 β), TNF α, and 
Interleukin-6 (IL-6)) were performed using DuoSet ELISA kits (R&D systems, Bio-techne, 
UK) according to the manufacturer’s instructions. Each ELISA was tested against 
standards of known concentrations to obtain a standard curve. This exercise was 
repeated in both the presence and absence of TiO2 NPs due to concerns regarding 
potential interactions between TiO2 NPs and the cytokine or antibody (see also Section 
3.6.5).  
Previously, where NPs have been shown to induce or fail to induce cytokine expression 
measured by ELISAs, it is important to recognise that the assay result can be affected 
by any binding between the NPs and the ELISA target or components of the assay 
system (Irshad et al., 2013). To date, only a small number of studies have 
acknowledged this issue. The presence of NPs has been shown to disrupt ELISAs with 
carbon NPs shown to adsorb to IL8 (Monteiro-Riviere and Inman, 2006, Hsiao and 
Huang, 2011) and TiO2 NPs to adsorb to IL-6 (Veranth et al., 2007).  
Investigators have reported that TiO2 NP exposure will stimulate the release of IL8 (as 
identified by use of ELISAs) from a variety of cell types including human endothelial 
cells (Peters et al., 2004) and human lung epithelial cells (Wilson et al., 2012). 
However, no consideration was given to the potential interaction between IL8 and TiO2 
NPs themselves. IL8 (CXCL8) is a pro-inflammatory chemokine and potent 
chemoattractant produced by a variety of cell types, specifically targeting neutrophils 
(Bickel, 1993). IL8 is key in the initiation and propagation of the acute inflammatory 
response. Previous studies using ELISA techniques to identify IL8 release in 
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experiments where TiO2 NPs are present have dismissed or ignored the potential for 
IL8-TiO2 NP interactions (Singh et al., 2007, Peters et al., 2004). 
7.1.1 ELISA standard curves in the presence and absence of TiO2 NPs - 
methods 
The cytokine panel selected consisted of IL8, IFN-ɣ, IL-1β, TNFα and IL-6. The rationale 
for choosing these cytokines was that they have previously been found at elevated 
levels in fluid exudate from inflamed tissue surrounding percutaneous Ti implants 
when compared with clinically healthy peri-implant tissues by our group (Grant et al., 
2010b). Inflammatory responses from the host immune system are essential in 
maintaining peri-implant health and indeed pro-inflammatory cytokines are present in 
fluid exudate collected from around failed Ti implants (Grant et al., 2010b). However, 
disordered or excessive host immune responses have been shown to produce tissue 
damage in periodontitis (Matthews et al., 2007), a similar clinical condition to peri-
implantitis.   
For each cytokine, manufacturer supplied standards were prepared in reagent diluent 
with 100ppm TiO2 NP supplementation, then incubated for 1 h and centrifuged at 150 
x 100 rpm for 5 min before making up standards in serial dilutions. Data were gathered 
as detailed in Section 2.10.1. 
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7.1.2  ELISA standard curves in the presence and absence of TiO2 NPs – results 
(Figure 7.1) 
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Fig. 7.1 (a-e) – A plot of cytokine concentration (replicate points shown) against absorbance 
(arbitrary units, AU) derived from ELISA (n=2) for the serially diluted specific standard and for 
the serially diluted specific standard following exposure to 100ppm TiO2 NPs for 24 h and 
centrifugation to remove insoluble contents.  
7.1.3 ELISA standard curves in the presence and absence of TiO2 NPs - 
conclusions 
In the absence of TiO2 NPs, the standard curves show a linear (IFN-ɣ, TNFα, IL-1β) and a 
log-linear (IL8, IL-6) relationship showing the concentrations of target cytokine. IL8 and 
IFN-ɣ exhibited a reduction in reading in the presence of TiO2 NPs  (discussed further in 
Section 7.2). 
a 
b 
c d 
e 
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7.1.4 ELISAs performed on supernatants from H400 cells  - aims 
The aim of this study was to establish the nature of inflammatory cytokine production 
from H400 cells stimulated by TiO2 NPs, pathogenic bacteria, and their combination. It 
has been established that TiO2 NPs may be pro-inflammatory as reported previously in 
lung epithelial cells (Singh et al., 2007). The same behaviour could be elicited from 
H400 cells, and the peri-implant situation involves a pathogenic bacterial challenge to 
which epithelial cells will respond. Exposure either previously or concurrently to TiO2 
NPs has the potential to modify any oral epithelial responses to pathogenic bacteria. 
7.1.5 ELISAs performed on supernatants from H400 cells  - methods 
ELISA kits were used as per the manufacturer’s instructions. Supernatants were 
prepared using 25 cm2 flasks to culture H400 cells to sub-confluence as in Section 2.2.2 
(where applicable) then treated as follows: 
Cell free control:  Cell culture medium only 
H400 control:  H400 cells cultured in standard medium 
H400 plus TiO2:  H400 cells cultured in standard medium then exposed to 
TiO2 100ppm for 24 h 
Cell free FN:  Heat killed FN at an equivalent MOI of 100:1 (determined by 
previous work by a colleague) 
H400 plus FN:  H400 cells cultured in standard medium then exposed to 
heat killed FN at an equivalent MOI of 100:1 for 4 h 
H400 plus TiO2 pre-treatment 
then FN 
H400 cells cultured in standard medium then exposed to 
TiO2 100ppm for 24 h then heat killed FN at an equivalent 
MOI of 100:1 for 4 h 
H400 plus TiO2 and FN:  H400 cells cultured in standard medium then exposed 
simultaneously to TiO2 100ppm and heat killed FN at an 
equivalent MOI of 100:1 for 4 h 
Cell free PG:  Heat killed PG at an equivalent MOI of 25:1 (Grant et al., 
2010a) 
H400 plus PG:  H400 cells cultured in standard medium then exposed to 
heat killed PG at an equivalent MOI of 25:1 for 4 h 
 
H400 plus TiO2 pre-treatment 
then PG:  
H400 cells cultured in standard medium then exposed to 
TiO2 100ppm for 24 h then heat killed PG at an equivalent 
MOI of 25:1 for 4 h 
H400 plus TiO2 and PG:  H400 cells cultured in standard medium then exposed 
simultaneously to TiO2 100ppm and heat killed PG at an 
equivalent MOI of 25:1 for 4 h 
Table 7.1 – ELISA sample preparation 
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All supernatants were aseptically aspirated from triplicate flasks, pooled and 
centrifuged at 15000 rpm for 5 min in order to remove TiO2 NPs as far as practically 
possible. FN = Fusobacterium nucleatum, PG = Porphyromonas gingivalis (see Section 
2.9.5). Supernatants were stored at 4 ± 1°C and allowed to equilibrate to room 
temperature before use. 
7.1.6 ELISAs performed on supernatants from H400 cells  - results 
 
Figure 7.2 – ELISA data showing absorbances representing cytokine concentration in 
supernatants as detailed in Section 7.1.5. Results from IL8 and IFN-ɣ were accounted for by 
interference of TiO2 NPs in the ELISA. Data from IL8 ELISA is shown for interest purposes only. 
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Condition IL8 TNFα IFN-ɣ IL-6 IL-1β 
H400 control +++ ns ns ns +++ 
H400 plus TiO
2
 ns ns ns ns +++ 
Cell free FN ns ns ns ns ns 
H400 + FN +++ ns ns ns +++ 
H400+TiO
2
 then FN +++ ns ns ns +++ 
H400 +TiO
2
/FN +++ ns ns ns ns 
Cell free PG ns ns ns ns ns 
H400 + PG +++ ns ns ns +++ 
H400+TiO
2
 then PG +++ ns ns ns +++ 
H400 +TiO
2
/PG +++ ns ns ns +++ 
 
Table 7.2 – table of ELISA data shown in Figure 7.2 summarised. +++ = significant elevation, ns 
= non-significant difference compared with cell free control (two tailed t-test assuming equal 
variances, p<0.05) 
 
Figure 7.2 shows cytokines produced by H400 cells in response to treatment with 
relevant bacteria and / or TiO2 NPs. The results for IL8 are, as previously mentioned, 
shown for interest rather than being taken as accurate due to the potential interaction 
between TiO2 NPs and IL8. TNFα was elevated significantly when FN was used as a 
stimulus either with or without TiO2 NPs when compared with all other conditions. This 
agrees with published data that FN induces production of human beta defensin 2 (hBD-
2) in oral epithelial cells via the production of TNFα (Krisanaprakornkit et al., 2000). 
Small variations are seen in the expressions of IL6 and IL1-β, however the patterns 
appear inconsistent and the magnitude of changes is minor. 
7.1.7 ELISAs performed on supernatants from H400 cells  - conclusions 
An important observation was the interaction between IL8 (and to a lesser extent IFN-
ɣ) and TiO2 NPs. The magnitude of expression of IL8 is large even as a background 
signal from H400 (as found by other researchers within the institution) but this 
decreases to cell free levels when TiO2 NPs were added.  
7.2  Interaction between TiO2 NPs and IL8 / IFNɣ 
The interaction between TiO2 NPs and both IL8 and IFN-ɣ can be noted in Figure 7.1 
where the detection of IL8 was depleted considerably after exposure to TiO2. IFN-ɣ 
detection was similarly affected although to a lesser extent. Other cytokines were 
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unaffected, therefore it can be concluded that there is a possibly a specific interaction 
taking place between the TiO2 NPs used and IL8 / IFN-ɣ. Due to the extent to which this 
occurs with IL8 and the fact that IL8 is such an important pro-inflammatory cytokine, 
an interaction with TiO2 could have clinical implications. 
To establish the likely nature of this interaction, a number of experiments were carried 
out which will be detailed in this Section. Binding between IL8 and TiO2 NPs has been 
reported in the literature (Horie et al., 2013), but not fully investigated beyond 
concluding that there is an association. ELISA use has been shown in this study to be 
inappropriate in detecting IL8 in the presence of TiO2 NPs, however this methodology 
has been used to quantify IL8 in the presence of TiO2 by multiple authors (Singh et al., 
2007, Wilson et al., 2012, Haleem-Smith et al., 2012).  
7.2.1  Interaction between TiO2 NPs and IL8 –ELISA investigation method 
To investigate whether the interaction between TiO2 NPs and IL8 is dependent upon 
the dose of TiO2 used, IL8 detection ELISAs were run on standard samples exposed to 
differing concentrations of TiO2 for 1 h at room temperature before centrifugation and 
serial dilution (see Section 2.1. for detailed ELISA methodology). NPs have a high 
surface free energy, therefore will adsorb biomolecules readily (<0.5 min) on contact 
with, for instance, biological fluids (Tenzer et al., 2013), therefore a 1 h incubation is 
more than adequate to allow an association to form. The resulting protein coating is 
known as the protein corona, and has shown to be reversible in part therefore 
allowing partial replacement of proteins already bound to the nanoparticle (Lundqvist 
et al., 2011). This means that the binding of IL8 and IFNɣ within the protein corona 
surrounding TiO2 NPs may be partially, but crucially is unlikely to be fully, reversible. It 
may also be possible that IL8 and IFNɣ would replace other proteins in a protein 
corona.  
To further test the specificity of IL8 adsorption to the TiO2 NPs the NPs were pre-
exposed to human serum to establish whether the avidity of IL8 to NP binding was 
affected by other proteins present in tissue fluids in vivo. Human serum was isolated 
from blood collected in a lithium-heparin containing 6 mL tube from a healthy 
volunteer with informed consent and ethical approval (number 10/H1208/48). Briefly, 
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the serum was isolated by incubating the tube at RT for 30 min then at 4 °C for 30 min. 
The tube was then centrifuged at 1000 rcf for 30 min at 4°C before aspirating the 
serum from the top of the tube. The serum was diluted 1 in 10 with sterile PBS to avoid 
saturating the ELISA plate with target. The resulting diluted serum was then used as a 
diluent for the high ELISA standard and exposed to TiO2 of differing concentrations and 
centrifuged before dilution as reported previously. The serum samples were compared 
with standard reagent diluent for reference.  
Interaction between TiO2 NPs and IL8 -ELISA results 
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Figure 7.3 – A plot of IL8 concentration (mean and SEM) against absorbance (arbitrary units) 
derived from ELISA (n=3) for the IL8 standard (0 ppm) serially diluted in standard reagent 
diluent (a) and human serum (1 in 10) (b) and for the IL8 standard following exposure to 1, 10, 
100 and 1000 ppm of TiO2 NPs for 1 h then serially diluted in reagent diluent or human serum 
(1 in 10), respectively before centrifugation to remove insoluble contents. Replicate data 
points shown, n=2.  
b 
a 
IL8 (pg/mL) 
Supplemented IL8 (pg/mL) 
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Interaction between TiO2 NPs and IL8 – conclusions 
The reported data shows a clear dose response, therefore concluding there is likely to 
be a specific binding between TiO2 and IL8 taking place. This fits with the results shown 
by Horie et al., 2013, where smaller NPs were shown to bind more IL8 than larger 
particles, therefore implying the surface area of TiO2 NPs available within a system will 
give its binding capacity for IL8. However, Horie et al., also reported that the protein 
corona of a NP is partially reversible, therefore in a physiological environment, where 
there will be a significantly more varied protein complex available, this binding 
between IL8 and TiO2 NPs may either be inhibited initially or other proteins may 
partially replace IL8 within the corona of the NP (Horie et al., 2013).  
A dose dependent reduction in signal occurred in the presence of a more complex 
protein field for both IL8 and IFNɣ, confirming that there is a specific affinity to bind IL8 
and IFNɣ to TiO2 NPS in preference to other proteins. 
7.2.2  Demonstration of IL8 / TiO2 NP binding 
To further confirm whether IL8 binds to TiO2 NPs a protein gel electrophoresis 
technique was employed. This technique will qualitatively demonstrate whether any 
IL8 was bound to TiO2 particles once centrifuged, and if there was depletion of the IL8 
signal in samples where the supernatant was tested post-centrifugation.  Section 2.13 
describes the methodology for this in detail, however in brief a panel of samples was 
prepared and summarised in Table 7.3. 
No. Preparation protocol Sample used 
1 IL8 in PBS 2000 pg/mL 
2a IL8 2000 pg/mL plus TiO2 1000 ppm in PBS incubated 
for 1 h at room temperature then centrifuged at 150 x 
100 rpm for 5 min (Geneflow SciSPin Micro) 
Supernatant  
2b TiO2 pellet washed in PBS 
and re-suspended 
3a TiO2 1000 ppm in PBS incubated for 1hr at room 
temperature then centrifuged at 150 x 100 rpm for 5 
min  
Supernatant 
3b TiO2 pellet washed in PBS 
and re-suspended 
4 IL8 added at 2000 pg/mL in 20% human serum 
5a IL8 added at 2000 pg/mL in 20% human serum plus 
TiO2 1000 ppm in PBS incubated for 1 h at room 
temperature then centrifuged at 150 x 100 rpm for 5 
min  
Supernatant 
5b TiO2 pellet washed in PBS 
and re-suspended 
Table 7.3 – Protein gel sample preparation 
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Following the sample concentration as detailed in Section 2.13, protein gel 
electrophoresis was performed in order to identify the presence of IL8 in the samples.  
 
Figure 7.4 – Sections taken from an imperial Blue stained protein gel. 1= IL8 2000 pg/mL in PBS 
(high standard used on ELISA) 
2a= Supernatant (SN) from IL8 2000 pg/mL in PBS plus 1000ppm TiO2 incubated overnight 
then centrifuged out 
2b=TiO2 particles centrifuged out and washed in PBS from 2a 
3a= SN from TiO2 in PBS only prepared as above 
3b= TiO2 particles centrifuged out and washed in PBS from 3a 
4= IL8 2000 pg/mL in 20% human serum, 80% PBS 
5a= SN from IL8 2000 pg/mL in 20% human serum plus TiO2 1000ppm prepared as above 
5b= TiO2 particles centrifuged and washed in PBS from 5a 
L= ladder 
+ = Positive control = IL8 at 100 ng/mL 
 
Samples showing the presence of IL8 (Figure 7.4) were the positive control, Lane 2b 
(where TiO2 NPS exposed previously to IL8 were separated by centrifugation and 
washed in PBS before electrophoresis) and Lane 5b (where TiO2 particles exposed 
previously to IL8 in 20% human serum were separated by centrifugation and washed in 
PBS before electrophoresis). The results support the ELISA data showing depletion of 
IL8 present in any supernatants where TiO2 NPs were introduced and then removed by 
centrifugation. This strongly implies that the IL8 is bound to TiO2 NPs and is removed 
L 1 + 2b 2a 4 3a 3b 5b 5a 
IL8 
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from the supernatant during centrifugation. The functional consequences of IL8 
depletion by TiO2 NPs were subsequently considered by studying the chemotaxis of 
human neutrophils.  
7.2.3 Chemotaxis assay as a functional measure of IL8 activity in the presence 
and absence of TiO2 – aims and method 
One of the principal functions of IL8 is to act as a chemoattractant for peripheral blood 
neutrophils (PBNs or neutrophils). This chemoattractant capability can be visualised 
and quantified using an assay for neutrophil chemotaxis. The method is described in 
detail in Section 2.9.6, but in brief involves exposing freshly isolated PBNs to a gradient 
of substrate being tested, and tracking the movement of the PBNs. Movement towards 
the stimulus implies the substrate is a chemoattractant, and the speed and velocity 
(movement towards the stimulus) of cell movement can be used to generate a 
measure of the strength of the chemoattractant, known as the Chemotactic Index (CI) 
(Roberts et al., 2015).  
Chemotaxis assays were run using freshly isolated PBNs from healthy volunteers and 
the substrates tested for their chemoattractant properties were as follows: 
RPMI – negative control. 
fMLP – a known strong chemoattractant 10 nm in 1% BSA PBS – positive control 
IL8 – Interleukin 8 at a concentration of 200 ng/mL in 1% BSA PBS 
IL8 supernatant – IL8 as above incubated with 100 ppm TiO2 for 1 h then centrifuged 
at 1500 rpm for 5 min. The supernatant was aspirated and formed this sample. 
TiO2 – TiO2 NPs (anatase <25nm, Sigma-Aldrich, UK) sonicated in water and added to 
1% BSA PBS at a concentration of 100 ppm 
TiO2 spun and washed – TiO2 pellet left from the preparation of IL8 supernatant 
sample washed twice in PBS and centrifuged as before then re-suspended at a 
concentration of approximately 100ppm in 1% BSA PBS.  
For each PBN sample, a video of responses to each substrate was captured and 
analysed as described in Section 2.9.7. 15 cells per video were manually tracked and 
the co-ordinates used to generate data on their speed and directional movement 
towards the stimulus. Results were pooled (n=6). The second data set is from 
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chemotaxis assays investigating to what extent dose dependence plays a role in 
affecting the chemoattractant properties of IL8 (200ng / mL) when exposed to TiO2 
NPs in 1% BSA PBS at a concentration on 0-1000ppm. This was repeated using PBNs 
from different volunteers. 
  
Figure 7.5 – examples of first (left) and last (right) frames of 40 frames of a chemotaxis video 
showing the coloured lines where a selection of randomly chosen cells were tracked. The 
coordinates of this movement were pooled and used to generate the subsequent dataset. 20 
points were generated from each video. 
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7.2.4 Chemotaxis assay as a functional measure of IL8 activity in the presence 
and absence of TiO2 – results 
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Figure 7.6 – Box-whisker plots showing data points plus mean and SD for Speed, Velocity and 
Chemotactic Index of PBNLs (n=6 donors) exposed to the positive (FMLP) and negative (RPMI) 
control chemoattractant and to the experimental chemoattractants. * indicates significant 
differences (α=0.05) from RPMI as determined using one-way ANOVA.  
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Figure 7.7 - Chemotaxis vector plots showing the proportion and directionality of movement of 
cells in each segment during the observation period. The larger the segment, the more cells 
moved preferentially in that direction. The inner numerical notation shows radially the 
distance moved and circumferential numerical notation the movement angle where the 
chemoattractant gradient is normal to 90 degrees. Clear directional movement towards the 
chemoattractant is observed for fMLP and IL8 by the more vertical direction of the segments.  
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Figure 7.8 – Data plots (n=3 donors, all data shown) showing data points, mean and SD of data 
for Speed, Velocity and Chemotactic Index of neutrophils exposed to the positive (fMLP) and 
negative (RPMI) control chemoattractant and to the experimental chemoattractants (IL8 at 
initially 200 ng/mL exposed to 1, 10, 100, 1000 ppm of TiO2 NPs for 1 h before centrifugation 
to remove the insoluble NPs.  
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Figure 7.9- Chemotaxis vector plots showing the proportion and directionality of movement of 
cells in each segment during the observation period. The inner numerical notation shows 
radially the distance moved and circumferential numerical notation the movement angle 
where the chemoattractant gradient is normal to 90 degrees. Clear directional movement 
towards the chemoattractant is observed for fMLP and for IL8 however >1ppm TiO2 exposure 
results in non-preferential directional movement. 
 
7.2.5 Chemotaxis assay as a functional measure of IL8 activity in the presence 
and absence of TiO2 – conclusion 
Figures 7.6 and 7.7 demonstrate the altered chemoattractant properties of IL8 once 
exposed to TiO2 NPs. Figures 7.8 and 7.9 indicate the loss of directional movement 
towards the supernatant remaining after the addition of TiO2 NPs to IL8 and 
centrifugation to remove insoluble material, indicating further that the IL8 is bound to 
the NPs. Once the NPs were re-suspended they did not act as a chemoattractant, 
therefore indicating that the association with IL8 is somewhat robust. The chemotactic 
index and velocity shown in Figures 7.8 and 7.9 demonstrate a dose dependent 
reduction in movement of neutrophils towards the chemoattractant with increasing 
amounts of TiO2 being present. Speed of neutrophils was not affected suggesting that 
the random movement of cells remained consistent but directional accuracy of this 
movement was lost. This is potentially a highly important finding, as in vivo, neutrophil 
recruitment into tissues is dependent upon directional movement in response to 
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chemoattractant gradients. If this ability is lost or perturbed, the immune response will 
be altered.  
7.3  ROS production 
Aside from chemotaxis, ROS release from neutrophils, once at the site of tissue injury 
or infection represents another important biological function. A variety of ROS exists 
including peroxides, superoxide and hydroxyl radicals. ROS are produced by cells as a 
natural by-product of oxygen metabolism but are produced in excess when cells are 
stressed (Battino et al., 1999). Cellular stress can be caused by a number of stimuli 
such as heat and ultraviolet light exposure (Cho et al., 2009), and exposure to chemical 
stimuli of pathogenic or other origins (Tschopp and Schroder, 2010). Excess of ROS can 
generate a state known as oxidative stress and can result in significant cellular damage, 
mutagenicity and tumorgenesis (Aruoma, 1998, Forsberg et al., 2001). However ROS 
are also known to act as an intracellular signalling system involved in cellular processes 
such as inflammation, cell cycle progression and apoptosis (Wang et al., 2010), so the 
balance and control of ROS production is critical for correct cellular function. 
Endogenous ROS are produced through multiple mechanisms including mitochondrial 
leakage and in particular within neutrophils via the NADPH- oxidase pathway 
(Holmstrom and Finkel, 2014). Other cell types such as epithelial cells produce ROS at a 
much lower concentration to modulate certain inflammatory processes such as 
regulation of NFκB (Chapple, 1996, Chapple, 1997). ROS can also be generated from 
exogenous sources. In the context of oral epithelium exposures to tobacco smoke, 
drugs or pollutants are relevant. 
Neutrophils constitute the majority of circulating white blood cells (WBCs). Neutrophils 
are often known as the “first responders” to sites of infection or tissue damage, and 
can be recruited by host- derived components such as chemokines or by bacterial 
products (Kobayashi et al., 2005). Neutrophils are recruited to the site of infection or 
injury by the generation of a chemoattractant gradient, where the highest 
concentration of a chemoattractant (e.g. a cytokine such as IL8) released by cells is in 
the vicinity of the injury. Chemoattractants attract neutrophils from the circulating 
blood to move to the site of injury via diffusion through tissues and cellular movement 
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known as chemotaxis (Bagorda and Parent, 2008). Once at a site of infection, 
neutrophils may phagocytose, kill and digest bacteria and fungi (Nauseef, 2007). 
Neutrophils are capable of producing an oxidative burst of ROS via the NADPH- oxides 
which is important in phagocytosis and pathogen killing. Released ROS are damaging to 
pathogenic organisms, but can also cause bystander damage to the host tissues and 
cells. The mechanisms of damage by ROS include peroxidation of lipids, oxidation of 
proteins, damage to nucleic acids and activation of cell death pathways (Bergamini et 
al., 2004). ROS damage to host structures has been demonstrated in the context of 
acute lung injury, inflammatory conditions such as rheumatoid arthritis, and possibly 
more pertinently in periodontal disease (Battino et al., 1999, Moraes et al., 2006, 
Matthews et al., 2007, Wright et al., 2010, Grommes and Soehnlein, 2011). Therefore, 
ROS turnover and activation is a process which must be closely regulated in order to 
maintain protection from pathogenic organisms whilst limiting excess ROS damage to 
host tissues. It is therefore important to assess whether ROS production is altered or 
stimulated in response to signalling molecules which may be produced by H400 cells, a 
process which could be perturbed by the presence of TiO2. 
7.3.1 ROS generation by neutrophils in response to stimulation by H400 
supernatants - method 
Due to the close relationship both mechanistically and anatomically between the oral 
epithelium and neutrophil function in the context of periodontal and peri-implant 
disease, (Tribble and Lamont, 2010) the effects of supernatants from H400 cells 
cultured with and without TiO2 NPs and periodontal pathogens on ROS production by 
neutrophil cells were investigated. Epithelial cells may produce cytokines when 
stimulated by TiO2 NPs which could in turn cause neutrophils to produce ROS in 
response, and an interaction between TiO2 NPs and epithelial cells could therefore 
influence the response of peripheral blood neutrophils to pathogens present in the 
peri-implant environment. This hypothesis was tested using the assay methods 
described in detail in Section 2.9. 
In summary, fresh neutrophils were isolated from the venous blood of healthy 
volunteers.  Luminol and Isoluminol were used to detect intracellular and extracellular 
ROS respectively. Wells containing neutrophils, luminol/isoluminol and RPMI were 
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placed in a 96-well plate reading luminometer to create a background reading. This 
methodology was validated by using known ROS production stimulants PMA (phorbol 
12-myristate 13-acetate) and bacteria (see Section 2.9.5 for bacterial stimulus 
preparation).  
 
Figure 7.10 – Plot showing verification of use of Luminol and assay described in Section 2.9 to 
detect oxidative burst (n=3, line shown is mean data). FN stimulates to a lesser degree when 
compared with opsonised S. aureus and PMA due to the different receptor pathways by which 
ROS production is activated (S. aureus via FcYR and FN via TLRs 2 and 4). However, given that 
the amount of ROS generation in response to supernatants in the next experiment is likely to 
be low, FN was used as a positive control. 
For preparation of supernatant samples used to stimulate neutrophils, H400 cells were 
cultured as detailed in Section 2.2.2. TiO2 NPs were added to the culture medium at 
the concentrations and times indicated: 
 H400 in cell culture medium (SN control) 
 H400 cells in cell culture medium (SN 1000ppm 4h) 
 H400 cells in cell culture medium (SN 10ppm 4h) 
 Cell free cell culture medium (Media) 
 Cell free PBS (negative control) (PBS) 
 FN (MOI 150) (positive control) (FN) 
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7.3.2 ROS generation by neutrophils in response to stimulation by H400 
supernatants – results and conclusions 
 
Figure 7.11 – ROS curve showing RLU generated by addition of supernatants as listed to wells 
containing neutrophils and luminol over time. Shows an unexpected rise in light production 
over time for some supernatants alongside the expected rise following addition of FN (n=1, 
typical pattern shown compared with repeated experiments).  
No significant ROS production was observed in response to stimulation of neutrophils 
with supernatants from H400 culture. However, an increase in light output after 
approximately 100 min is indicative of interaction between the contents of cell culture 
medium and assay components. This may be due to the presence of proteins within 
the cell culture medium. To study the potential interactions between the ROS assay 
and cell culture media, cell free wells containing luminol in a range of cell culture 
media to which 0.5% H2O2 was added to produce a simulation ROS burst were 
subjected to the same assay as before. 
 215 
 
 
 
Figure 7.12 – Cell free simulated ROS burst generated by H2O2 addition to wells containing 
luminol and media as listed, TiO2 was suspended in water. Suggests interaction of ROS 
occurring in media containing foetal calf serum (FCS) (n=3, mean data shown). 
Wells containing no protein (absence of FCS) showed the expected pattern of a peak in 
light output following peroxide addition then a reduction to baseline levels as the H2O2 
was exhausted. Wells containing FCS showed both a reduced ROS peak and then a 
constant signal which indicates quenching of luminol by the presence of protein, an 
interaction which has previously been described (Lundqvist et al., 1995). Protein free 
medium was therefore used as in the previously described method. 
7.3.3  H400 growth in RPMI (Roswell Park Memorial Institute) medium  
RPMI is a composition of medium traditionally used for certain types of cell culture 
(ion particular cells from lymphoid tissue). RPMI was piloted as a possible FCS free 
growth medium for H400 cells in order to obtain supernatants containing released 
cytokines, but no FCS to affect the ROS assay.  
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Figure 7.13 – A typical optical micrograph illustrating the growth of H400 cells at 24 h (left) and 
48 h (right) post seeding at 2 x 105 cells in standard H400 cell culture medium. Images show 
the typical growth as observed and detailed in Chapter 3. 
  
Figure 7.14 – A typical optical micrograph illustrating the growth of H400 cells at 24 h (left) and 
48 h (right) post seeding at 2 x 105 cells in RPMI medium. Images show altered morphology, 
reduced adherence, potential loss of viability and limited growth. 
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Figure 7.15 – A typical optical micrograph illustrating the growth of H400 cells at 24 h (left) and 
48 h (right) post seeding at 2 x 105 cells initially in standard H400 cell culture medium, then 
exchanging medium post 24 h to RPMI, therefore 24 h post seeding image in immediately post 
medium exchange and 48 h post seeding image is 24 h post medium change to RPMI. Appears 
to show normal morphology and growth in cells. 
Due to the visible growth inhibition and morphological changes seen in Figure 7.14 
when culturing H400 cells without FCS supplementation, cells were cultured in DMEM 
medium supplemented with FCS according to previously described methods until sub 
confluent. This was then exchanged for RPMI containing the appropriate stimulus. The 
medium change may have caused an alteration in cellular responses, however cell 
growth and morphology remained normal as examined by light microscopy within the 
time frame stated.  
7.3.4 ROS assay using supernatants from H400 cell culture as priming agents 
to freshly isolated neutrophils  
Due to issues with interference in the assay from the addition of cell culture medium 
containing FCS, the following supernatants were prepared by aseptically aspirating cell 
culture medium from a 25 cm2 flask and centrifuged at 15000 rpm for 5 min (Geneflow 
SciSPin Micro) to largely remove TiO2 NPs. 10 µL of the centrifuged supernatant was 
then added to each well after a background reading was established (see Section 2.9 
for full method for ROS generation assay). No stimulation of neutrophils was seen 
when using supernatants as stimulants (data not shown). The same supernatants were 
then used as priming agents (added 20 µL to wells for 20 min prior to stimulation with 
opsonised Sa (ops Sa)).  
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 Cells and medium - H400 in RPMI (SN control) 
 As control plus 1000 ppm TiO2 for 4 h (SN 1000ppm 4h) 
  As control plus 10 ppm TiO2 for 4 h (SN 10ppm 4h) 
 Cell free RPMI(Media) 
 Cell free PBS (negative control) (PBS) 
 As control plus FN (MOI 150) (positive control) (FN). 
 
7.3.5 ROS assay using supernatants from H400 cell culture as priming agents to 
freshly isolated neutrophils – results 
 
Figure 7.16 - Box and whisker plot (n=5) to show relative oxidative burst responses of 
neutrophils stimulated with ops Sa when primed with RPMI based supernatant from H400 cells 
normalised to PBS. No evidence of any priming effects of H400 supernatant on neutrophils 
compared with controls. Data are normalised to PBS 
 
7.3.6 ROS assay using supernatants from H400 cell culture as priming agents 
to freshly isolated neutrophils – conclusions 
The data presented in Figure 7.16 show that there is unlikely to be significant cytokine 
release from H400 cells when stimulated by TiO2 NPs at concentrations up to 1000ppm 
to either subsequently influence neutrophil function. Therefore, it is unlikely that 
stimulation of H400 cells by TiO2 NPs alone will cause significant effects on neutrophil 
function via the mechanism of stimulation of a ROS response either by stimulation of 
ROS production or priming of neutrophils. 
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7.3.7  Effect of TiO2 NPs on the priming action of IFNɣ  
An interaction between TiO2 NPs and IFNɣ was observed in an ELISA assay.  IFNɣ is a 
known primer of neutrophils for enhanced activity upon secondary activation (Ellis and 
Beaman, 2004). Therefore, if the activity of IFNɣ is inhibited in part by the presence of 
TiO2 NPs to which it becomes bound, this may inhibit the enhancement of a neutrophil 
response within tissues. To assess if there is a functional impairment of IFNɣ by binding 
to TiO2, further ROS assays were performed (see Section 2.9). PBNs were primed with 
either: 
 TiO2 NPs alone (50 ppm) 
 IFNɣ alone (110 units)  
 Both TiO2 and IFNɣ 
 No primer 
and were then stimulated with PMA or PBS (control) and oxidative burst measured.  
 
Figure 7.17 – ROS generation of neutrophils primed with 110 units of IFNɣ +/- TiO2 NPs 
(50ppm) then stimulated with PMA compared with control cells (no primer or stimulation) and 
cells primed with PBS then stimulated with PMA. Shows a reduction in the ROS peak when 
TiNPs are added to IFNɣ, therefore showing a functional assay where a known priming 
cytokine is being affected by the presence of TiO2 NPs in the system. n=1 shown here but 
representative data.  
Figure 7.17 shows that the priming action of IFNɣ is reduced upon the addition of TiO2 
NPs to levels below that of either TiO2 or IFNɣ alone. However, TiO2 NPs alone show 
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some priming ability. This confirms the potential in an in vivo situation for the potential 
alteration of priming of neutrophils within tissues if Ti species are present and come 
into contact with certain chemokines.  
7.4  Chapter conclusions 
The results reported in this chapter show that TiO2 NPs can preferentially bind IL8 and 
to a lesser extent IFNɣ when compared with other cytokines. It can be concluded that 
the mechanism of binding between TiO2 NPs and IL8 or IFNɣ has some specificity. If IL8 
is rendered inactive by binding to TiO2 NPs then this could also have important 
implications for the recruitment of neutrophils at a site infection or injury. If structural 
cells are generating IL8 as a pro-inflammatory cytokine into tissues but this is 
inactivated by the presence of TiO2 NPs, the inflammatory response may be 
compromised. IL8 also induces processes important in host defences such as 
phagocytosis, therefore this process could also be adversely affected by the presence 
of TiO2 NPs within tissues. The impairment of IL8 as a chemoattractant by the addition 
of TiO2 NPs is not a phenomenon widely discussed in the literature. TiO2 NPs have 
been shown to cause increased inflammation resulting in increased chemotactic 
responses (Renwick et al., 2004) and also to impair the chemotactic and phagocytic 
ability of alveolar macrophages (Liu et al., 2010). While this study has concentrated on 
the interaction between TiO2 NPs and IL8 due to the extent of the knockdown in 
detection of IL8 in the presence of TiO2, it is important to note that IFNɣ also appears 
to selectively bind to TiO2 NPs to a lesser extent. The functions of IFNɣ could also 
therefore be affected by the presence of TiO2 NPs within tissues, further hampering 
host immune responses. It has been demonstrated that IFNɣ is less efficient at priming 
PBN cells when in the presence of TiO2 NPs and is further evidence of a potential 
immunomodulatory role in an extra-cellular context.  
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Chapter 8 
Discussion, conclusions and further work 
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Introduction 
8.1  Discussion 
8.1.1  Epithelial function and structure 
The primary function of epithelium is to provide a structural barrier to prevent injury 
to the underlying tissues from a variety of sources, including physical, chemical, and 
biological damage. The structure of epithelium is ideally suited to these roles as it 
consists of adherent (Wertz and Squier, 1991) cells with tight cell-cell junctions, 
therefore inhibiting intracellular ingress of pathogens or other noxious stimuli (Wertz 
and Squier, 1991). Furthermore, epithelium is stratified and layers are able to be shed 
constantly, allowing healing of, and mechanical protection for, underlying structures, 
(Nanci, 2013). Epithelial tissues vary in their complexity and structural functions 
throughout the body, dependent on their specific site; for instance, alveolar epithelial 
lining secretes mucous to the apical areas of constituent cells in order to entrap 
pathogens or irritants, while the epithelia which line the small intestine secrete 
digestive enzymes (Rieux et al., 2005).  
The oral epithelium is specialised to provide multi- layered protection to associated 
tissues such as connective tissues, muscle and alveolar bone. Mechanically, the 
stratified squamous structure seen in masticatory epithelium is protective against  the 
forces and potential injury generated during mastication (Squier and Kremer, 2001b). 
This epithelium is keratinised in areas of high masticatory load such as the dorsum of 
the tongue, hard palate and the attached gingivae (Nanci, 2013). Areas of the mouth 
which are required to be elastic in order to accommodate speech and mastication such 
as the unattached gingivae are non–keratinised (Wertz and Squier, 1991). The 
stratification of epithelium is more complex than simply comprising layers of identical 
cells, and exhibits distinct layers of cells with variations of differentiation between the 
surface layers and basal membrane (Squier and Kremer, 2001b, Nanci, 2013). In 
addition to mechanical and chemical protection due to its structure, the oral 
epithelium exhibits a diverse array of functions when exposed to bacterial challenge 
producing chemokines and cytokines relevant to initiating and promoting an 
inflammatory response  (Philpott et al., 2001, Milward et al., 2007). In the peri-implant 
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situation, there are differences between the periodontal tissues and peri-implant 
tissues, which include: 
 the absence of the complex sub-epithelial architecture adjacent to implanted 
devices than is seen in the periodontal tissues (Palmer, 1999, Lang et al., 
2011);  
 no periodontal ligament (PDL) is present adjacent to implanted devices, and 
osseointegration means, by definition, there should be direct contact 
between the implant surface and osseous cells (Palmer, 1999, Carlsson et al., 
1986); 
 Gingival fibres do not insert into the implanted Ti device as they would into 
the cementum of a periodontally healthy tooth, as in a peri-implant situation 
ligament fibres are predominantly circular, affording less resistance to pocket 
probing (Lang et al., 2011). 
It has been argued that there is limited evidence to support the theory that structural 
differences in the tissues surrounding implants and teeth affects disease initiation and 
progression (Lang et al., 2011). However the same authors also report that the 
“detailed molecular aspects of the (implant) adhesion of the connective tissue are not 
known”(Lang et al., 2011). Given the complex disease processes which continue to be 
characterised in the periodontium, the statement that structural differences do not 
affect the host response in peri-implant tissues seems likely to be an 
oversimplification. Authors have reported a variety of findings when discussing the 
keratinisation of peri-implant tissues; however the literature has also identified 
considerable variation in the width and amount of keratinised epithelium present 
adjacent to implants (Chung et al., 2006).  
8.1.2  Implant derivatives within oral epithelial cells and associated tissues 
Derivatives of Ti implants, in multiple Ti speciations, have been identified within tissues 
adjacent to implanted devices which have been identified as insoluble particles in a 
variety of size, composition and cellular associations. Addison et al., described the 
scattering of Ti based species from the nano-scale up to micron scale located within 
epithelium excised from inflamed transmucosal Ti devices (Addison et al., 2012). Ti and 
Fe species were also identified using synchrotron X-ray spectroscopy in hard and soft 
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tissue samples taken from patients exhibiting clinical features of peri-implantitis 
(Fretwurst et al., 2016). Olmedo et al., described metallic particle distribution from 
cytology samples surrounding implants to be increased (2.44 ppb in sample sediment) 
with clinical signs of peri-implantitis when compared with clinically healthy Ti implants 
(0.88 ppb in sample sediment) and controls with no implants (0 ppb) (Olmedo et al., 
2012). These pieces of evidence suggest that inflamed or infected mucosa surrounding 
Ti implants is more likely to contain higher amounts of Ti debris than do healthy 
tissues; is this a causative issue or reactive? It has been established that the corrosion 
behaviour of Ti is adversely affected by lower pH (Duffo et al., 1999), so there may be a 
cyclic effect of acidification and particle release. 
The effect within oral peri-implant tissues of the presence of metallic species is an area 
in which there is a lack of published data. Much of the current literature involving the 
interactions between epithelium and small scale metal or metal-oxide particles is 
related to respiratory epithelium. A synopsis of this literature can be found in Chapter 
1, but below are some key findings pertinent to TiO2 NPs and interactions observed 
with human epithelial cells. 
 TiO2 NPs have been shown to be internalized by human alveolar epithelial 
cells, but in contrast to other metal oxide NPs such as copper oxides, they did 
not induce cell death (Moschini et al., 2013). These findings are entirely 
consistent with the results described within this thesis and are probably due 
to the chemical stability of TiO2 compared with other metal oxides such as 
CuO (see Section 5.1). 
 TiO2 NPs were reported to produce a dose and time dependent decrease in 
cell viability in a lung cancer cell line (Lee et al., 2009). Other studies have also 
reported dose dependent cytotoxic effects of TiO2 NPs on human alveolar 
epithelial cell lines involving both necrotic and apoptotic pathways (Kim et al., 
2010) and at relatively low concentrations (30 ppm) have shown an increase 
in ROS production by alveolar cells at 4 h (Limbach et al., 2007). ROS were also 
found to be elevated by Singh et al., (Singh et al., 2007), in common with 
previously mentioned publications; however this paper also reports the use of 
ELISA detection of IL8 release post TiO2 exposure in alveolar epithelium, a 
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finding which may not be valid in light of issues identified with the binding 
between IL8 and TiO2 discussed within this thesis (see Section 7.2).  
 Srivistava et al., have also highlighted the potential for TiO2 NPs to be 
genotoxic in human lung cancer cell lines as well as apoptotic (Srivastava et 
al., 2013). However apoptotic states were not noted as being increased within 
H400 cell populations exposed to a variety of concentrations of TiO2 NPs 
compared with controls when examined using HCS (Section 5.2.5). 
It can therefore be surmised that many previous authors have found TiO2 NPs to have 
significant cytotoxic potential to certain epithelial cells. The literature in the context of 
oral epithelial cells specifically is limited, however it seems unlikely from both the 
findings within this thesis and the clinical picture of epithelium surrounding implanted 
Ti devices that Ti implant derivatives will themselves significantly influence oral 
epithelial cell viability. However, it is more plausible that implant derived species 
within tissues surrounding implants may influence cell-cell signalling and the complex 
pathways which are known to take place during inflammation in response to bacterial 
challenge or mechanical injury. 
The inflammatory exudate immediately adjacent to inflamed peri-implant tissues has 
been demonstrated to contain a range of inflammatory cytokines including IL8 and 
IFN-  (Grant et al., 2010b). Therefore, the interactions between Ti implant derivatives 
and inflammatory mediators may be potentially clinically relevant within these tissues. 
IL8 and IFN-ɣ have been shown within this work to interact withTiO2 NPs however only 
a narrow range of cytokines were explored. Due to the complex nature of cell to cell 
signalling and the wide variety of cytokines and chemokines produced in vivo both by 
and in response to epithelial cells, there is potential for wide ranging interactions with 
metal derived species located within tissues. Furthermore, the movement of implant 
derived particles once within tissues may take a variety of paths. Intracellularisation of 
TiO2 NPs by oral epithelial cells has been shown within this thesis. What the fate of 
these intracellular particles is following cellular replication and eventual epithelial 
shedding is an area where further research is warranted. It could be that particles 
persist in daughter cells, and localised accumulation of metallic particles is an ongoing 
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process, or it may be that these particles are shed within cells once they are exfoliated 
from the epithelial surface. 
Due to the process of liberation of Ti debris from implant surfaces being a likely 
consequence of MACC, physiochemical corrosion, and cellular-gated corrosion 
mechanisms (Cadosch et al., 2009a) it can be assumed that the entry of these products 
into tissues will be a continuous process, potentially leading to accumulation of 
metallic particles within the epithelium. Figures 1.3 and 1.4 in Section 1.4.3 
demonstrate a sub-epithelial accumulation of Ti debris within tissue samples and 
relative accumulation may be considered due to epithelial shedding. Whether these 
particles would remain fixed in location within tissues or be transported, passively or 
actively, by different cell types, is an area where further enquiry is needed, as each 
outcome has implications for the longer term effects of the presence of these species 
within tissues.  
8.1.3  Effects of TiO2 NPs on the viability of oral epithelial cells 
Conventional assays which measure ATPase activity, LDH levels and Caspse 3/7 activity 
as markers of epithelial cell viability all showed minimal changes in the presence of 
TiO2 NPs of up to 1000 ppm. However, contrasting evidence from HCS methods 
suggested some reduced viability in both long term cultures (>24 h) and at increasing 
exposure concentrations.  
It is difficult to clearly define the effects of TiO2 NPs on the viability of oral epithelial 
cells given the differences in results presented in this work. Previously published 
literature suggests there is the potential for viability to be compromised in certain cell 
lines at higher NP exposure concentrations (Section 5.1). However, limited evidence 
for this was found here, with the exception of HCS results. Sytox green staining showed 
an increase in the number of non-viable cells and these non-viable cells appeared to be 
located adjacent to NP agglomeration; however, data quantification using the methods 
described in Section 5.1.5 is difficult, and using a well format to measure total light 
output with this assay as opposed to imaging individual cells may well lead to a loss of 
discrimination of the signal. HCS techniques overcome this problem by imaging a large 
number of cells and computationally generating an average from this complex 2D 
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image rather than arriving at an average at the point of detection. The use of HCS 
techniques as opposed to more simple conventional techniques when investigating the 
problem of a heterogeneous response to non-uniform exposures is discussed further in 
Section 8.1.5. 
From a clinical perspective, the results showing that viability of oral epithelial cells is 
relatively unaffected by clinically relevant concentrations of TiO2 NPs, is entirely 
consistent with the clinical presentation of the peri-implant tissues. Epithelium does 
not appear to slough away from implant sites with even advanced peri-implantitis 
lesions. Peri-implant mucositis, where inflammation is clearly present within the 
epithelial tissues surrounding an implant, is not consistently associated with deeper 
levels of tissue destruction affecting underlying bone (Lindhe and Meyle, 2008). A 
more complex picture of disease initiation and progression rather than simply 
disruption of the viability of epithelial cells in response to implant metal debris within 
tissues is much more plausible.  
8.1.4  Intracellularisation of TiO2 NPs by epithelial cells 
Imaging the interactions between TiO2 NPs and oral epithelial cells is challenging for a 
number of reasons. The size of the TiO2 NPs used in the majority of experiments in this 
thesis was nominally <25 nm diameter, although agglomeration of NPs always occurs 
when in cell culture medium. This means that simple light microscopy even at 
relatively high magnifications can only be used to detect larger agglomerations of TiO2 
NPs. 
Both TEM and confocal reflectance microscopy showed that there were intracellular 
agglomerations of NPs within both H400 and primary oral epithelial cells. However, 
extrapolating the number of cells in a population which appeared to have intracellular 
TiO2 NPs becomes difficult to determine from methods with such narrow fields of 
views. An estimation of the proportion of cells with clearly visible agglomerations was 
approximately 1/3 of an exposed H400 cell population. Currently the literature on the 
intracellularisation of NPs in epithelial cells is not extensive. Polystyrene NPs have 
been shown to accumulate in HeLa cells (Smith et al., 2012), however in their paper 
the signal of fluorescence from NPs was taken as the measure of intracellular NPs so 
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the proportion of the cell population containing NPs was not quantified. The fact that 
oral epithelial cells will uptake NPs is discussed in a paper by Chan et al., (Chan et al., 
2011), and TEM imaging was used to demonstrate this process, however the 
proportion of cells which showed intracellular NPs was again not clarified. Here, the 
use of SR-XRF mapping allowed further discrimination of the number of cells 
interacting with TiO2 NPs. This technique provides significantly higher discriminatory 
ability than optical microscopy and revealed that the proportion of cells interacting 
was much higher at approximately 2/3 of a H400 cell population. This finding is 
important insofar that the results of biological assays should be interpreted with the 
knowledge that one third of the exposed population interacted with large 
agglomerations, one third with small agglomerations or individual NPs and the 
remaining third appears to be unstimulated. This informs the approach to future 
studies as it shows that not all cells are either exposed to or likely to be responding 
equally to the NPs, and furthermore that the local concentration of NPs in the space 
immediately surrounding each cell may be vastly different.  
While the uptake of TiO2 NPs was imaged in H400 cells and primary epithelial cells, due 
to limitations in the number or primary cells available for processing and imaging there 
were fewer cells imaged than H400 cells (this is fully discussed in chapter 3). Other 
considerations when using primary cells would be the variation between donors, and 
the likelihood that a cell population harvested and cultured from oral tissues may not 
be purely epithelial in phenotype. For this reason, it would be experimentally 
challenging to produce robust data using only primary tissue harvested epithelial cells.  
8.1.5  Dose responses of epithelial cells to TiO2 NPs 
TiO2 is insoluble and agglomerates in cell culture mediums. Therefore, the local 
concentration in the immediate environ of each cell within a population will not be 
uniform. The non-uniform distribution of TiO2 NPs within the specific experimental 
model used in this thesis is likely to lead to a variety of responses from cells within a 
population, a feature which may lead to blurring or loss of results if a measure of the 
whole population is made (for example, the microarray techniques detailed in chapter 
6). The likelihood of gaining a more representative result is increased when using 
methods such as HCS which will reduce background noise, as cells are labelled 
 229 
 
individually as opposed to results being pooled. This was demonstrated by the 
apparent differences between epithelial cell ‘viability’ post exposure to TiO2 NPs when 
investigated using conventional vs HCS techniques, as discussed in Section 5.2.6.  
The implications of this variation in response are important both in the in vitro study of 
NP-cell interactions and the appreciation of the likely variability of cell responses to 
NPs in vivo. This work strongly suggests that HCS techniques may be more appropriate 
than conventional techniques when examining the effects of NPs within cell culture 
medium on cell responses. Also it is important to realise that in vivo, cells will be 
exposed to a wide variety of ‘local’ concentrations, so a biologically relevant 
concentration of NPs is difficult if not impossible to define (Addison et al., 2012),. 
Deciding on what constitutes a clinically relevant dose is complex and the exact 
exposure of an individual cell within the model systems used in this thesis was 
impossible to define.  
Future work would be to further qualify and characterise the pattern of NP uptake to 
include more primary cell investigations, and to investigate the effect on the pattern of 
uptake variables such as NP size, NP species and particle shape may have alongside 
concentration and duration of exposure. It was not possible to concentrate on the 
responses of a small number of cells adjacent to particles within the cell culture model 
used within this work, therefore the results gained from biological assays of whole 
populations are likely to provide both an underestimation and a combination of 
responses to different events.  
 
8.1.6 Interference of TiO2 NPs in suspension with known assays and difficulties 
of using conventional assays only 
As outlined in Chapter 3, insoluble TiO2 NPs were distributed evenly in water post- 
sonication, however on being added to cell culture medium, some agglomeration 
inevitably occurs. This leads to an uneven distribution of NP stimulus and also a change 
in optical density of the cell culture medium which may influence colourmetric or light 
emitting assays. It is therefore essential to verify assay performance prior to use. A 
variety of assays were judged to be significantly influenced by the NP stimulus, despite 
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data from equivalent assays being regularly reported in the NP literature. For example, 
the MTT assay is colourmetric, and the altered optical density spectral absorbance of 
the resulting solution is altered significantly by the addition of TiO2 NPs. Also IL8 
appeared to be bound by TiO2 NPs, negating the results of ELISA testing for this 
cytokine (see Section 7.2), and to a lesser extent IFN-ɣ. Therefore, it is imperative to 
rigorously test assays for use in conjunction with exposure stimuli prior to use. This 
issue has been only previously discussed briefly by a limited number of investigators 
(Holder et al., 2012, Kroll et al., 2009). 
8.1.7  Effects of TiO2 on inflammation involving oral epithelial cells 
Known pathways that are stimulated in epithelial cells in response to bacterial 
challenges such as the translocation of NFκB were investigated using conventional and 
HCS techniques. A small reduction in NFκB activation in response to pre-treatment 
with TiO2 NPs before exposure to relevant periodontal pathogens was found when 
using conventional staining, however this was not clear from the HCS techniques used. 
The fact that TiO2 NPs will bind to IL8 (and to a lesser extent IFNɣ, as discussed in 
chapter 7) may well affect the inflammation process in vivo. It has been shown that 
IFNɣ is less efficient at priming PMNLs when in the presence of TiO2 NPs, meaning that 
the inflammatory process may be further disrupted in by other mechanisms other than 
the binding of IL8.  
Within the clinical picture, the concept that Ti implant derived particles could act as 
islands within tissues which are capable of binding cytokines is potentially very 
interesting. If cells are responding to inflammation by producing pro-inflammatory 
cytokines, such as IL8 and these are being bound to particles within tissues then this 
may have the capacity to disorder the immune response. Furthermore, it is unknown if 
the IL8 is inactivated by being bound to TiO2 NPs, or if this process is reversible. There 
is potential for the perturbation of immune responses via this mechanism by a wide 
range of particles and involving a wide range of targets; expanded from the small panel 
looked at within this thesis, IFNɣ and IL8 both appear to interact with TiO2. The 
ramifications of this from a clinical point of view could be far reaching, potentially 
causing the inactivation of some attempts by cells to mount an inflammatory response, 
or if pro-inflammatory cytokines are still active when bound, potential to deflect 
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inflammatory responses towards islands of metallic debris within tissues. These 
hypotheses would require extensive further work to unpick exactly what is likely to be 
occurring, but they do fit with the clinical picture of peri-implantitis being more 
progressive in nature when compared with periodontitis.  
 
 
Figure 8.1 – diagrammatic representation of cell-cell signalling involving oral epithelial cells and 
related cell types during periodontal inflammation and associated bone resorption (Sahingur 
and Yeudall, 2015). The number of chemokines and cytokines involved is large and the cell-cell 
signalling mechanisms are complex, meaning the binding between TiO2 NPs and two cytokines 
found within this work could potentially be only two of many more interactions capable of 
perturbing the inflammatory response. 
The only species of TiO2 NP investigated in this context was anatase, particle size 
<25nm. There is likely to be variation in the interaction between IL8 and IFNɣ when 
cytokines are exposed to different species of metal oxides, as well as different sizes 
and shapes of particle. The number of variables possible to examine is huge, so 
characterising other biologically relevant species would be a valid starting point for 
future investigations into this phenomenon. 
8.2  Relevance of findings in the clinical context of peri-implant disease  
The viability of epithelial cells does not appear to be compromised clinically adjacent 
to implanted Ti devices. This fits with the findings in this work that the effects on cell 
viability in vitro appear to be fairly minimal in response to TiO2 NP exposure alone. 
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More pertinent to the clinical situation of peri-implant disease is the potential of Ti 
species being present within tissues to act as a modifying factor in the complex host – 
bacterial imbalance which is known to produce significant inflammation and tissue 
destruction in peri-implant disease. Current research on the presence of cytokines in 
peri-implant disease highlights Interleukin 12 (IL-12) and TNFα as being prevalent in 
severe peri-implantitis compared with health or mucositis (Duarte et al., 2009) and IL8 
and MIP1-α as significantly elevated chemokines in advanced peri-implantitis when 
compared with early peri-implantitis (Petković et al., 2010). Extensive research into 
potential biomarkers for peri-implant disease has been published (Heitz-Mayfield, 
2008), where peri-implant fluid and saliva have been tested for markers of soft tissue 
inflammation and bone resorption. Clinically, the processes occurring during advanced 
peri-implantitis will involve bone resorption and therefore osteoclastic activity, 
therefore it is expected that osteoclastic markers will be elevated in tissues 
surrounding implants which are ‘failing’ (Grant et al., 2010b). The inflammatory 
process within gingival tissues is complex with multiple cell signalling molecules 
involved in periodontal disease (King, 2008, Darveau, 2010), and any of these 
processes could potentially be altered by the presence of Ti debris in some form in the 
peri-implant situation. From the data presented in this thesis, it is therefore important 
to appreciate that Ti products within tissues have the potential to affect cell-cell 
signalling in terms of biological processes such as inflammation as demonstrated by 
the dose dependent inactivation of IL8 when exposed to TiO2 NPS, and a similar 
process may occur involving other markers of inflammation or bone resorption. 
It is not being suggested that the presence of metallic particles within tissues are 
potentially causing peri-implant diseases, but the presence of these particles may have 
the capacity to modify other risk factors for peri-implantitis. Probably the greatest risk 
factor for the development of both peri-implantitis and periodontitis is poor oral 
hygiene (Heitz-Mayfield and Lang, 2010, Feloutzis et al., 2003). Poor oral hygiene will 
ensure a persistent bacterial challenge, with increasing virulence over time as the 
composition of the biofilm changes (Hajishengallis et al., 2011, van Winkelhoff et al., 
2002). Destruction of the periodontal tissues occurs in periodontitis as a result of the 
host response to the bacterial challenge; a process which is regulated by the secretion 
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of cytokines and other cell signalling molecules. In the situation where periodontal 
pathogens or their products are present within tissues, the presence of implant 
derived species could once again form interferences in the cell-cell signalling processes 
which occur within tissues via perturbation of either the free movement of cytokines, 
or by potentially inactivating released cytokines.  
A history of, or indeed the concurrent presence of, periodontitis is a known risk factor 
for loss of osseointegration (Heitz-Mayfield, 2008). Patients who suffer with chronic 
periodontitis have been shown to exhibit neutrophil hyper-reactivity in response to IL8 
(Ling et al., 2015), therefore if implant derived species within tissues are inhibiting the 
presence or directionality of the concentration gradient of IL8 within tissues, a 
disordering of inflammation may occur. It has been shown that patients with a ‘thin’ 
mucosal biotype are at higher risk of peri-implantitis than those with a ‘thick’ biotype 
(Aguirre-Zorzano et al., 2013). Thin biotype is associated with looser connective tissue 
than the ‘thick’ biotype (Abraham et al., 2014). This has potential significance when 
considering the presence of implant derived particles within the tissues. Implant 
derived particles could potentially enter and move through tissue layers more readily 
in patients exhibiting a ‘thin’ biotype, therefore the potential for the presence and 
perhaps amount of metal species present could be higher in these patients. This thesis 
has shown specific binding capacity for IL8 to TiO2 NPs even within a serum containing 
environment, meaning within a complex protein panel TiO2 NPs appear to 
preferentially bind and deactivate IL8. The variety of metallic species which could be 
present within tissues adjacent to implanted Ti devices is large, not just in speciation 
but in size and shape, which are factors which have been shown to influence binding 
characteristics (Albanese et al., 2012).  
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8.3  Overall conclusions 
There are a number of issues surrounding the use of an insoluble NP stimulus within a 
biological system. These include: 
 TiO2 NPs have been shown to interfere with results gained from some types of 
assay, e.g. the MTT assay (see Section 3.3). This factor has limited the variety 
of assay techniques which were used within this thesis, but has also 
highlighted that previously published work may not be accurate due to the 
lack of attention paid to this phenomenon; 
 The dose of stimulus which each cell was exposed to within the model system, 
developed in Chapter 3 is impossible to quantify accurately. Agglomeration of 
TiO2 NPs within the culture system means that the localised concentration 
adjacent to some cells may be many multiples of the exposure concentration. 
This has implications for the study of NPs within biological systems on a wider 
scale;  
 High Content Screening (HCS) techniques may give a more accurate 
representation of cellular responses, due to the loss of background ‘noise’ due 
to the categorisation of each cell rather than looking at overall cellular 
product output across a population; 
 The viability of both H400 cells and primary oral epithelial cells is unaffected 
by the presence of TiO2 NPs at concentrations of up to 100ppm. This is to be 
expected when the clinical picture of an implanted device is considered, as 
epithelial destruction and sloughing is not seen adjacent to implanted Ti 
devices. 
Intracellularisation of TiO2 NPs occurs in both H400 cells and primary oral epithelial 
cells following co-culture: 
 The pattern of uptake appeared to be both time and dose dependent; 
 Intracellularisation of TiO2 NPs was not consistent across a cell population. A 
subset of the cell population appears to take up TiO2 NPs, whilst other cells 
appear to not intracellularise NPs; 
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 Intracellularisation of TiO2 NPs by oral epithelial cells is partly, but not wholly, 
due to clathrin mediated endocytosis. 
The gene expression changes expressed by H400 cells exposed to TiO2 NPs compared 
with control cells at 6h and 24 h exposure appear to be limited: 
 Data are clearly limited by a lack of knowledge of the exposure concentration 
and inconsistency in the nature of exposures to individual cells within a 
population; 
 Primary oral epithelial cells express ID genes differently to H400 cells. 
Therefore, the gene expression findings for H400 cells may not be 
representative of the behaviours of primary oral epithelial cells; 
 When oral epithelial cells are exposed to a bacterial challenges, the addition 
of TiO2 NPs appear to potentially modify gene expression changes.  
TiO2 NP species on the nanoscale have the potential to bind to biomolecules: 
 IL8 and IFNɣ have both been shown be depleted in the presence of TiO2 NPs; 
 IL8 has been shown to selectively bind to TiO2 NPs even in the presence of a 
complex protein environment; 
 IL8 as a chemoattractant is inhibited in a dose dependent manner by the 
addition of TiO2 NPs. 
These points are of potential clinical relevance. 
The null hypothesis that “Ti species similar to those released from implanted Ti devices 
do not elicit significant biological responses from oral epithelial cells” has been 
disproved.
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8.4  Future work 
This thesis has been a wide ranging, diverse piece of work which has looked at 
numerous techniques, and has provided the starting point for many potential avenues 
of research. 
There are a number of areas presented within this thesis where repetitions and 
modifications of experiments would be of benefit. Initially, a repeat of the microarray 
at different time-points and a repeat with exposure to known periodontal pathogens in 
the presence and absence of TiO2 NPs would help to elucidate the potential 
modification of epithelial cellular responses in this context.  
Also the HCS data gathered was limited due to practicalities of transporting viable cell 
cultures at different time points to an external assay provider. However, the results 
were interesting and investigation of co-culture models involving pathogens and TiO2 
NPs across a panel of other inflammatory markers would be valuable. 
A further area which would be highly informative would be to investigate the 
mechanism in more detail of the binding shown between IL8 and TiO2 NPs. A number 
of questions are still unknown with regard to this interaction: 
 Is the binding exhibited reversible? If so, under which conditions? 
 Is the binding capacity affected by NP shape and size, and to what extent? 
 Does IL8 remain active when bound, or are certain receptor sites blocked? 
 Does any inactivation continue once released if binding is reversible?  
Investigation (both by ELISA and functional assays) of a wider panel of cytokines 
involved in the immune response would give more information on potential 
interactions between cytokines and metallic particles. Furthermore, the TiO2 NPs 
stimulus was limited to anatase particles of a specific shape and size throughout this 
work; it is important to appreciate that a variety of species have been identified within 
tissues adjacent to implanted Ti devices, so widening the panel of stimuli will enable 
investigation of other potential interactions. 
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